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A chiral vinyl sulfoxide has been developed that undergoes highly 
diastereoselective Diels−Alder cycloadditions with various substituted furans in excellent 
yield. The cycloadducts can be stereoselectively transformed into tetrasubstituted 
tetrahydrofurans via ring-opening metathesis/cross-metathesis or oxidative cleavage and 
refunctionalization.   
A partial synthesis of the bioactive diketopiperazine containing natural product 
gliocladin C was achieved in nine steps, and 13.4% overall yield.  The synthesis featured 
several novel transformations including the construction of the core structure by an 
elimination and nucleophilic addition sequence, followed by a Lewis acid promoted 
coupling with indole giving the key quaternary oxindole intermediate.  A new protocol 
for intramolecular reductive coupling of the oxoindole and bis-unsaturated 





Table of Contents 
List of Tables ......................................................................................................... xi 
List of Figures ....................................................................................................... xii 
List of Illustrations ............................................................................................... xiv 
Chapter 1:  Enantioselective Synthesis of 2,2,5-Tri- and 2,2,5,5-Tetrasubstituted 
Tetrahydrofurans ..........................................................................................1 
1.1. 2,2,5-TRI AND 2,2,5,5-TETRASUBSTITUTED TETRAHYDROFURAN 
CONTAINING NATURAL PRODUCTS ......................................................1 
1.1. EXISTING ROUTES TO ACCESS HIGHLY SUBSTITUTED TETRAHYDROFURANS
................................................................................................................2 
1.1.1. Acid, base, or metal promoted cyclization of ene-ols ..............2 
1.1.2. Oxidative cyclization of 1,5-dienes ...........................................6 
1.1.3. Reductive cyclization of acetylenic aldehydes .........................9 
1.1.4. Synthesis of substituted tetrahydrofurans via cycloaddition .9 
1.2. THE MARTIN GROUP APPROACH TO THE ENANTIOSELECTIVE SYNTHESIS 
OF 2,2,5-TRI- AND 2,2,5,5-TETRASUBSTITUTED TETRAHYDROFURANS14 
1.2.1. Martin group strategy to access 2,2,5-tri- and 2,2,5,5-
tetrasubstiuted tetrahydrofurans and key challenges ...........14 
1.2.2:  Overview of existing methodology for the enantioselective 
Diels-Alder cycloaddition with furans ....................................16 
1.2.3: Overview of existing methodology for the enantioselective Diels-
Alder cycloaddition with chiral sulfones or chiral sulfoxide 
activating groups. ......................................................................21 
1.2.4. Proposed selectivity model for chiral vinyl sulfoxides ..........25 
1.2.5. Background information related to the development of a chiral 
Lewis acid catalyzed cycloaddition with α,β-unsaturated 
sulfones. ......................................................................................29 
1.4. DEVELOPMENT OF THE ENANTIOSELECTIVE SYNTHESIS OF 2,2,5-TRI- AND 
2,2,5,5 TETRASUBSTITUTED TETRAHYDROFURANS VIA [4 + 2] 
CYCLOADDITION AND RING-OPENING CROSS-METATHESIS ...............34 
1.4.1. Development of the enantioselective Diels-Alder reaction ...34 
1.4.1.1. Exploration of enantioselective cycloaddition with chiral 
Lewis acids.........................................................................34 
 viii 
1.4.1.2. Exploration of diastereoselective cycloaddition with chiral 
vinyl sulfoxide 1.82 ...........................................................45 
1.4.1.2. Diastereoselective cycloaddition with chiral bis-sulfoxide 
1.79.....................................................................................51 
1.4.1.3. Improvement and optimization of the cycloaddition ...57 
1.4.2. Development of the Ring-Opening Cross Metathesis (ROCM)
.....................................................................................................79 
1.4.3. Development of the oxidative ring-opening .........................109 
1.5. CLEAVAGE OF THE SULFONE AUXILIARY ............................................115 
1.5. SUMMARY AND CONCLUSIONS .............................................................119 
Chapter 2:  Synthesis of diketopiperazine containing natural products ......121 
2.1. INTRODUCTION TO DIKETOPIPERAZINE CONTAINING ALKALOIDS ....121 
2.1.1. Hexahydropyrroloindoline diketopiperazine alkaloids biological 
activity and structure ..............................................................121 
2.1.2. Previous synthetic studies toward hexahydropyrroloindoline 
diketopiperazine natural products ........................................125 
2.1.2.1. Overman’s first total synthesis of gliocladin C ..........125 
2.1.2.2. Overman’s second generation approach to gliocladin C127 
2.1.2.3. Movassaghi’s total synthesis of gliocladin C .............130 
2.1.2.4. Chaeotocin A .......................................................................133 
2.1.2.5. Gliocladine C .......................................................................135 
2.1.3. Dihydrooxepine epidithiodiketopiperazine natural products 
structure and biological activity. ...........................................138 
2.1.4. Synthetic methods to access substituted 4,5-dihydrooxepins140 
2.1.4.1. Stepwise ring construction using nucleophilic ring-closure 
and elimination ...............................................................140 
2.1.4.2. Epoxidation of cyclobutenes and ring expansion to oxepins
..........................................................................................142 
2.1.4.3. Constructions of oxepins by Cope rearrangement of divinyl 
epoxides ...........................................................................143 
2.1.4.4. Oxepin synthesis via the retro-homo Diels-Alder reaction 
of epoxides .......................................................................145 
 ix 
2.2. PROPOSED ROUTES TOWARD DIKETOPIPERAZINE CONTAINING NATURAL 
PRODUCTS AND PRECEDENT ..............................................................147 
2.2.1. Retrosynthesis of hexahydropyrroloindoline diketopiperazine 
alkaloids ...................................................................................147 
2.2.2. Precedent for the synthesis of hexahydropyrroloindoline 
alkaloids ...................................................................................149 
2.2.2.1. Ionization and nucleophilic capture of 3-
hyrdoxyoxoindoles ..........................................................149 
2.2.2.2. Nucleophilic attack using didehydro diketopiperazines152 
2.2.2.3. Intramolecular reductive ring closure .......................153 
2.2.2.4. Oxidation of the internal enamide double bond ........155 
2.2.2.5. Installation of the disulfide .........................................159 
2.2.3. Proposed route to substituted oxepins by sequential pyrone 
cycloaddition and retro-homo Diels-Alder cycloaddition ...161 
2.2.3.1. Proposed model study..................................................161 
2.2.3.2. Precedent for model system ........................................162 
2.2.4. Route to MCP1001 core structure by Cope rearrangement of 
divinyl epoxide .........................................................................164 
2.2.4.1. Proposed route to MCP1001 core structure 2.176 .....164 
2.2.4.2. Precedent for the conversion of 2.178 to divinyl epoxide 
2.177.................................................................................165 
2.3. MARTIN GROUP SYNTHETIC EFFORTS TO DIKETOPIPERAZINE CONTAINING 
ALKALOIDS.........................................................................................168 
2.3.1. Synthetic efforts toward the synthesis of 
hexahydropyrroloindoline alkaloids .....................................168 
2.3.1.1. Exploration of the cation capture using diketopiperazine 
2.106 as a nucleophile .....................................................168 




 generation synthesis of 2.209 by base induced 
nucleophilic attack ..........................................................176 
2.3.1.4. Development of the reductive ring-closure of 2.209 ..186 
2.3.1.5. Oxidation of diene 2.222 .............................................195 
 x 
2.3.2. RESULTS AND DISCUSSION: MPC1001 CORE STRUCTURE VIA RETRO 
HOMO-DIELS-ALDER CYCLOADDITION OR BY COPE REARRANGEMENT 
OF DIVINYL EPOXIDES ........................................................................208 
2.3.2.1. Sequential pyrone cycloaddition and retro-homo Diels-Alder 
cycloaddition ............................................................................208 
2.3.2.2. Cope rearrangement of divinyl epoxides ..........................223 
2.3.2.3. Summary and Conclusions ................................................225 
Chapter 3: Experimental Section .....................................................................227 
References ...........................................................................................................292 
 xi 
List of Tables 
Table 1.1: Optimization of the trimethylaluminum promoted Diels-Alder reaction38 
Table 1.2: Application of the trimethylaluminum conditions to 1.126, 1.132, and 
1.133..................................................................................................40 
Table 1.3: Screening of variables to find optimal reaction conditions .................48 
Table 1.4: Screening of dienophile 1.79 with dimethyl furan under various conditions
...........................................................................................................55 
Table 1.5: Trend in yield among the aryl vinyl sulfoxides ...................................68 
Table 1.6: Optimized cycloaddition conditions for all furans ..............................75 
Table 1.7: Optimized cycloaddition for all substrates using oxidative workup 
protocol .............................................................................................79 
Table 1.8: Unreactive olefin cross-partners with cycloadduct 1.200 ....................87 
Table 1.9: Summary of successful ring-opening cross metathesis examples for 1.202
.........................................................................................................107 
Table 1.10: Summary of successful ring-opening cross metathesis examples for 1.200
.........................................................................................................108 
 xii 
List of Figures 
Figure 1.1: Natural products containing the 2,5-polysubstituted tetrahydrofuran 
moiety .................................................................................................1 
Figure 1.2: Diastereoselectivity model for Kagan’s sulfoxonium salt 1.82 .........25 
Figure 1.3: Selectivity model for Aggarwal’s bis-sulfoxide 1.79 .........................26 
Figure 1.4: Selected dienophiles for chiral Lewis acid study ...............................35 
Figure 1.5: Crystal structure of major endo-cycloadduct 1.140 ...........................39 
Figure 1.6: The collection of ligands or Lewis-acids to be screened in the 
cycloaddition .....................................................................................40 
Figure 1.7: Kagan’s sulfoxonium salt 1.82 and Aggarwal’s chiral bis-sulfoxide 1.79
...........................................................................................................45 
Figure 1.8: Crystal structures of the major endo and exo cycloadducts 1.161 and 
1.162..................................................................................................49 
Figure 1.9: Crystal structure of endo cycloadduct 1.181 ......................................60 
Figure 1.10: Crystal structure of exo cycloadduct 1.194 ......................................69 
Figure 1.11: Crystal structure of endo cycloadduct 1.195 ....................................70 
Figure 1.12: Crystal structure of endo-cycloadduct 1.196 ....................................71 
Figure 1.13: Crystal Structure of the recrystallized diastereomer 1.197 ..............73 
Figure 1.14: X-ray crystal structure of oxidized cycloadduct 1.200 ....................77 
Figure 1.15: Metathesis catalysts ..........................................................................81 
Figure 1.16: Possible catalyst chelation with the sulfoxide oxygen .....................81 
Figure 1.17: X-ray structure of tetrahydrofuran 1.223 .........................................88 
Figure 1.18: Possible stabilized intermediate related to the sulfone directing effect
...........................................................................................................90 
 xiii 
Figure 1.19: Likely allyl acetate intermediate alkylidine species .........................92 
Figure 2.1: Common core structures of hexahydropyrroloindoline alkaloids ....122 
Figure 2.2: 3-indole substituted hexahydropyrroloindoline natural products.....123 
Figure 2.3: Symmetrical dimeric hexahydropyrroloindoline containing natural 
products ...........................................................................................124 
Figure 2.4: Dihydrooxepine epidithiodiketopiperazine containing natural products.
.........................................................................................................138 
Figure 2.6: Observations during the course of the condition screening .............172 
Figure 2.7: Major side product during the base-promoted nucleophilic addition174 
Figure 2.8: Isolation and structure determination of side product 2.206 ............176 
Figure 2.9: X-ray crystal structure 2.202 ............................................................184 
Figure 2.10 Structure confirmation of 2.209 with X-ray crystallography ..........186 
Figure 2.11: X-ray crystal structure of hydrogenated derivative 2.234. .............195 
Figure 2.12: X-ray crystal structures of 2.255 and 2.256 ...................................211 
Figure 2.13: X-ray crystal structure of 2.268 ......................................................214 
Figure 2.14: X-ray crystal structure of 2.279 ......................................................217 
Figure 2.15: X-ray crystal structure of 2.281. .....................................................220 
 xiv 
List of Illustrations 
Scheme 1.1: Acid, base, or metal promoted cyclization of 1,5-eneols ...................3 
Scheme 1.2: Myer’s anionic ring-closure to form tetrahydrofurans .......................4 
Scheme 1.3: Morimoto’s sequential oxacyclization in the synthesis of (+)-
omaezakianol ................................................................................5 
Scheme 1.4: Palladium catalyzed carbocyclization to give tetrahydrofurans .........5 
Scheme 1.5:  Oxidative cyclization of 1,5-dienes ...................................................6 
Scheme 1.6: Ruthenium tetroxide catalyzed oxidative cyclizations .......................7 
Scheme 1.7: Stereoselective synthesis of 21,22-di-epi-membrarollin ....................8 
Scheme 1.8: Enantioselective oxidative cyclization by phase transfer catalysis ....8 
Scheme 1.9: Highly enantioselective reductive cyclization of acetylenic aldehydes
.......................................................................................................9 
Scheme 1.10: [3+2] cycloaddition of aryl aldehydes to give substituted 
tetrahydrofurans ..........................................................................10 
Scheme 1.11: Oxidative cleavage of 3-oxidopyrilium betaine-derived cycloadducts
.....................................................................................................11 
Scheme 1.12: [5+2] Pyrone-alkene cycloaddition approach to tetrahydrofurans .12 
Scheme 1.13: Intramolecular Diels-Alder reaction followed by oxidative ring-
opening ........................................................................................13 
Scheme 1.14: Regioselective ring-opening cross metathesis strategy ..................14 
Scheme 1.15: Martin group strategy to access enantioenriched tetrahydrofurans 15 
Scheme 1.16: Early example of an enantioselective Diels-Alder reaction with a furan
.....................................................................................................17 
 xv 
Scheme 1.17: Hayashi’s HfCl4 promoted Diels-Alder with furan and chiral acrylate
.....................................................................................................18 
Scheme 1.18: Chiral Lewis acid directed enantioselective furan Diels-Alder reaction
.....................................................................................................19 
Scheme 1.19: Corey’s oxazaborolidine catalyzed Diels-Alder with furans..........20 
Scheme 1.20: The multi-step cleavage of an ester functional group ....................20 
Scheme 1.21: Ruano’s chiral sulfoxide directed dienophile .................................22 
Scheme 1.22: Carretaro’s bis-substituted chiral dienophile ..................................22 
Scheme 1.23: Highly selective norephedrine derived chiral vinyl sulfonamide 
dienophile ....................................................................................23 
Scheme 1.24: Use of Aggarwal’s bis-sulfoxide dienophile ..................................23 
Scheme 1.25: Kagan’s highly diastereoselective Diels-Alder reaction ................24 
Scheme 1.26: Possible facial approaches and products after desulfurization for 1.82
.....................................................................................................27 
Scheme 1.27: Full map of facial approaches for 1.79 and result after desulfurization
.....................................................................................................28 
Scheme 1.28: Lewis acid directed addition-hydrogen atom transfer to sulfones ..30 
Scheme 1.29: Organocatalytic asymmetric sulfur Michael additions to vinyl 
sulfonates. ...................................................................................31 
Scheme 1.30: Retrosynthesis of 1.1 using a chiral Lewis acid promoted cycloaddition
.....................................................................................................31 
Scheme 1.31: Paquette’s use of phenyl vinyl sulfone as a dienophile ..................32 
Scheme 1.32: example of a Lewis-acid catalyzed vinyl sulfonamide Diels-Alder 
reaction ........................................................................................33 
Scheme 1.33: Synthesis of phenyl vinyl sulfone (1.126) ......................................35 
 xvi 
Scheme 1.34: Synthesis of vinyl sulfonamide 1.133 ............................................36 
Scheme 1.35: Synthesis of vinyl sulfonate 1.132 ..................................................36 
Scheme 1.36: Screening for Lewis acid catalysis .................................................37 
Scheme 1.37: Preparation of valine derived chiral ligand 1.153 ..........................41 
Scheme 1.38: Failed attempts or derivatize 1.145 for HPLC studies ...................42 
Scheme 1.39: Method for derivatization of 1.145, leading to visibility by HPLC 
detectors ......................................................................................43 
Scheme 1.40: Synthesis of chiral vinyl sulfoxide 1.81, and activation by Meerwein’s 
salt ...............................................................................................46 
Scheme 1.41: Previously reported cycloaddition results in Martin lab
8
 ...............47 
Scheme 1.42: Testing of dienophile 1.82 with 2-methylfuran ..............................51 
Scheme 1.43: Testing of dienophile 1.82 with 2-furaldehyde ..............................51 
Scheme 1.44: Synthesis of Aggarwal’s bis-sulfoxide 1.79 ...................................52 
Scheme 1.45: Preparation of phenyl vinyl sulfoxide for catalyst screening .........58 
Scheme 1.46: Failed Lewis acid screening for phenyl vinyl sulfone Diels-Alder 58 
Scheme 1.47: First successful Lewis acid catalysis with BF3•OEt2 ......................59 
Scheme 1.48: Successful promotion of the cyclization using TMSOTf ...............59 
Scheme 1.49: Control experiment for triflic acid catalysis ...................................60 
Scheme 1.50: Attempt to active phenyl sulfoxide 1.178 with acetic anhydride ...61 
Scheme 1.51: Attempt to activate phenyl sulfoxide 1.178 with trifluoroacetic 
anhydride.....................................................................................61 
Scheme 1.52: Furan equivalence screening ..........................................................62 
Scheme 1.53: Additives screening, and further optimization ...............................63 
Scheme 1.54: Diastereomeric resolution of dienophile (±)-1.178 ........................65 
Scheme 1.55: Synthesis of racemic vinyl sulfoxide 1.81 ......................................66 
 xvii 
Scheme 1.56:  Application of Lewis-acid catalyzed condition to tolyl sulfoxide 1.81
.....................................................................................................67 
Scheme 1.57: Synthesis of novel dienophiles with electron withdrawing aryl 
substituents ..................................................................................67 
Scheme 1.58: Improved dienophile 1.191 cycloaddition with furan ....................69 
Scheme 1.59: Troublesome Diels-Alder reaction with 2-methylfuran .................70 
Scheme 1.60: Diastereomeric resolution of dienophile (±)-1.191 ........................72 
Scheme 1.61: Highly stereoselective Diels-Alder reaction with 1.191.................74 
Scheme 1.62: Model study for determining optimal oxidative workup conditions77 
Scheme 1.63: One-pot cycloaddition and oxidation procedure ............................78 
Scheme 1.64: Early attempts at ring-opening cross metathesis ............................80 
Scheme 1.65: Attempts at ROCM with Lewis acid additives ...............................82 
Scheme 1.66: First successful ring-opening cross metathesis using styrene ........83 
Scheme 1.67: Improved results using the sulfone auxiliary ..................................84 
Scheme 1.68: No reaction with ethyl vinyl ether cross-partner ............................84 
Scheme 1.69: Cross metathesis of cycloadduct 1.194 ..........................................85 
Scheme 1.70: Failed cross metathesis olefins with substrate 1.194 ......................85 
Scheme 1.71: Successful ring opening of cycloadduct 1.200 with various cross 
partners ........................................................................................86 
Scheme 1.72: Cross metathesis of endo 1.200 will allyltrimethylsilane ...............88 
Scheme 1.73: Reaction of exo-cycloadduct 1.243 and detection of the other 
regioisomer .................................................................................89 
Scheme 1.74: Absence of reactivity with 1,4-cis-butene diacetate cross-partner .92 
Scheme 1.76: Results of ring-opening cross metathesis under ethylene atmosphere
.....................................................................................................95 
 xviii 
Scheme 1.77: Optimized cross-metathesis conditions under ethylene atmosphere96 
Scheme 1.78: Cross metathesis of cycloadduct 1.200 using ethylene ..................96 
Scheme 1.79: Probing the reaction pathway .........................................................97 
Scheme 1.80: Further probing of the cross metathesis..........................................98 
Scheme 1.81: Probing the mechanism of the cross metathesis using methylpropene 
gas ...............................................................................................99 
Scheme 1.82: Proposed mechanistic pathway to generate product 1.257 .............99 
Scheme 1.83: Addition of various simple olefins in place of ethylene ...............101 
Scheme 1.84: Failure of the ethylene atmosphere technique with other cross-partners
...................................................................................................102 
Scheme 1.85: ROCM of mono-substituted system .............................................103 
Scheme 1.86: Possible temperature dependent alkylidine formation .................104 
Scheme 1.87: Screening of various metathesis cross-partners ............................105 
Scheme 1.88: Optimized conditions for the ROCM with methylacrylate...........106 
Scheme 1.89: Failed attempts at oxidative ring-opening ....................................110 
Scheme 1.90: Failed attempts to oxidize sulfone substituted cycloadduct 1.200111 
Scheme 1.92: First successful oxidative cleavage ..............................................112 
Scheme  1.93: Two-step oxidation and reduction sequence to give diol 1.280 ..113 
Scheme 1.94: Addition of 2,6-lutidine improves oxidation yield .......................113 
Scheme 1.95: Possible mechanistic explanations for the improved yield with base114 
Scheme 1.96: Oxidation followed by Ohira-Bestmann reaction sequence .........115 
Scheme 1.98: General screening of common known sulfone cleavage conditions117 
Scheme 1.99: Distribution of products with sodium amalgam in wet methanol 118 
Scheme 1.100: Optimized desulfurization conditions.........................................119 
 xix 
Scheme 1.101: Summary of the enantioselective cycloaddition and ring-opening 
reactions ....................................................................................120 
Scheme 2.1: Overman’s total synthesis of gliocladin C ......................................126 
Scheme 2.2: Completion of Overman’s synthesis of gliocladin C ......................127 
Scheme 2.3: Overman’s second generation synthesis of gliocladin C ................129 
Scheme 2.4: Completion of the enantioselective synthesis of (+)-gliocladin C .130 
Scheme 2.5: Movassaghi’s total synthesis of gliocladine C ...............................132 
Scheme 2.6: Movassaghi’s total synthesis of chaetocin A ..................................134 
Scheme 2.7: Overman’s total synthesis of (+)-gliocladine C..............................137 
Scheme 2.8: Clive’s approach to the MPC1001 core structure...........................141 
Scheme 2.9: Synthesis of the dihydrooxepine core of acetylaranotin .................142 
Scheme 2.10:  Ring expansion of strained cyclobutanes ....................................143 
Scheme 2.11: Synthesis of substituted dihydrooxepins by Cope rearrangement 145 
Scheme 2.12: Application of the retro-Diels-Alder/epoxide opening. ................147 
Scheme 2.13: Retrosynthetic analysis of 2.9, 2.12, and 2.6 ................................148 
Scheme 2.14: Key ionic coupling between π-cation 2.108 and nucleophile 2.106…
...................................................................................................149 
Scheme 2.15: Cerium catalyzed double addition of indole to isatin ...................150 
Scheme 2.16: Bifunctional cinchona alkaloid controlled asymmetric addition to 
isatins ........................................................................................151 
Scheme 2.17: Chiral Lewis acid controlled synthesis of 3-hydroxyoxindoles ...152 
Scheme 2.19: Reduction of methyl amide to the tricyclic aminal with LiAlH4..153 
Scheme 2.20:  Two-step reductive coupling with lithium triethylborohydride and HCl
...................................................................................................154 
Scheme 2.21: Buchwald’s use of alane-dimethylethylamine complex ...............154 
 xx 
Scheme 2.22: Sequential de-activation of reactive free-amides and reductive coupling
...................................................................................................155 
Scheme 2.23:  Late-stage oxidation to give desmethoxy-verrucluogen TR-2 (2.134)
...................................................................................................156 
Scheme 2.24: Oxidative conditions using NBS and water ..................................157 
Scheme 2.25:  Oxidation of exocyclic enamides with dimethyldioxirane ..........158 
Scheme 2.26: Oxidation using mCPBA followed by conversion to the diol ......158 
Scheme 2.27: Overman’s model study toward the synthesis of 
epidithiodiketopiperazines ........................................................160 
Scheme 2.28: Sulfur installation with BF3OEt2 and hydrogen sulfide. ..............160 
Scheme 2.29: Proposed forward synthesis of the 4,5-dihydrooxepin substructure 
2.162..........................................................................................161 
Scheme 2.31: Intramolecular pyrone Diels-Alder followed by loss of carbon dioxide
...................................................................................................163 
Scheme 2.32: Proposed examination of endo and exo epoxides .........................164 
Scheme 2.34: Epoxidation by addition of a vinyl sulfonium ylide .....................166 
Scheme 2.35: Formation of cis-divinyl epoxides from unsaturated aldehydes...166 
Scheme 2.36: Brown-type allylation of aldehydes to generate chlorohydrins ....167 
Scheme 2.38: Piperidine catalyzed synthesis of 3-hydroxy oxoindole 2.107. ....169 
Scheme 2.39: Dimerization of serine and elimination to access nucleophile 2.106170 
Scheme 2.40: Initial failed attempts to form disubstituted oxindole 2.109 .........171 
Scheme 2.41: Reworked forward synthesis of 2.104 ..........................................173 
Scheme 2.42: Base screening to access 3-hydroxyoxoindole 2.202 ...................174 
Scheme 2.43: Attempted ionization and indole trapping. ...................................175 
 xxi 
Scheme 2.44: Redesigned route using mono-methyl diketopiperazine nucleophile 
2.132..........................................................................................177 
Scheme 2.45: Synthesis of N-methyl serine derivative 2.210. ............................178 
Scheme 2.46: Three step synthesis of acetyl-serine methyl ester 2.213. ............178 
Scheme 2.47: Failed coupling of 2.210 and 2.213 due to labile acetates ............179 
Scheme 2.48: Synthesis of N-Methyl-N-CBz-serine 2.217 from 2.210. .............179 
Scheme 2.49: Coupling of peptides 2.217 and 2.194, and failed cyclization conditions
...................................................................................................181 
Scheme 2.50: Successful deprotection and cyclization sequence .......................182 
Scheme 2.51: Development of the one-pot activation, elimination, and isatin addition
...................................................................................................183 
Scheme 2.52: Ionization and indole trapping to access 3,3-disubstituted oxoindole 
2.209..........................................................................................185 
Scheme 2.53 Improved conversion of 2.202 to 2.209 using TMSOTf. ..............185 
Scheme 2.54: Failed reductive coupling of 2.209 with common reducing agents187 
Scheme 2.55: 1,4-Reduction of the external olefin using lithium aluminum hydride
...................................................................................................188 
Scheme 2.56: Deprotonation with LDA prior to addition of hydride sources ....189 
Scheme 2.48: Possible mechanistic explanation for the fragmentation of 2.209.190 
Scheme 2.57: First successful reductive coupling of 2.209 to give core structure 
2.222..........................................................................................191 
Scheme 2.58: Screening of various Lewis acids and reducing agents to access 2.222
...................................................................................................192 
Scheme 2.59: Optimized reductive coupling conditions .....................................193 
Scheme 2.60: Structural elucidation of 2.150 by characterization of derivatives194 
 xxii 
Scheme 2.61: Double dihydroxylation of 2.222 .................................................196 
Scheme 2.62: Possible fragmentation pathway leading to the instability of 2.238.197 
Scheme 2.64: In-situ boronic ester formation using alternate boronic acid 2.242.199 
Scheme 2.65: Attempted epoxidations to access 2.238 ......................................200 
Scheme 2.67: Improved oxidative cleavage conditions using NMO and PhI(OAc)2.
...................................................................................................201 
Scheme 2.68: Attempted benzyl group removal under hydrogenolysis conditions203 
Scheme 2.69: Five step route from serine protected N-methyl-amino acid 2.217.204 
Scheme 2.70: Synthesis of diketopiperazine 2.221, and formation of core structure 
2.222..........................................................................................205 
Scheme 2.71: Final elaborations into hexahydropyrroloindoline natural products207 
Scheme 2.72: Diels-Alder to synthesize bicyclic lactone 2.249. ........................208 
Scheme 2.73: Attempted epoxidation of 2.249. ..................................................209 
Scheme 2.74: Halohydrin formation conditions and TBCA. ..............................210 
Scheme 2.75: Mechanistic explanation for the observed products. ....................211 
Scheme 2.76: Proposed model system to avoid unwanted rearrangements ........212 
Scheme 2.77: Intramolecular [4+2] cycloaddition ..............................................213 
Scheme 2.78: Failed epoxide formation ..............................................................215 
Scheme 2.79: Synthesis of bicyclic bromohydrin 2.271 .....................................216 
Scheme 2.80: Screening of dienophiles ..............................................................216 
Scheme 2.81: Attempted oxidation of electron deficient olefin 2.279 ................218 
Scheme 2.82: Synthetic route to access 2.280. ...................................................219 
Scheme 2.85: Failed conditions for the retro-homo Diels-Alder reaction ..........222 
Scheme 2.87: Attempted use of organo-titanate nucleophiles to form alcohol 2.286.
...................................................................................................224 
 xxiii 
Scheme 2.88: Attempted tin promoted addition of allyl chloride .......................224 




Chapter 1:  Enantioselective Synthesis of 2,2,5-Tri- and 2,2,5,5-
Tetrasubstituted Tetrahydrofurans 
1.1. 2,2,5-TRI AND 2,2,5,5-TETRASUBSTITUTED TETRAHYDROFURAN CONTAINING 
NATURAL PRODUCTS 
Highly substituted tetrahydrofurans are a common structural motif found in a 
broad array of natural products and other biologically important molecules.
1,2,3 
 
Considerable attention has been given to this class of molecules due to their diverse range 
of biological activities that include antitumor, antimalarial, antimicrobial, and anti-
angiogenesis.
4,7  
Because of the importance of these types of molecules, there has been a 
great deal of effort put toward the development of new methodologies to access these 
substructures.
5,6
   The Martin group gained an explicit interest in a class of 
tetrahydrofuran that is highly-substituted only at the 2- and 5- positions such as 1.1 
(Figure 1.1).  Our attention to this specific motif was spurred by our ongoing total 
synthesis of tetrahydrofuran-containing natural product cortistatin A 1.2.
7,8 
 





While examining routes to cortistatin A (1.2), a survey of the literature revealed 
that while there were examples of the synthesis of structures similar to 1.1, but there was 
not a generally applicable method for the enantioselective synthesis of these subunits.
9
 
Additionally, we found that there were numerous other biologically active natural 
products that contained similar 2,2,5-tri or 2,2,5,5-tetrasubstituted tetrahydrofurans, such 
as davanone (1.3)
10
 and tonantzitlolone 1 (1.4).
11 
  Thus, owing to the lack of general 
entries into these important substructures, we sought to develop a method that could 
access motifs such as 1.1 in an enantioselective manner that might find application within 
the synthesis of complex natural products.  
 
 
1.1. EXISTING ROUTES TO ACCESS HIGHLY SUBSTITUTED TETRAHYDROFURANS 
1.1.1. Acid, base, or metal promoted cyclization of ene-ols 
The majority of effective methods to access 2,5-substituted tetrahydrofurans can 
be summarized by a few general techniques.  Each section outlines a recent example of 
some of the most common and effective approaches within each category.  Each route 
has advantages and disadvantages; however, none of the existing technologies were 
suitable for the general asymmetric synthesis of 2,2,5-tri and 2,2,5,5-tetrasubstituted 
tetrahydrofurans that we had in mind.  
The first of such methodologies, and by far the most common approach to these 
pervasive heterocycles, involves the acid, base, or metal catalyzed cyclization of a 1,5-






This has been widely applied to the construction of poly-tetrahydrofuran containing 




Scheme 1.1: Acid, base, or metal promoted cyclization of 1,5-eneols 
 
 
A recent example of an anionic ring closure was reported by Myers in his 
synthesis of the cytotoxic cembranolide uprolide D 1.8 (Scheme 1.2).
12
  The bis-epoxide 
1.9, was synthesized, which has an adjacent bromide that serves as a functional handle to 
open the epoxide after oxidative insertion by zinc metal.  Nucleophilic attack of the 
resultant anion opened the proximal epoxide giving 2,2,5-trisubsubstituted 
tetrahydrofuran 1.10 in 82% yield.  Further transformations led to the final target 1.8.  In 
general, this method works well for tetrahydrofurans with minimal substitution at the 2- 
and 5- positions; however, the yield and diastereoselectivity decreased when trying to 
form 2,2,5,5-tetrasubstituted tetrahydrofurans.
13,14
  Additionally, as steric bulk around the 









Scheme 1.2: Myer’s anionic ring-closure to form tetrahydrofurans 
 
 
An example of a protic-acid catalyzed synthesis of poly-tetrahydrofurans was 
performed by Morimoto in his total synthesis of (+)-omaezakianol (Scheme 1.3).
 16
 In the 
key transformation, camphorsulfonic acid was used to initiate a sequential 5-exo-tet 
cascade oxacyclization of triepoxy alcohol 1.11, giving key intermediate 1.12 in 40% 
yield.  This type of cascade ring closure is the most commonly used method for the 
construction of poly-tetrahydrofuran targets.  This type of cyclization is characterized by 
lower yields and poor diastereoselectivity when forming tetra-substituted 
tetrahydrofurans.
17
  It also requires the multi-step synthesis of complex starting materials 
containing multiple pre-set stereocenters.  Additionally, as with the previous example, 
competing tetrahydropyran formation can be a problem with increased steric bulk of the 










Scheme 1.3: Morimoto’s sequential oxacyclization in the synthesis of (+)-omaezakianol 
 
 
A lesser used technique for the preparation of highly substituted tetrahydrofurans 
involves the metal catalyzed carboetherification of acyclic internal alkenes.  Wolfe and 
coworkers reported the stereoselective synthesis of tetrahydrofurans containing up to 
three stereocenters (Scheme 1.4).
19
  The authors used a palladium catalyst to cyclize 
tertiary alcohols such as 1.13 onto disubstituted olefins; subsequently coupling to aryl 
bromides, gave trisubstituted tetrahydrofurans such as 1.14 in good yield and 
diastereoselectivity.  A Disadvantage to this method is the requirement of having an 
aromatic group appended to the resultant tetrahydrofuran ring.  Furthermore, 
diastereoselectivity decreases with increased steric bulk of the substituents around the 
alcohol or olefin or when cyclizing to form tetrasubstituted tetrahydrofurans.
20,21
   
 





1.1.2. Oxidative cyclization of 1,5-dienes 
The oxidative cyclization of 1,5-dienes has recently emerged as one of the most 
capable methods to access THFs in a single step (Scheme 1.5).
22
   cyclization of the  
diene 1.15 using metal oxidants such as potassium permanganate, osmium tetroxide, or 
ruthenium tetroxide gives highly oxidized tetrahydrofurans such as 1.16.  This 
methodology features the creation of four chiral carbons from a simple diene, as well as 
the introduction of two new alcohols at the C1 and C6 carbons of 1.16.  It suffers the 





drastically when forming tetrasubstituted tetrahydrofurans.  The oxidation requires the 
use of harsh reagents, and yields are often poor.  Furthermore, there are few options to do 




Scheme 1.5:  Oxidative cyclization of 1,5-dienes 
 
 
In a procedure developed by Stark and co-workers, 1,5-dienes 1.17 induced to 
undergo oxidative cyclization with ruthenium tetroxide and sodium periodate as the 
terminal oxidant (Scheme 1.6).
26
  This oxidation improves upon previous oxidative 
cyclization techniques and gives tetrahydrofurans 1.18 in good to excellent yields and 




established for a wide variety of substrates and proved to be applicable for the formation 
of trisubstituted tetrahydrofurans, but not 2,2,5,5-tetrasubstituted tetrahydrofurans. 
 
Scheme 1.6: Ruthenium tetroxide catalyzed oxidative cyclizations 
 
 
Brown and co-workers published an unusualexample of a diastereoselective 
oxidative cyclization of yne-diene 1.19 in their total synthesis of 21,22-di-
epimembrarollin (1.20).
27
  A metal-oxo-mediated oxidative cyclization gave di-
substituted tetrahydrofuran 1.21 as a single isomer in 57% yield (Scheme 1.7).  The 
selectivity was directed by camphorsultam auxiliary 1.22.  Tetrahydrofuran 1.21 was then 
carried through a second oxo-cyclization and then onto the final target 1.20.  Similar 
examples of stereoselective oxidative cyclization with 2,2,5,5-tetrasubstituted 











Scheme 1.7: Stereoselective synthesis of 21,22-di-epi-membrarollin 
 
 
Brown and Keily obtained moderate levels of enantioselection by performing the 
oxidation of 1,5-dieneones 1.23 in the presence of substoichiometric amounts of chiral 
tertiary ammonium salt 1.24 (Scheme 1.8).
28
  The cyclization, which was performed 
under biphasic conditions, gave trisubstituted tetrahydrofurans 1.25 in low to moderate 
yield, and isolated as a single diastereomer.  This reaction is not preparatively useful at 
this time due to the low yields and enantioselectivity, future iterations of this type of 
methodology may be valuable synthetic tools.   
 





1.1.3. Reductive cyclization of acetylenic aldehydes 
Recent reports by Krische and co-workers showcased the utility of a rhodium-
catalyzed reductive cyclization of acetylenic aldehydes (Scheme 1.9).
29
  They cyclized a 
variety of aldehydes such as 1.26 in the presence of 5% rhodium catalyst and the chiral 
ligand 1.27 to give densely functionalized tetrahydrofuran cores such as 1.28.  Yields for 
this process were generally good, ranging from 67 to 99%.  Enantioselectivity of the 
reaction is excellent at 91-99% enantiomeric excess.  This method worked extremely well 
to access densely functionalized tetrahydrofurans such as 1.28; however, the route is not 
applicable 2,2,5-tri and 2,2,5,5-tetra-substituted tetrahydrofuran cores (1.1) that have no 
substitution at the 3- and 4-positions. 
 
Scheme 1.9: Highly enantioselective reductive cyclization of acetylenic aldehydes 
 
 
1.1.4. Synthesis of substituted tetrahydrofurans via cycloaddition 
A powerful strategy for preparation of substituted tetrahydrofuran substructures 
uses a [3+2] cycloaddition to generate a five-membered ring.  One common and effective 
approach to this construction involves the rhodium-catalyzed reaction of a stabilized 




recent example of this type of transformation is the rhodium tetraacetate catalyzed 
generation of carbonyl ylide 1.29 from aryl aldehyde 1.30 and dimethyl diazomalonate 
(1.31) (Scheme 1.10).
30
  Intermediate 1.29 underwent a [3+2] cycloaddition with 
activated olefin 1.32, giving substituted tetrahydrofuran 1.33, as a single diastereomer.  
Transformations such as this are severely limited by the types of functionality and 
substitution that can be present on each reactive unit.  For example, the olefin must be 
activated by a strongly electron withdrawing group, and the diazo-component must be 
stabilized by adjacent ketones.  Furthermore the ylide must be derived from an aryl 
substituted aldehyde or ketone in order to achieve good yields and selectivities. 
 
Scheme 1.10: [3+2] cycloaddition of aryl aldehydes to give substituted tetrahydrofurans 
 
 
Fishwick and co-workers have reported a sequence involving a [3+2] 
cycloaddition followed by oxidative ring-opening to access highly-functionalized, 
substituted tetrahydrofurans.
31
  The route consists of generating of a highly reactive 3-




1.34 then cyclized with electron rich olefin partners such as 1.36 to give cycloadducts 
1.37 after a diastereoselective reduction (Scheme 1.11).  Cycloadduct 1.37 was cleaved 
by exposure to ozone.  Reduction of the resultant aldehydes with lithium aluminum 
hydride, and acylation of the resultant alcohols led to tetrahydrofuran 1.38 as a single 
diastereomer in moderate yields.  Despite the good selectivity, the poor yields and the 
fact that this route, to the best of our knowledge, has not been applied to prepare more 
complex tetra-substituted tetrahydrofurans limits its usefulness. 
  
Scheme 1.11: Oxidative cleavage of 3-oxidopyrilium betaine-derived cycloadducts 
 
 
Mascarenas and co-workers reported a route to the core of racemic (±)-
nemorensic acid 1.39 by an intramolecular [5+2] cycloaddition of 1.40 (Scheme 1.12).
32
  
The resulting oxabicyclo[3.2.1]octane 1.41 was elaborated to the core structure 1.42 by 
silicon deprotection, oxidative cleavage with lead tetraacetate, and Jones oxidation.
33
  
This route constitutes a method to access 2,2,5,5-tetrasubstituted tetrahydrofuran cores, 






Scheme 1.12: [5+2] Pyrone-alkene cycloaddition approach to tetrahydrofurans  
 
 
The [4+2] cycloadditions between substituted furans and dienophiles has been 
used to construct bicyclic systems.
34,35 
These structurally rigid norbornene derivatives 
may then undergo ring opening to give substituted tetrahydrofurans.   For example, Klein 
and co-workers heated 2,5-disubstituted furan 1.43 to induce an intramolecular Diels-
Alder reaction to give bridged oxa-bicycle 1.44 in 60% yield overall after three recycles 
of the starting material (Scheme 1.13).
36
  A likely reason for the poor conversion during 
the Diels-Alder cycloaddition is that furan is considered a moderately reactive diene, and 
generally requires forcing conditions to cyclize with unactivated olefins.
 37,38,39,40
 With 
1.44 in hand, protection of the free alcohol, ozonolysis, and desulfurization led to 2,2,5,5-
tetrasubstituted tetrahydrofuran 1.45 in low yield.  This approach is notable because, 




serves as a very direct way to access highly substituted tetrahydrofurans from simple 
starting materials, and serves as useful precedent for our approach to tetrahydrofuran 
synthesis. 
 
Scheme 1.13: Intramolecular Diels-Alder reaction followed by oxidative ring-opening 
 
 
Similarly relevant was some recent work by Rainier and co-workers, who 
promoted the reaction of furan (1.46) with phenylvinyl sulfone (1.47) under Lewis-acid 
promoted conditions to give endo-substituted oxabicycle 1.48 (Scheme 1.14).
41,42
  This 
bicycle was then opened in a highly regioselective manner using Grubbs 2
nd
 generation 
catalyst in the presence of excess ethyl vinyl ether to give the disubstituted 
tetrahydrofuran 1.49 as a single regioisomer.  While the origin of the high regioselectivity 
is unknown, it was suggested that it was directed by either an electronic or steric effect 
from the sulfone group.   This technique of ring-opening cross metathesis caught our 
attention as a useful tool for the rapid synthesis of a diverse array of tetrahydrofurans 
from a single simple starting material, and it served as additional inspiration for our 
developing methodology.  Encouraged by this precedent, we sought to develop a 
methodology that would permit for the construction of 2,2,5,5-tetrahydrofurans that was 




accomplish this, we would need to develop a technique for the removal any substituents 
from the 3- and 4- positions of the tetrahydrofuran. 
 




1.2. THE MARTIN GROUP APPROACH TO THE ENANTIOSELECTIVE SYNTHESIS OF 2,2,5-
TRI- AND 2,2,5,5-TETRASUBSTITUTED TETRAHYDROFURANS 
1.2.1. Martin group strategy to access 2,2,5-tri- and 2,2,5,5-tetrasubstiuted 
tetrahydrofurans and key challenges 
As mentioned previously, our goal was to develop a methodology to access 
enantioenriched, highly substituted tetrahydrofuran cores related to scaffold 1.1 (Scheme 
1.X).  This would not only allow us to access the core of a number of natural products, 
but it would also provide a means to synthesize a wide variety of tetrahydrofuran cores 
from simple starting materials.  The enantioselective approach, along with the use of 
simple and inexpensive starting materials, are key requirements for our route, because we 
hope to apply this methodology to multistep total synthesis.  Based on inspiration from 
our ongoing total synthesis of cortistatin A, along with the aforementioned literature 
examples, we conceived of the general strategy for access into 2,2,5-tri- and 2,2,5,5-




Scheme 1.15: Martin group strategy to access enantioenriched tetrahydrofurans    
 
 
The plan begins with an intermolecular asymmetric [4+2] cycloaddition between 
the furan 1.50, which is substituted at the 2- and/or 5-positions and an activated olefin 
represented as 1.51.  This stereoselective Diels-Alder reaction, directed by either a chiral 
Lewis-acid or chiral auxiliary, would lead to the enantioenriched oxanorbornene cores 
1.52 (Scheme 1.1.15).  The critical requirement for this cycloaddition is to achieve a 
preparatively useful, stereoselective Diels-Alder reaction, that is suitable for use in 
multistep synthesis.  With this in mind, we faced a number of unique challenges.  (1) Due 
to the fact that we will be preparing substituted furans as a starting material, use of a large 
excess of furan must be avoided. Lowering the stoichiometry of furan will be a challenge 
since Diels-Alder reactions of furan generally require a large excess of furan.
38,39,37
  (2) 
Owing to the poor reactivity of furan, we require the use of a dienophile that is activated 
with an electron withdrawing group in order to achieve good reactivity.  This activating 
group must be removed later in the synthesis, so that we may access tetrahydrofurans that 
are either unsubstituted or minimally substituted at the 3- and 4- positions such as 1.1.  
(3) When using a Diels-Alder reaction to construct more complex systems, selectivity 




components (endo/exo ratio).  We require a highly selective Diels-Alder reaction, so the 
use of high temperatures must be avoided in order to maintain stereoselectivity.    
The second stage of the sequence in Scheme 1.15 involves the ring-opening of the 
oxabicycle 1.52, followed by refunctionalization of the electron-withdrawing group to 
give the target tetrahydrofuran 1.1.  We envisioned two potential options for this step.  
The first option involved the oxidative cleavage of the olefin to give ketones, esters, or 




 = CHO, CO2H, CO2R).  The second option 





 = CH=CHR, CH=CH2).  The key challenge for this ring opening is finding 
suitable conditions to achieve a fully regioselective cross metathesis, so a mixture of 
regioisomers of 1.1 was not obtained.   
 
1.2.2:  Overview of existing methodology for the enantioselective Diels-Alder 
cycloaddition with furans 
A survey of the literature reveals that there are many excellent methodologies for 
inducing enantioselective Diels-Alder reactions, but there are few technologies that use 
furan as the diene partner.  One such example of the enantioselective [4+2] cycloaddition 
involving furan is the cycloaddition between chiral 2-methylaminofuran 1.53 and maleic 
anhydride (1.54) (Scheme 1.16).
43
  The chiral α-methyl-benzyl substituent 1.55 induces 
the diastereoselectivity of the tricyclic product 1.56.  The reaction proceeded in excellent 
yield; however, it failed to achieve a useful (>90%) level of diastereoselection.  For our 
methodology, ring-opening of tricycles such as 1.56 would result in a tetrahydrofuran that 
has substitution at the 3- and 4- positions that would be tedious for us to remove, thus is it 




Scheme 1.16: Early example of an enantioselective Diels-Alder reaction with a furan 
 
 
Hayashi and co-workers reported the Lewis acid-promoted Diels-Alder reaction 
between furan (1.46) and the chiral acrylate derivative 1.57 (Scheme 1.17).
44
  The chiral 
acrylate 1.57, which was originally developed by Corey and Sarakinos,
45
  combined with 
Hayashi’s low temperature conditions, using HfCl4 as a stoichiometric promoter, led to 
good selectivities and yields. While they achieved good diastereomeric excess at 87% for 
the major endo product and 91% for the exo product, the endo:exo ratio was only 7:3. 

















Scheme 1.17: Hayashi’s HfCl4 promoted Diels-Alder with furan and chiral acrylate 
 
 
Narasaka and co-workers developed a useful catalytic system to induce the 
cycloaddition between the electron rich furan 1.61 and the acryloyl oxazolidinone 1.62, 
to give the oxabicycloheptene derivative 1.63 (Scheme 1.18).
47
  Using a 10% loading of 
the chiral Lewis acid 1.64, they were able to catalyze the cycloaddition in excellent yield 
and good endo:exo selectivity and enantiomeric excess.  However, this method has not 











Scheme 1.18: Chiral Lewis acid directed enantioselective furan Diels-Alder reaction 
 
 
Corey and co-workers have recently developed what is arguably the most 
impressive technology to date for the enantioselective Diels-Alder of a furan.
 48
  Using a 
variant of his signature chiral oxazaborolidine catalyst 1.65 as a Lewis acid to promote 
the [4+2] cycloaddition of activated trifluoroethyl acrylate 1.66 and 2,5-dimethylfuran 
(1.67) (Scheme 1.19), the cycloadduct 1.68 was obtained in 98% yield, 97% enantiomeric 
excess, and 32:1 endo:exo selectivity.  The excellent yields and selectivity prompted us to 
closely examine this technology for possible application to  our own methodology and 










Scheme 1.19: Corey’s oxazaborolidine catalyzed Diels-Alder with furans 
 
 
While Corey’s methodology achieved impressive results, it faces a major 
downside when trying to access target tetrahydrofurans such as 1.1.  Namely, 
trifluoroethyl-ester auxiliary must be cleaved from the molecule 1.69 (Scheme 1.20).  
The most likely approach for removing an ester group from substituted oxanorbornene 
1.69 would be by a hydrolysis of the ester followed by a trans-esterification to make 
Barton-ester 1.70.
49
  This activated ester can then undergo a radical decarboxylation to 
give 1.71, which, after ring-opening leads to the tetrahydrofuran structure 1.1.  Because 
auxiliary cleavage process would add two or three steps to the sequence, we looked for an 
alternative activating group that could be more readily cleaved or re-functionalized than 
the ester group of 1.68. 
 





The ideal activating group for a dienophile would be one that could be removed in 
a single step.  It would thus act as an ethylene equivalent in the Diels-Alder reaction, 
leading directly to oxabicycles such as 1.71 without significant manipulation.  With this 
in mind, we turned our attention toward vinyl sulfoxides and vinyl sulfones as potential 
activating groups.  Sulfones and sulfoxides are known to be readily cleaved under 





1.2.3: Overview of existing methodology for the enantioselective Diels-Alder 
cycloaddition with chiral sulfones or chiral sulfoxide activating groups. 
With the aim of finding a suitable sulfone or sulfoxide-activated dienophile for 
our methodology, we surveyed the literature possibilities.  While a number of vinyl 
sulfones and sulfoxides have been used for asymmetric Diels-Alder reactions, only a few 
led to good yields and stereoselectivities, and were potentially be readily cleavable from 
the molecule.  
One early example was reported by Ruano and co-workers, who performed an 
asymmetric cycloaddition between chiral vinyl sulfoxide 1.72 and furan (1.46) under 
high pressure (Scheme 1.21).
53
  Under these forcing conditions, they were obtained high 
conversion to the endo-product 1.73, but the enantioselectivities were low.  Even if the 
enantioselectivity could be improved, the additional benzyl-ester substituent hinders its 







Scheme 1.21: Ruano’s chiral sulfoxide directed dienophile 
 
 
Using the related chiral vinyl sulfoxide 1.74, Carretero and co-workers performed 
a cycloaddition with cyclopentadiene (1.75) in the presence of titanium tetrachloride as a 
Lewis-acid promoter to give cycloadduct 1.76 in 68% yield (Scheme 1.22).
54
  The 
diastereoselectivity under these conditions was good, and the resulting product, 1.76, 
possessed two carbon-sulfur bonds, which could theoretically be cleaved from the 
molecule in a single step.  This would allow 1.74 to act as a masked ethylene dienophile.  
However, this cycloaddition was not examined using furan as the diene partner.  Furan 
1.46 is a significantly poorer cycloaddition partner than cyclopentadiene (1.75); so, this 
sluggish five day long reaction does not hold promise to be applicable with furans. 
 
Scheme 1.22: Carretaro’s bis-substituted chiral dienophile 
 
Chiral vinyl sulfonamide 1.77, which was prepared by the Bernabeu group from 
norephedrine, was used to achieve a highly selective Diels-Alder cycloaddition with an 
excess of cyclopentadiene (1.75) (Scheme 1.23).
55
   The reactions were performed at -40 




diastereoselectivity.  Although the selectivity is impressive, this novel dienophile has not 
been demonstrated to react with furans.   
 
Scheme 1.23: Highly selective norephedrine derived chiral vinyl sulfonamide dienophile 
 
 
Aggarwal and co-workers used bis-sulfoxide 1.79 as a dienophile that reacted 
with furan (1.46) in the presence of a Lewis acid, to deliver 1.80 with 94% 
diastereoselectivity and in 65% yield (Scheme 1.24).
56
  We became interested in this 
dienophile due to the high selectivity and the fact that the bis-sulfoxide moiety could 
possibly be cleaved from the molecule in a single step under reductive conditions.
57
   
 
Scheme 1.24: Use of Aggarwal’s bis-sulfoxide dienophile 
 
 
Kagan’s group has developed one of the most reactive and selective chiral vinyl 




activated it with Meerwein’s salt, giving the active sulfoxonium species 1.82, which was 
used directly in the next step (Scheme 1.25).
58,59
   After stirring salt 1.82 with furan at 0 
ºC for several days, they isolated a mixture (3:2) of endo-cycloadduct 1.83 and exo-
product 1.84.  This cycloaddition is notable because it represented the first example 
involving furan that was both highly diastereoselective and high yielding.  However, 
there are disadvantages to this methodology, including the requirement of an extra 
alkylation step to prepare the sulfoxonium intermediate 1.82 and the need for a strongly 
basic workup in order to cleave the O-alkyl group and generate 1.83 and 1.84. 
 
Scheme 1.25: Kagan’s highly diastereoselective Diels-Alder reaction 
 
 
Sulfoxonium salt 1.82 (Scheme 1.25) and bis-sulfoxide 1.79 (Scheme 1.24) have 
exhibited the highest reported diasteriomeric excesses for the reaction of any known 
chiral vinyl sulfoxide or sulfoxonium salt with furan.  The use of these dienophiles could 
be optimized and expanded to be 2,5-disubstituted furans, it would constitute a useful 
means for the synthesis of enantioenriched oxabicycles.  These oxabicycles, that could be 
elaborated into 2,2,5,5-tetrahydrofurans.   Both of these dienophiles 1.79 and 1.82 were 
studied for adaption to our methodology to access tetrahydrofuran cores represented by 




1.2.4. Proposed selectivity model for chiral vinyl sulfoxides 
Diastereoselectivity in Diels-Alder reactions employing chiral vinyl sulfoxides is 
believed to be a consequence of two factors: the approach of the diene to the least 
sterically crowded face of the vinyl sulfoxide and the restriction of the dienophile to a 
single reactive s-cis conformation.
60,61
  Sulfoxonium salt 1.82, as suggested by Ronan and 
Kagan
59
, prefers an s-cis conformation when reacting with a diene. Approaching dienes 
favor a path from the face opposite of the large tolyl group 1.83 versus the sterically 
hindered facial pathway depicted by 1.84 (Figure 1.2).
   
No explanation was given as to 





Figure 1.2: Diastereoselectivity model for Kagan’s sulfoxonium salt 1.82 
 
 
The interpretation of the stereoselectivity of bis-sulfoxide 1.79 is more 
straightforward.  The stereochemical outcome of the [4+2] cycloaddition of 1.79 with 
furan can be rationalized by the two transition states 1.85 and 1.86.
56




transition state 1.86 suffers from greater nonbonding interactions between the axial 
oxygen atom and the 3- and 4-positions of furan (Figure 1.3).
  
 




The factors behind the stereoselectivity become increasingly complex once a 
more substituted diene is used as the reaction partner with 1.82 or 1.79.  As shown in 
Scheme 1.26, there are eight possible transition states (1.87-1.94) that lead to eight 
different possible products (1.95-1.102) when a 2,5-disubstituted furan is allowed to react 
with dienophile 1.82.  Transition states 1.87-1.90 are favored, assuming the approach of 
the diene is to the less hindered face of 1.82, as opposed to transition states 1.91-1.94 









Scheme 1.26: Possible facial approaches and products after desulfurization for 1.82 
 
 
 Because the carbon-sulfur bond will be cleaved after the cycloaddition only the 
facial selectivity is  relevent to us.  Cycloadducts 1.95, 1.96, 1.99, and 1.100 all lead to 
final product 1.103 after desulfurization, because the vinyl sulfoxide approaches from the 
re-face of the diene.  Likewise, desulfurization of substrates 1.97, 1.98, 1.101, 1.102 
would give oxabicycle 1.104 because these substrates are formed by si-facial approach on 
the diene. 
 The number of possible products is halved by the Diels-Alder reaction of 2,5-
disubstituted furans with dieneophile 1.79 since there are no endo:exo isomers.  Of the 




based on Aggarwal’s stereochemical model.  Transition states 1.107 and 1.108 are 
disfavored due to nonbonding interactions of the 3- and 4- atoms of furan and the axial 
oxygen atom of the dieneophile. Desulfurization of substrates 1.109 and 1.111 would 
lead to oxabicycle 1.113.  Similarly 1.110 and 1.112 would be transformed into 1.114 
upon cleavage of the carbon sulfur bonds. 
 








1.2.5. Background information related to the development of a chiral Lewis acid 
catalyzed cycloaddition with α,β-unsaturated sulfones. 
If we were able to use a chiral Lewis acid to catalyze the cycloaddition between 
achiral starting materials, we could avoid the use of stoichiometric chiral auxilliary.  To 
our knowledge, a chiral Lewis acid-directed, enantioselective Diels-Alder reaction 
between an achiral vinyl sulfone, sulfonamide, or sulfonate and furan has never been 
reported.  Although this area is unsupported by direct precedent there have been reports 
of chiral Lewis acid mediated reactions involving similar vinyl sulfones and vinyl 
sulfonamides (vida infra). 
For example, Toru and co-workers, reported an enantioselective hydrogen atom 
transfer to α-sulfonyl radicals (Scheme 1.28).
62
  This reaction was controlled by the 
coordination of chiral Lewis acids to the sulfonyl oxygen atoms.  The radical was 
generated by the addition of butyl-radical to the terminus of the double bond of 1.115.  
The resulting α-sulfonyl radical was then quenched by hydride from the tin-hydride, 
presumably directed by the Lewis acid that was formed from zinc triflate and the chiral 
ligands 1.116 or 1.117.  The enantioenriched products 1.118 were obtained in good 
yields, but generally poor enantiomeric excesses were observed.  Nevertheless, this 
example suggests that stereocontrol of vinyl sulfones may be possible with a chiral Lewis 








Scheme 1.28: Lewis acid directed addition-hydrogen atom transfer to sulfones 
 
 
Enders and Hoffman  also developed an enantioselective-organocatalytic Michael 
addition of sulfur nucleophiles to unsaturated sulfonates (Scheme 1.29).
63
  Starting from a 
variety of achiral vinyl-sulfonates 1.119, they added sulfur nucleophiles 1.20 to the β-
carbon by activation with the bifunctional thiourea catalyst 1.121.  The yields and 
enantioenrichment of adduct 1.222 varied greatly, resulting in a method that lacks 
generality.  However, this does represent an example of stereochemical induction using a 








Scheme 1.29: Organocatalytic asymmetric sulfur Michael additions to vinyl sulfonates. 
 
 
Because of the available precedent suggesting that vinyl sulfones can undergo 
asymmetric reactions under chiral Lewis and Brønsted acid catalysis, we believed we 
might be able to establish conditions for an Lewis acid-catalyzed asymmetric 
intermolecular Diels-Alder between a vinyl sulfone and a furan.  Accordingly, the 2,2,5- 
tri and 2,2,5,5-tetrasubstituted tetrahydrofurans 1.1 would be formed by the ring-opening 
of enantioenriched oxabicycle 1.123, which would be generated by the asymmetric 
cycloaddition between achiral sulfone 1.124 and substituted-furan 1.125 (Scheme 1.30).   
 





The first step in probing the feasibility of the plan would be to determine whether 
we could use a Lewis acid to catalyze the cycloaddition between substituted furan 1.125 
and various vinyl sulfur derivatives of 1.124.  Once these conditions had been 
established, we would investigate the asymmetric reaction with chiral Lewis acids.  Vinyl 
sulfones had previously been used as dienophiles in Diels-Alder reactions, but the use of 
catalysts or promoters to enhance the reaction had not been reported.   
One example of a thermally promoted Diels-Alder reaction was published by 
Paquette and co-workers, who  treated phenyl vinyl sulfone 1.126 with  simple 
dienophiles, including cyclopentadiene (1.75) and cyclohexadiene (1.127), under 
somewhat forcing thermal conditions.
51
  The corresponding cycloadducts 1.128 and 
1.129 were produced in good yields, but mixtures of endo/exo isomers (2:1) were 
obtained (Scheme 1.31).   Discouragingly, however, he adds that “the generally available 
Lewis acid catalysts give no evidence of accelerating these reactions…”  
 






Despite this claim, there was evidence that Lewis acids could indeed enhance the 
rate of Diels-Alder reactions with sulfone derivatives.  Namely, Lee demonstrated that 
vinyl sultam 1.130 cyclized with dimethylfuran at high temperatures, forming 
cycloadduct 1.131 in good yield (Scheme 1.32).
64
  When titanium tetraethoxide was 
added, the temperature required was significantly lower.   
 
Scheme 1.32: example of a Lewis-acid catalyzed vinyl sulfonamide Diels-Alder reaction 
 
 
 There exists significant precedent to suggest that we might be able to catalyze an 
enantioselective cycloaddition between a vinyl sulfone or sulfonamide and furan.  We set 
out to explore the feasibility of this transformation, modeling our reactions after the 





1.4. DEVELOPMENT OF THE ENANTIOSELECTIVE SYNTHESIS OF 2,2,5-TRI- AND 2,2,5,5 
TETRASUBSTITUTED TETRAHYDROFURANS VIA [4 + 2] CYCLOADDITION AND RING-
OPENING CROSS-METATHESIS 
1.4.1. Development of the enantioselective Diels-Alder reaction 
1.4.1.1. Exploration of enantioselective cycloaddition with chiral Lewis acids 
 As reported earlier, there is literature precedent for the use of a chiral auxiliary to 
direct an asymmetric cycloaddition between furan, and a dienophile with a cleavable 
activating group.
56,59
  While many of the aforementioned examples appeared to be 
promising starting points for our methodology (Schemes 1.23, 12.4 and 1.25), they all 
shared a single disadvantage; by using a sulfoxide or sulfonamide as the activating group 
it required a stoichiometric amount of chiral auxiliary.  We thus sought to find a 
technique to perform an asymmetric [4+2] cycloaddition using achiral starting material, 
and a chiral Lewis acid.  To accomplish this, we first aimed to find a suitable Lewis acid 
to catalyze the cycloaddition.  After achieving this goal, we would then seek a chiral 
variant to achieve enantioselection.   
After a survey of the literature, we selected the three different unsaturated sulfur-
activated dienophiles, vinyl sulfone 1.126, vinyl sulfonate 1.132, and vinyl sulfonamide 
1.133.  Each of these olefins is either known to undergo [4+2] cycloadditions readily or is 










Figure 1.4: Selected dienophiles for chiral Lewis acid study 
 
 
 Phenylvinyl sulfone (1.126) was synthesized by the addition of thiolate 1.134 to 
dibromoethane to give vinyl sulfide 1.135 in 31% yield by a literature procedure (Scheme 
1.33).
67
  The procedure can easily be done on large scale and required only a simple 
distillation to isolate the pure product.  The thioether 1.135 was then oxidized in the 
presence of an excess of hydrogen peroxide in acetic acid to give 1.126 in 79% yield.  
This route was not optimized as it was sufficient to produce enough 1.126 for our 
purposes. 
 
Scheme 1.33: Synthesis of phenyl vinyl sulfone (1.126) 
 
 
Dienophile 1.133 was synthesized by the addition of commercially available 
oxazolidinone 1.136 to chloroethane sulfonyl chloride (1.137) in the presence of 
triethylamine (Scheme 1.34).
68
  The key to obtaining good yields in this reaction was a 
change in the order of addition, so 1.137 was added dropwise to 1.136 in the presence of 




Scheme 1.34: Synthesis of vinyl sulfonamide 1.133 
 
 
Vinyl sulfonate 1.132 was synthesized by a known procedure from chloroethane 
sulfonyl chloride (1.137) and phenol (1.138) (Scheme 1.35).
69
   
 
Scheme 1.35: Synthesis of vinyl sulfonate 1.132 
 
 
With dienophiles 1.126, 1.132 and 1.133 in hand, the next task was to identify 
Lewis acids capable of catalyzing the [4+2] cycloaddition reaction.  We first used phenyl 
vinyl sulfone (1.126), because it was well precedented to serve as an active Diels-Alder 
partner.
66
  We added a wide variety of Lewis acids to a solution of sulfone 1.126 in the 
presence of 2,5-dimethylfuran (1.67)  to screen for catalytic activity (Scheme 1.36).  The 
Lewis acids shown in bold are those that promoted at least some reaction.  
Trimethylaluminum gave approximately 7% conversion as judged by H
1 
NMR spectrum 
of the crude reaction mixture.  Boron trifluoride diethyl etherate and other aluminum 
based Lewis acids were also capable of generating trace amounts of 1.139, but these 




Scheme 1.36: Screening for Lewis acid catalysis  
 
 
The trimethylaluminum-promoted reaction was then examined in more detail and 
optimized to see if synthetically useful yields could be obtained (Table 1.1).  The relative 
equivalence of all reagents, reaction concentration, and temperature were varied, and we 
found that increasing the equivalents of dimethylfuran, the Lewis acid, and the reaction 
concentration all significantly improved the percent conversion.   Lowering the 
temperature improved the endo/exo selectivity.  Varying the solvent had little effect on 
the yield. The major endo-cycloadduct 1.140 was recrystallized, and its structure was 
proven by X-ray crystallography (Figure 1.5).  The ratio of the endo/exo-cycloadducts 
was determined by integration of the proton alpha to the sulfone in the 
1
H NMR spectrum 
of the purified mixture.  The characteristic proton appears at δ 3.54 ppm for 1.140 and at 









Table 1.1: Optimization of the trimethylaluminum promoted Diels-Alder reaction 
 
 
All reactions run for 36 h in anhydrous CH2Cl2.  
a
AlMe3 added as a 2 M solution in 
hexane.  
b
Percent conversion measured by HNMR integration.  
c
Ratio measured by 
HNMR integration.  Other solvents screened: hexanes, CH3CN, DMF, Et2O, THF, 




















Figure 1.5: Crystal structure of major endo-cycloadduct 1.140 
 
 
With these results in hand, we applied the same conditions to the other 
dienophiles 1.132 and 1.133 (Table 1.2).  We found that we were able to catalyze each 
reaction with dimethyl furan 1.67 in acceptable yield, giving the respective cycloadducts 
1.143, 1.144. 1.145 in 62-95% conversion by analysis of the 
1
H NMR spectrum of the 
crude reaction mixture.  The results represent the first Lewis acid catalyzed Diels-Alder 













Table 1.2: Application of the trimethylaluminum conditions to 1.126, 1.132, and 1.133 
 
 
Having found conditions to promote the cycloaddition of each dienophile with 
furan 1.167, we examined the series of chiral ligands 1.146-1.149 that might be used to 
pair with aluminum Lewis-acids (Figure 1.6).  Ligands 1.147-1.148 and Lewis acid 1.146 
were already on-hand, and ligand 1.149 was synthesized according to a known literature 
procedure.
70
  Lewis acid 1.146 came pre-prepared with the aluminum metal center, 
whereas ligands 1.147, 1.148, and 1.149 needed to be premixed with an aluminum Lewis 
acid to form the active catalyst. 
 





Chiral ligand 1.149 was prepared from (L)-valine (1.150) via the three-step 
sequence shown in Scheme 1.37.
70
  The reduction of 1.150 to alcohol 1.151 was 
performed using LiAlH4,
71
 and the aziridine 1.152 was prepared from 1.151 via an 
intramolecular displacement and used without purification.  Ring-opening of 1.152 with 
benzylamine gave the desired ligand 1.153 along with side product 1.154, which was not 




CNMR spectra.   
 
Scheme 1.37: Preparation of valine derived chiral ligand 1.153 
 
 
Before we could begin a full chiral Lewis acid screening, we prepared racemic 
samples of cycloadducts 1.143-1.145 in order to develop HPLC methods to determine 
enantiomeric excesses.  When working with cycloadduct 1.145, we quickly realized that 
we could not detect its isomers using HPLC UV absorbance detectors, this made it very 




effort to append a UV active group onto 1.145, we attempted to ring-open the 
oxazolidinone ring of 1.145 with aromatic nucleophiles (Scheme 1.38).  Despite some 





Scheme 1.38: Failed attempts or derivatize 1.145 for HPLC studies 
 
 
As a result of some related work, we found that the oxazolidinone of oxabicycle 
1.145 could be decarbonylated in to alcohol 1.158 76% yield upon exposure to sodium-
mercury amalgam in methanol.  The free hydroxyl group of 1.158 was then benzoylated 




yield (Scheme 1.39).  This method would enable us to determine the enantioenrichment 
of cycloadduct 1.145. 
 
Scheme 1.39: Method for derivatization of 1.145, leading to visibility by HPLC detectors 
 
 
Chiral Lewis acid 1.146 and chiral ligands 1.147-1.149 were screened in the [4+2] 
cycloaddition between dimethylfuran 1.67 and vinyl sulfone 1.126 (equation 1.1), vinyl 
sulfonate 1.132 (equation 1.2), and vinyl sulfonamide 1.133 (equation 1.3).  The yields 
and selectivities varied from poor to moderate under each set of circumstances; below is a 
summary of the best of those results for olefins 1.126, 1.132, and 1.133. 
Enantioselective Diels alder of the vinyl sulfone 1.126 with 1.67 worked 
optimally when promoted by bis-triflamide ligand 1.148 complexed with 
trimethylaluminum to give a 43% yield of cycloadduct 1.139 as a ratio (1.4:1.0) of 
endo:exo isomers as determined by analysis of the 
1
H NMR spectrum of the purified 
cycloadduct (equation 1.1).  However, the enantiomeric excess, was only 11% for the 
major endo-isomer.  Similarly, vinyl sulfonate 1.132 reacted with dimethylfuran 1.67 in 
the presence of ligand 1.148 and trimethylaluminum, to give 50% yield of 1.44 as a 
mixture (2:1) of endo/exo-isomers by analysis of the 
1
H NMR spectrum of the purified 
cycloadduct (equation 1.2), with the characteristic protons alpha to the sulfonate 




for the major isomer.  Finally, the best conditions for the Diels-Alder cycloaddition of 
sulfonamide 1.135 involved using precomplexed ligand 1.146, to give cycloadduct 1.145 
in 54% yield as a mixture (1:1) of endo- and exo-isomers by analysis of the 
1
H NMR 
spectrum, with the characteristic protons alpha to the sulfonamide appearing at 2.26 ppm 
and 2.01 ppm.  Unfortunately, the enantiomeric excess of the major isomer was also only 




While the preceding reactions represent the first examples of an enantioselective 
Diels-Alder cycloaddition of a vinyl sulfone with a furan that was promoted by chiral 




acceptable catalyst loadings to be synthetically useful.  Accordingly, we are no longer 
exploring chiral Lewis-acid mediated cycloadditions of this type.   
 
1.4.1.2. Exploration of diastereoselective cycloaddition with chiral vinyl sulfoxide 1.82 
With the failure of the exploratory survey of chiral Lewis acid mediated 
cycloadditions of vinyl sulfone derivatives with furan, we turned our attention towards a 
more precedented technology.  We focused on two promising methodologies:  
Aggarwal’s chiral bis-sulfoxide 1.79 (Scheme 1.24), and Kagan’s highly reactive chiral 
vinyl sulfoxide 1.81 (Scheme 1.25).  Several questions stood out when assessing whether 
these methodologies would be suitable for our needs.  Firstly, will these methods work 
with substituted tetrahydrofurans?  Secondly, can we improve upon the disadvantages of 
each technique to create a simple, effective, and versatile methodology?   
Based on our survey of the chemical literature, chiral sulfoxonium salt 1.82 and 
the bis-sulfoxide 1.79 became of interest to us due to their promising results (Schemes 
1.24 and 1.25) with furan (Figure 1.7).  Accordingly, screened dienophiles 1.82 and 1.79 
for encouraging reactivity with 2,5-substiuted furans, and to create a starting point for 
any improvements or developments needed for the methodology.   
 






Dienophile 1.81 was prepared from (-)-(1R)-menthyl (S)-p-toluenesulfinate 
(1.160) by a procedure that was a modification of the literature report (Scheme 1.40).
58
  
Namely, it had been previously determined in the Martin group that the displacement of 
the menthyl group of 1.160 with freshly prepared vinylmagnesium bromide to form 1.81 
proceeded more smoothly in benzene rather than in ether as reported earlier.
8
    Finally, 
alkylation of 1.81 using ethyl Meerwein’s reagent afforded 1.82, which was directly used 
in the cycloaddition. 
 
Scheme 1.40: Synthesis of chiral vinyl sulfoxide 1.81, and activation by Meerwein’s salt 
 
 
Initial screening of dienophile 1.82 began with using 2,5-dimethylfuran (1.67) as 
the cycloaddition partner,  because it had previously been shown in the Martin lab to 
react with 1.82 in moderate yield (73%), endo:exo selectivity (2:1) of cycloadducts 1.161 
and 1.162, and π-facial selectivity (endo d.e. = 77%, exo d.e. = 82%) after some minor 
optimization (Scheme 1.41).
8
  The hope was that we could enhance these results and 











Dienophile 1.82 was subjected to a number of conditions (Table 1.3) to determine 
the effects of temperature and solvent on the reaction.  The diasteriomeric excess (de) 
refers to the excess between the two possible endo adducts 1.161 or the ratio between the 
two possible exo adducts 1.162, as determined by analysis of the 
1
H NMR spectrum, with 
the characteristic protons alpha to the sulfoxide appearing at 3.19 ppm  and 2.88 ppm, 
respectively.   The absolute structural assignments of 1.161 and 1.162 were confirmed by 






































1 CH3CN 12 -20 65% 87 68 4:1 
2 CH2Cl2 12 -20 >95% 90 84 5:1 
3
b
 EtOAc 12 -20 40% n/a n/a n/a 
4
b
 Toluene 12 -20 50% n/a n/a 3:1 
5
b
 CHCl3 12 -20 <10% 90 n/a 5:1 
6 CH2Cl2 48 -20 >95% 90 84 5:1 
7
c
 CH2Cl2 12 -78 <5% n/a n/a n/a 
8 CH2Cl2 12 -40 54% 82 77 3:1 
10
d
 CH2Cl2 12 0 >90 80 85 2:1 
11
d
 CH2Cl2 12 25 >40% n/a n/a n/a 
12
e
 CH2Cl2 12 50 0% n/a n/a n/a 
aYields and diasteriomeric excess calculated by NMR integration of characteristic protons of  1.81, 1.161 and 1.162. 
bUnidentified impurities in NMR did not allow for accurate integration of characteristic protons.cRecovered starting 
material, no detectable product ratios by NMR.. dSignificant decomposition to a mixture of unidentified side products.  
Product appears to be mostly exo.  eNo visible product or starting material via nmr.fReaction stirred for 1 h at -78 ºC, then 









Figure 1.8: Crystal structures of the major endo and exo cycloadducts 1.161 and 1.162. 
 
 
The results using dichloromethane as a solvent (Table 1.3, entry 2) were 
encouraging because they demonstrated that substitution on the 2- and 5-positions of 
furan actually have little or no effect on the selectivity of the reaction relative to those 
obtained with furan itself.  While the diastereomeric excess and yield are very close to 
those reported by Kagan with furan (Scheme 1.25), the endo:exo ratio improved  from 3:2 
to 5:1.  The improved selectivity probably occured because the reaction was conducted at 
lower temperature than with furan.  The greater reactivity of dimethylfuran can be 
attributed to higher HOMO levels than those of furan.
73
  
 We were initially concerned that mild heating during the removal of solvent in the 
work-up procedure might cause a retro Diels-Alder that could either equilibrate the 
products or reduce yield.  However, temperature studies in an NMR tube containing pure 
diastereomers of the main endo-product 1.161 and exo-product 1.162 showed no trace of 







In an effort to expand the scope of the cycloaddition, 2-methylfuran (1.163) and 
2-furaldehyde (1.164) were tested with dienophile 1.82.  The reaction of methylfuran 
1.163 was comparable to that of 2,5-dimethyl furan, giving a ratio of three isomers of 
cycloadducts 1.165 in greater than 95% yield in a ratio of 50:10:1 by NMR (Scheme 
1.42).  All attempts to purify the individual diastereomers by reverse phase HPLC were 
unsuccessful.  The main isomer was identified as the endo isomer based on the 
characteristic downfield shift of the proton alpha to the sulfoxide (δ 3.05 ppm).  After 
some optimization, the main product was isolated by normal phase HPLC using a chiral 
ODH analytical column.  The stereochemistry relative to the bridgehead methy group 
was determined by a distinct NOE coupling between the aromatic proton and the endo 
proton beta to the sulfur (a) along with the COESY and NOE coupling of the endo-proton 








Scheme 1.42: Testing of dienophile 1.82 with 2-methylfuran 
 
 
The electron deficient diene 2-furaldehyde (1.165) was unreactive with dienophile 
1.82 and gave only recovered starting material (Scheme 1.43).   
 
Scheme 1.43: Testing of dienophile 1.82 with 2-furaldehyde 
 
 
1.4.1.2. Diastereoselective cycloaddition with chiral bis-sulfoxide 1.79 
In order to determine the most suitable dienophile we synthesized 1.79 according 
to a known procedure (Scheme 1.44).
74
  Accordingly, benzyloxyacetaldehyde dimethyl 
acetal (1.67) was converted to thioacetal 1.169 using ethanedithiol (1.168) and HCl. 
Although the original procedure required a chromatographic purification of 1.169, we 
found this tedious step could be avoided by working up the reaction with multiple 




and mixed S,O-acetal 1.170 from the reaction mixture.  Diastereoselective oxidation of 
thioacetal 1.169 afforded 1.171 in 56% yield as compared to the 68% reported in the 
literature.
75
  The enantiomeric excess was determined to be 96% by chiral HPLC.  Some 
over-oxidized product 1.176 and mono-oxidized substrate 1.177 were isolated along with 
recovered starting material.   
 
Scheme 1.44: Synthesis of Aggarwal’s bis-sulfoxide 1.79 
 
 
The reported conditions for converting of 1.174 to the tertiary amine 1.175 used 




dimethylamine gas is prohibitively expensive. Conditions were screened using 
commercially available dimethylamine in a variety of solvents, and we eventually found 
that dimethylamine in ethanol (33%) gave 1.175 in 96% yield.  The purification of 1.175 
proved to be exceptionally difficult due to its high polarity and instability on silica gel.  
When 1.172 was purified by chromatography on silica in the presence of methanol, only 
methoxy-substituted product 1.175 was recovered.  Various solvent systems on silica and 
neutral and basic alumina were tested, and eventually we found that using 100% acetone 
with 0.1% triethylamine on silica was found to be an acceptable chromatographic system 
for the purification of 1.172 without any detectable loss due to conjugate addition.   
 The Hoffman elimination to convert 1.172 to target dienophile 1.79 also led to a 
difficult purification step. The bis-sulfoxide 1.79 was reportedly purified by column 
chromatography with acetone.   Surprisingly, these conditions led exclusively to the 
formation of a number of unidentified side products.  Dienophile 1.79 appears to be 
sensitive to prolonged exposure to water, which prevented any aqueous workup of the 
reaction.  The reaction mixture was thus concentrated, and crude 1.79 was isolated along 
with a large amount of ammonium salts.  Some attempts to precipitate the salts from 
pentane/ether mixtures were mildly successful, giving 1.79 in ≈80% purity.  Column 
chromatography conditions were screened, and it was found that 1.79 could be isolated in 
good yield with minimal formation of unwanted side products by filtering the crude 
material through a short silica gel column with pure acetonitrile.   
Similar to the reported reaction of 1.79 with furan, we found that 1.79 underwent 
facile cycloaddition with dimethylfuran (1.67) at room temperature.  Although the 
reaction in dichloromethane gave slightly better diastereomeric excess (Table 1.4, entry 




catalysis with residual acid (Table 1.4, entry 3).  Chloroform was thus chosen as the 
optimal solvent due to the assumption that the increased reactivity may allow us to 
perform the reaction at lower temperatures, thus hopefully achieving greater 
stereoselectivity.  A number of Lewis acids were screened, tin tetrachloride and scandium 
triflate improved the diastereomeric excesses (Table 1.4, entries 8 and 9).  Structures of 
1.176 and 1.177 were assigned tentatively based on a further downfield shift of the 
protons beta to the sulfoxides at δ 2.60 ppm for 1.176, versus δ 2.39 ppm for 1.177.  
However, determination of the structures has not been achieved.  Although the 
cycloaddition proceeds cleanly and in high yield, separation conditions for 1.176 and 
















Table 1.4: Screening of dienophile 1.79 with dimethyl furan under various conditions 
 







1 CH2Cl2 12 25 88 86 none 
2 CH3CN 50 25 86 81 none 
3 CHCl3 5 25 >95 83 none 
4 CHCl3 12 -20 17 82 none 
5 CHCl3 12 0 49 82 none 
6
 c
 CHCl3 10 50 54 87 none 
7 CHCl3 12 25 70 82 ZnCl2 
8 CHCl3 12 25 64 89 Sc(OTf)3 
9
 d
 CH3CN 8 -78 n/a 90 SnCl4 
10 CH3CN 8 -78 30 74 BF3OEt 
a
Yields and diasteriomeric excess calculated by NMR integration of the characteristic 
protons beta to the sulfoxide. 
b
1 eq of additive. 
c
Crude mixture contained significant 
decomposed material.  
d
Unidentified impurities in NMR did not allow for accurate 
integration of characteristic protons.  
 
A summary of the best results from the early development work with tolyl vinyl 
sulfoxide 1.81 and chiral bis-sulfoxide 1.79 are summarized in equations 1.6 and 1.7.  
Activated vinyl sulfoxide 1.82 reacted with dimethylfuran 1.67, giving a mixture (5:1) of 
cycloadducts 1.161 and 1.162 in 95% yield (equation 1.7).  The major product was endo-




Bis-sulfoxide 1.79 reacted with 1.67, without the need for a promoter at room 





Both of these results were promising, and we hoped to use one of these 
dienophiles as the starting point for developing our new methodology.  When examining 
equation 1.6 and equation 1.7, we decided to pursue the adaptation of chiral vinyl 
sulfoxonium salt 1.82, and discontinue explorations using bis-sulfoxide 1.79.  This 
decision was made because the synthesis of 1.79 was long and problematic due to the 
many difficulties encountered during purification and scale-up.  Additionally, the 
separation and visualization of adducts 1.176 and 1.177 was quite difficult by both HPLC 





1.4.1.3. Improvement and optimization of the cycloaddition 
Based upon our results with the vinyl sulfoxide 1.81, we concluded that there 
were several shortcomings that needed to be overcome.  We wanted to eliminate the 
additional step to form the sulfoxonium salt 1.82 from the sulfoxide 1.81 (Scheme 1.25), 
perhaps using a Lewis acid instead of Meerwein’s salt as an activator.  Secondly, we 
wanted to reduce the furan loading as this is important when this methodology is applied 
to more substituted furans.  For example, a high furan loading would lead to an 
inefficient route in the context of our ongoing total synthesis of coristatin A.
8
  Lastly, we 
wanted to improve the yield, endo:exo ratio, and enantioselectivity. 
In an effort to avoid using ethyl Meerwein’s salt to form a sulfoxonium salt 1.81, 
we explored the possibility of a Lewis acid catalyzed reaction.  We decided to use 
racemic vinyl sulfoxide 1.178 in order to screen cycloaddition conditions.  To this end, 
racemic vinyl sulfoxide 1.79 was synthesized from thiophenol (1.179) and dibromoethane 
to give 1.180 in 31% yield (Scheme 1.45).  Compound 1.180 was distilled from the 
reaction mixture and used directly in the oxidation with hydrogen peroxide to give 
racemic 1.178 in good yield along with trace over-oxidized phenyl vinyl sulfone.  It 
should be noted that phenyl vinyl sulfoxide (1.178) was prepared for our model system 










Scheme 1.45: Preparation of phenyl vinyl sulfoxide for catalyst screening 
 
 
We explored Lewis acid-catalyzed reactions of 1.178 with dimethylfuran 1.67.  
Use of AlMe3, SnCl4, TiCl4, and Sc(OTf)3 failed to give any detectible amount of desired 
cycloadduct 1.181 (Scheme 1.46).   
 
Scheme 1.46: Failed Lewis acid screening for phenyl vinyl sulfone Diels-Alder 
 
 
However, we discovered that BF3OEt2 promoted the cycloaddition between 1.178 
and 1.67 giving 1.181 in 38% yield as a mixture (1.00:0.86) of endo and exo isomers 
(Scheme 1.47).  The endo:exo ratio was determined by integration of the characteristic 
protons alpha to the sulfoxide by 
1
HNMR, with the endo isomer appearing at δ 3.05 ppm 






Scheme 1.47: First successful Lewis acid catalysis with BF3•OEt2 
 
 
When the Lewis-acid was switched to TMSOTf, 1.178 underwent cycloaddition 
with dimethylfuran to give 1.67 in good yield (Scheme 1.48).  The stereochemistry of 
cycloadduct 1.181 was determined to be solely the endo isomer by analysis of the 
1
H 
NMR spectrum of the purified cycloadducts.  The structure of 1.181 was confirmed by X-
ray crystallography (Figure 1.9).  As the number of equivalents of TMSOTf was dropped 
from two to one-half, the yield dropped from 73% to 49%. 
 









Figure 1.9: Crystal structure of endo cycloadduct 1.181 
 
 
A control reaction was performed to determine whether the reaction was 
catalyzed by trace amounts of triflic acid (Scheme 1.49).  Phenyl vinyl sulfoxide (1.178) 
was exposed to half an equivalent of triflic acid in the presence of dimethylfuran 1.67.  
Because only a trace amount of 1.181 was observed, we concluded that the reactions 
were not catalyzed by Brønsted acid. 
 
Scheme 1.49: Control experiment for triflic acid catalysis 
 
 
In a related study, we examined whether other activating agents such as acylation 




to acetic anhydride with a catalytic amount of DMAP in the presence of dimethylfuran 
1.67 at room temperature, no reaction was observed by TLC (Scheme 1.50).   
 
Scheme 1.50: Attempt to active phenyl sulfoxide 1.178 with acetic anhydride 
 
 
When triflic anhydride was used as an acylating agent the sulfoxide 1.178 
decomposed rapidly, even at low temperatures (Scheme 1.51).  No trace of cycloadduct 
1.181 was detected.  No further exploration into activation of the sulfoxide via acylation 
was done. 
 
Scheme 1.51: Attempt to activate phenyl sulfoxide 1.178 with trifluoroacetic anhydride 
 
 
 We then sought to optimize the conditions for the cycloaddition of 1.178.  
Optimization began with an initial solvent screen with toluene, Et2O, THF, hexane, 
CH2Cl2, and CH3CN.  Of these solvents, the reaction worked in Et2O and CH3CN; 




and temperature were then explored, and we found that higher concentrations improved 
the yield.  Concentrations higher than 1 M tended to become too viscous or freeze at low 
temperatures.  Temperatures lower than -30 °C made the reaction sluggish, and raising 
the temperature eroded the endo:exo ratio.   
After we had found the optimal Lewis-acid, solvent, temperature, and 
concentration for the cycloaddition, we sought to lower the number of equivalents of 
furan (Scheme 1.52).  The yield of 1.181 dropped only 10% when only one equivalent of 
dimethylfuran 1.67 was used, giving cycloadduct 1.181 in 63% yield.  When ten 
equivalents of dimethylfuran was used, the yield remained essentially unchanged from 
when five equivalents were used, forming adduct 1.181 in 72% yield.  Encouraged by the 
fact that yields were only slightly lower when using one equivalent of furan, we hoped 
that with further optimization, we might be able to lower the furan equivalence without a 
significant decrease in yield. 
 
Scheme 1.52: Furan equivalence screening 
 
 
The tendency of TMSOTf to hydrolyze rapidly in the presence of trace amounts 
of moisture led us to suspect that traces of protic acid may interfere with the reaction; 




by adding hindered bases or water scavengers to the reaction and neutralize any residual 
acid present (Scheme 1.53).  A number of additives were screened, including, 2,6-di-tert-
butylpyridine (1.182), diisopropylethylamine, tetramethylpiperidine 1.183, triethylamine, 
lutidine, NaH, molecular sieves, and proton sponge 1.184.  We found that 2,6-di-tert-
butylpyridine (1.182) successfully limited the amount of polymerization of the furan and 
led to an improvement in the yield of 1.181 from 63% to 82%.  The addition of this 
hindered base also allowed us to lower the TMSOTf loading from two to one equivalent.   
 







 After successfully optimizing the cycloaddition of 1.67 with racemic phenyl vinyl 
sulfoxide (1.178), it was necessary to develop a procedure to synthesize 1.178 in 
enantiopure form.  A procedure involving a diastereomeric resolution with (-)-menthol 
has been used to prepare p-tolyl vinyl sulfoxide (1.81),
76
 and we adopted a similar 
procedure for the synthesis phenyl vinyl sulfoxide (1.178) (Scheme 1.54).  Addition of (-
)-menthol to racemic 1.178 gave a mixture (1:1) of diastereomers 1.185 in 36% yield 
(Scheme 1.56).  This mixture was separated by repeated recrystallization from pentane at 
low temperature to give 1.186 in 31% yield and 93% diastereomeric excess and 1.187 in 
35% yield and 90% diastereomeric excess.  The double bond was then regenerated using 
potassium hydride in THF and methyl iodide to trap the mentholate.  This led to the 
formation of pure vinyl sulfoxides (-)-1.178 and (+)-1.178, both in 90% or greater 
enantiomeric excess as determined by HPLC.  In an attempt to improve the 
diastereoselectivity, the same procedure was performed with (-)-borneol (1.188); 




















We wanted to confirm that that phenyl-substituted vinyl sulfoxide 1.178 was 
indeed a better dienophile for the cycloaddition than p-tol-substituted vinyl sulfoxide 1.81 
under optimized conditions.  In order to synthesize racemic 1.81 for the study, p-
thiocresol (1.189) was deprotonated with NaOEt and then treated with dibromoethane; 
elimination occurred in situ to give 1.190 in 29% yield (Scheme 1.55).  Thioether 1.190 
could be distilled from the crude reaction mixture and used directly in the subsequent 
oxidation with m-CPBA to give racemic 1.81 in 68% yield after chromatography.  
  
Scheme 1.55: Synthesis of racemic vinyl sulfoxide 1.81 
 
 
 We then allowed (±)-1.81 and dimethylfuran 1.67 to react in the presence of 
TMSOTf.  The endo adduct 1.161 was isolated in 54% yield (Scheme 1.56).  The 
structural assignment was based on the characteristic downfield 
1
HNMR chemical shift 









Scheme 1.56:  Application of Lewis-acid catalyzed condition to tolyl sulfoxide 1.81 
 
 
We hypothesized that perhaps the electron donating character of the methyl group 
of 1.81 was responsible for the decreased yield relative to 1.178.  To probe the electronic 
effects chlorophenyl vinyl sulfoxide 1.191 was synthesized following the procedure 
outlined in Scheme 1.57.  The disulfide 1.192 was reduced with NaBH4 to give 
thiophenol
77
 and then deprotonated with freshly prepared sodium ethoxide and treated 
with dibromoethane, elimination occurred in situ to give the vinyl sulfide 1.193.  
Oxidation of the sulfide to sulfoxides with hydrogen peroxide in acetic acid gave the 
vinyl sulfoxide 1.191. 
 
Scheme 1.57: Synthesis of novel dienophiles with electron withdrawing aryl substituents 
  
In order to compare the reactivity of all vinyl sulfoxides, 1.81, 1.178, and 1.191 




chlorovinyl sulfoxide 1.191, cyclized with dimethylfuran to give 1.194 in 98% yield as a 
mixture (20:1) of endo:exo adducts.  The endo:exo ratio was determined by integrating 
the characteristic chemical shifts of the proton alpha to the sulfoxide.  The endo isomer 
alpha proton appears at δ 3.39 ppm and the exo isomer at δ 2.75 ppm in the 
1
H NMR 
spectrum.  We believe that this increase in yield is likely a consequence of the lowering 
of the LUMO of the dienophile by the increased electron deficiency caused by changes in 
the orbital coefficients, which cause stronger secondary orbital interactions and a larger 
regiochemical preference.
78
 The structure of the exo cycloadduct was determined by X-
ray crystallography (Figure 1.10).  Based on these results, we chose to develop 1.191 as 
the dienophile for our methodology. 
 








Figure 1.10: Crystal structure of exo cycloadduct 1.194 
 
 
 We found that 1.191 reacted with furan (1.46) to give 1.195 in 99% yield, albeit 
with a lower endo:exo selectivity (1.6:1) (Scheme 1.58).  The endo:exo ratio was 
determined by integrating the characteristic chemical shifts of the proton alpha to the 
sulfoxide.  The endo isomer alpha proton appears at 3.69 ppm and the exo isomer at 3.11 
ppm in the 
1
H NMR spectrum.  The structure of the major endo product was determined 
by X-ray crystallography (Figure 1.11).  Furan proved to be very prone to polymerization 
even in the presence of base, so a large excess of furan was required.   
 






Figure 1.11: Crystal structure of endo cycloadduct 1.195 
 
 
The Diels-Alder reaction between racemic sulfoxide 1.191 and 2-methylfuran 
(1.163) was more difficult than with dimethylfuran.  Although the reaction was complete 
within two hours, giving almost entirely the endo cycloadduct as a single regioisomer in 
approximately 65% yield (Scheme 1.59).  The reaction was problematic due to the 
propensity of 2-methylfuran (1.163) to polymerize, causing the solution to become 
viscous.  Product purification and identification was also made difficult because of the 
presence of intractable polymer residue.  The structure of 1.196 was confirmed by 
obtaining an X-ray crystallography (Figure 1.12). 
 







Figure 1.12: Crystal structure of endo-cycloadduct 1.196 
 
 
We sought to demonstrate that we could synthesize 1.191 enantioselectively.  
Following a procedure, similar to that used previously for 1.178, we added (-)-menthol to 
1.191 in a conjugate fashion giving a mixture (1:1) of diastereomers 1.197 and 1.98 in 
81% yield (Scheme 1.60).  After a single recrystallization, we obtained 1.197 in >95% 
diastereomeric excess by 
1
H NMR spectroscopy and 37% yield.  We obtained 1.197 in 
35% yield after column chromatography of the mother liquor and in >95% diastereomeric 
excess by integration of the characteristic protons alpha to the sulfoxide in the 
1
H NMR 
spectrum.  The chemical shifts of the alpha protons for 1.197 appeared at 3.57 ppm and 
1.198 at 3.76 ppm.  The structure of 1.197 was determined by obtaining an X-ray 
crystallography (Figure 1.13). We also examined (-)-borneol (1.188) and  (R,S)-trans-2-
phenylcyclohexanol (1.199) and as potential resolving agents, but both gave inseparable 














Figure 1.13: Crystal Structure of the recrystallized diastereomer 1.197 
 
 
With diastereomerically pure 1.197 and 1.198 in hand, we explored the 
elimination of the mentholate to give the desired enantiopure chiral vinyl sulfoxide 1.191.  
Previously this type of elimination was done with KH in the presence of MeI, a procedure 
that unfortunately destroyed the mentholate.
76
  These conditions gave 1.191 in 30% yield; 
but, before optimizing this procedure, we sought to develop conditions that would allow 
for the recovery of the menthol.  We would thus further improve the utility of the method.  
After screening a number of bases, we found that freshly prepared LiHMDS was the 
optimal base for eliminating the mentholate, giving (-)-1.191 in 61% yield and >99% 
enantiomeric excess by HPLC, and (+)-1.191 in 66% yield and >99% enantiomeric 
excess by HPLC (Scheme 1.60). 
 All that remained was to determine the diastereoselectivity of the cycloaddition of 
1.67 with enantiopure sulfoxide 1.191 under our optimized conditions.  Chiral sulfoxide 
(-)-1.191 thus underwent the Diels-Alder with dimethylfuran 1.67 to give 1.194 in 98% 






Scheme 1.61: Highly stereoselective Diels-Alder reaction with 1.191 
 
 
We then needed to address the polymerization issue when using 2-methylfuran 
(1.163).  We thus found that use of TBSOTf as the Lewis-acid avoided furan 
polymerization.  In the case of 2-methylfuran (1.163), we were able to lower the furan 
loading from 30 to 2 equivalents (Table 1.6).  This change improved the yield of the 
monosubstituted bicyclic sulfoxide 1.196 from 65% yield (Scheme 1.159) to 89% yield.  
In the cases of methylfuran 1.163 and dimethylfuran 1.67, it was possible to use a 
substoichiometric amount of TBSOTf and still obtain high yield and diastereomeric 
excess.  The use of one equivalent of Lewis acid was still required to obtain complete 
consumption of the sulfoxide in the case of furan (1.46).  The yield and selectivities 
achieved when reacting 1.191 with furan (1.46) are better than those reported by Kagan 
using 1.81; there was a 26% improvement in yield and a 19% increase in diastereomeric 
excess.
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The Diels-Alder cycloaddition of 1.191 was thus developed to a satisfactory level, 
but, we would later find that the chemistry used to elaborate the oxabicyclic cycloadducts 
to the tetrahydrofurans 1.1 was more amenable to a sulfone moiety rather than the 
sulfoxide functionality (vida infra).  Specifically, oxidative cleavage and ROCM of 
cycloadducts 1.194 and 1.196 was only viable with their sulfone analogues.  We thus 
needed a way to oxidize the sulfoxide to the sulfone without affecting the yield or 
enantioselectivity.  Moreover, we wanted to avoid an additional synthetic step.  




Our initial goal was to find an oxidant that could oxidize the sulfoxide 1.194 to 
the sulfone 1.200.  To avoid the additional complication of running the cycloaddition 
prior to screening each potential oxidant, we instead added various oxidants to a solution 
of pure 1.194 in dichloromethane (Scheme 1.62).  No reaction was detected with aqueous 
hydrogen peroxide.  Addition of mCPBA resulted in a rapid oxidation of 1.194 to a 
mixture (2:1) of 1.200 and epoxy-sulfone 1.201.  Oxone failed to react with 1.194 until 
acetone was added to the reaction mixture, whereupon it gave a mixture (25:1) of 1.200 
and over oxidized side product 1.201 in 95% yield.  The formation of 1.201 might arise 
from the generation of dimethyldioxirane from acetone and Oxone.   
To better simulate the quench with NaHCO3 during the one pot 
cycloaddition/oxidation sequence, we added aqueous NaHCO3 to a solution of pure 1.194 
in dichloromethane prior to the addition of the Oxone and acetone.  We found a much 
poorer ratio (2:1) of sulfone 1.200 and over-oxidized product 1.201.  This may be due to 
increased formation of DMDO, promoted by the NaHCO3.
79
  By lowering the 
temperature to 0 °C the over oxidation could be better controlled, giving a mixture (13:1) 
of 1.200 and 1.201 in 90% yield.  The structure of the main product 1.200 was confirmed 









Scheme 1.62: Model study for determining optimal oxidative workup conditions 
 
Figure 1.14: X-ray crystal structure of oxidized cycloadduct 1.200 
          
 
A one-pot cycloaddition, quench, and oxidation was performed with vinyl 
sulfoxide 1.191 and dimethylfuran 1.67 the optimized cycloaddition conditions.  After 




mixture was stirred for 6 h at room temperature; the sulfone 1.200 was thus isolated in 
80% yield  along with epoxide 1.201 in 8% yield (Scheme 1.63).   
 
Scheme 1.63: One-pot cycloaddition and oxidation procedure 
 
 
The one-pot oxidative workup procedure was then modified to use triethylamine 
instead of NaHCO3 as the quenching base; the use of triethylamine improved the yield 
and minimized the amount of over oxidized product 1.201.   We now sought to conduct 
this new one-pot sequence with each furan, and the results are summarized in Table 1.7.  
Although the yield of the cycloadducts 1.200 and 1.202 dropped slightly to 81 and 88%.  











Table 1.7: Optimized cycloaddition for all substrates using oxidative workup protocol 
 
 
1.4.2. Development of the Ring-Opening Cross Metathesis (ROCM) 
With an established method for the asymmetric synthesis of substituted 
oxabicycles, we turned our attention toward developing techniques for elaborating such 
systems into tetrahydrofurans such as 1.1.  Specifically, we were interested in routes to 
open oxabicyclic systems such as 1.194 or 1.200 by either cleavage of the olefin, thereby 
generating a tetrahydrofuran.  One method of interest was by ring-opening cross 






Initial explorations into the ROCM were performed using oxabicyclic sulfoxide 
1.181.  Our screening began using conditions comparable to those reported by Rainier for 
a similar oxabicyclic system, wherein ethyl vinyl ether was used as a metathesis cross-
partner.
41
  A solution of cycloadduct 1.181 and ethyl vinyl ether was exposed to a variety 
of common metathesis catalysis (Scheme 1.64), including Grubbs 1
st
 generation catalyst 
1.204, Grubbs 2
nd
 generation catalyst 1.205, or Hoveyda-Grubbs 2
nd
 generation catalyst 
1.206 (Figure 1.15).  However, all catalysis failed to give any of the desired 
tetrahydrofuran 1.207.  The regioselectivity shown in Scheme 1.64 reflects that of the 
example by Rainier (Scheme 1.14). 
 











Figure 1.15: Metathesis catalysts 
 
 
Sulfoxides are known to complex with ruthenium catalysts, so we hypothesized 
that the Lewis-basic oxygen atom of the sulfoxide might be forming a chelate such as 
1.208 thereby halting the catalysis (Figure 1.16).
80
  In an effort to break up this putative 
interaction, we screened several Lewis acids, but, MgBr2, LiCl, and Sc(OTf)3 all failed to 
give any trace of ring-opened tetrahydrofuran 1.207; upon heating these reaction the retro 
[4+2] cycloaddition ensued (Scheme 1.65).  Ti(OiPr)4 was the only Lewis acid that did 
not promote the retro-cycloaddition; but, it also failed to induce the ROCM.   
 







Scheme 1.65: Attempts at ROCM with Lewis acid additives 
 
 
When a similar reaction was performed with 1.181 and styrene the 
tetrahydrofuran 1.209 was isolated in 99% yield and the ring opened material was 
isolated in 99% yield, as a single regio- and diastereoisomer (Scheme 1.66).  No 1.210 
was detected.  The regiochemical structural assignment was based on the nOe coupling 
between the vinylic protons of the styrene moiety and the tertiary methyl group.  The 
trans configuration was assigned based upon the coupling constants of the vinylic protons 
(J = 15.9 Hz).  Catalyst loading lower than 10 mol % resulted in exceptionally long 









Scheme 1.66: First successful ring-opening cross metathesis using styrene 
 
 
The ROCM of styrene with sulfoxide 1.181 required a high catalyst loading, so, 
we queried whether the ROCM with the less Lewis basic sulfone 1.140 might require less 
catalyst.  We found that sulfone 1.140 reacted with styrene to give tetrahydrofuran 1.211 
as a single regio- and stereoisomer in 99% yield and required only 2 mol % catalyst 
loading (Scheme 1.67).   The structural assignments were made on the basis of the nOe 
interaction between the vinylic protons and the tertiary methyl groups.  The trans 
configuration was assigned based on the coupling constants (J = 15.8 Hz) of the vinylic 










Scheme 1.67: Improved results using the sulfone auxiliary 
 
 
However, 1.140 failed to react with ethyl vinyl ether in the presence of any of the 
catalysts 1.204-1.206 (Scheme 1.68).  This lack of reactivity was surprising, considering 
how well this olefin cross-partner performed in similar literature reports.
41 
 
Scheme 1.68: No reaction with ethyl vinyl ether cross-partner 
 
 
Since the cycloaddition of the p-chlorophenyl substituted vinyl sulfoxide 1.191 
with furans were higher yielding than those with 1.178, we examined the ROCM reaction 
of cycloadduct 1.194.  The ring opening cross-metathesis of 1.194 delivered 1.213 as a 
single isomer, but the yield was only 63% (Scheme 1.69).  The reason for this decrease in 
yield is unknown, although it could be due to the more electron deficient nature of 





Scheme 1.69: Cross metathesis of cycloadduct 1.194 
 
 
The reactions of a number of electronically diverse cross partners 1.214-1.219 
were screened under similar conditions, but, all of them failed to give any trace of the 
desired product 1.220 (Scheme 1.70). 
 
Scheme 1.70: Failed cross metathesis olefins with substrate 1.194 
 
 
Again suspecting that the Lewis basic oxygen atom of the sulfoxide might be 




sulfone 1.200 in the presence of Grubbs II 1.205 or Hoveyda-Grubbs II 1.206 catalysts 
and a with variety of cross-partners (Scheme 1.71).   
 
Scheme 1.71: Successful ring opening of cycloadduct 1.200 with various cross partners 
 
 
We screened a wide range of cross-partners, with varied results.  Some cross-
partners such as 1.225-1.228 were excellent substrates, giving yields of 1.221-1.224 
between 82% and 96%, but other olefins such as 1.229-1.242 (table 1.8) were completely 
unreactive.  Examination of the structures of successful cross-partners reveals that only 
non-polar cross-partners work well in this ROCM.  It is unclear why this is the case.  
Tetrahydrofurans 1.221-1.224 were isolated as a single regio- and stereoisomer.  The 




protons and the tertiary methyl groups.  The trans configuration of the alkenes were 
assigned based on the coupling constants of the vinylic protons.   
 
Table 1.8: Unreactive olefin cross-partners with cycloadduct 1.200 
 
 
In an effort to gain some insight into origin of the regioselectivity of the ROCM, 
endo-sulfone 1.200 (Scheme 1.72) and exo-isomer 1.243 (Scheme 1.73) were compared.  
These systems were of interest because the inductive effect from the electron 
withdrawing sulfones in both systems should be very similar, so a difference in the 
regioselectivity of these two systems will be primarily a comparison of steric and 
coordinative effects.  Endo-sulfone 1.200 was allowed to react with an excess of 
allyltrimethylsilane in the presence of Hoveyda-Grubbs II (1.205), and the product 1.223 




initially assigned by nOe NMR experiments and later confirmed by X-ray 
crystallography (Figure 1.17). 
 
Scheme 1.72: Cross metathesis of endo 1.200 will allyltrimethylsilane 
 
 
Figure 1.17: X-ray structure of tetrahydrofuran 1.223 
                           
 
When the exo-sulfone 1.243 was allowed to react with allyltrimethylsilane under 
identical conditions, an inseparable mixture (4:1) of the expected isomer 1.223 and the 




significant, but not total erosion in regioselectivity.  While there is a slight difference in 
reactivity between endo-1.200 and exo-1.243, they both gave 1.223 as the major product, 
suggesting that the regioselectivity is based in part due to on the electron withdrawing 
nature of the sulfone, which may polarize the olefin for a regioselective cross-metathesis.   
This polarization effect, which is approximately equivalent in both the case of 1.200 and 
1.243 is not, however, does not account for the observed difference in regioselectivity. 
 
Scheme 1.73: Reaction of exo-cycloadduct 1.243 and detection of the other regioisomer  
 
The slight erosion in the regioselectivity in the case of 1.243 may be accounted 
for in by loss of a coordinative affect that is present only in the endo isomer 1.200.  This 
coordination effect could be manifested through a stabilized intermediate such as 1.245 
and intermediate 1.246 (Figure 1.18).  When the metathesis catalyst loads onto an 
oxabicycle such as 1.200, it can either load to the olefin terminus proximal to the sulfone, 
generating intermediate 1.245, or it can load onto the terminus opposite the sulfone 
leading to intermediate 1.246.  Alkylidine intermediate 1.245 may be stabilized by a 
coordination of the metal center of the catalyst to the sulfone oxygen atoms, discouraging 




We speculate that the 1.245 is the kinetically and thermodynamically favored alkylidine, 
and when the intramolecular coordination is not present as in 1.243, the stabilization 
effect from the sulfone is lost and the preference of 1.245 over 1.246 is lessened.   The 
structural assignments of tetrahydrofurans 1.223 and 1.244 were made on the basis of the 
nOe interaction between the vinylic protons and the tertiary methyl groups.  The trans 
configurations of 1.223 and 1.244 were assigned based on the coupling constants of (J = 
15.2 Hz and 15.1 Hz) of the vinylic protons.    
 






Only unpolarized olefins had been used successfully as reaction partners for the 
ROCM sequence (Scheme 1.71).  Efforts were thus directed to conduct the ring-opening 
reaction with a more functionalized cross partner.  Efforts to use allyl acetate 1.240 as a 
cross metathesis partner failed (Table 1.8).  However, 1,4-cis-butene-diacetate (1.247), 
which is known to be a highly reactive cross-partner due to the relief of the allylic strain 
upon metathesis, was chosen for the screening.
81
  The product of a cross metathesis 
reaction with 1,4-cis-butene-diacetate (1.247) contains a functional handle for further 
transformations via well-precedented allylic alkylation chemistry.
82,83
 However, 
oxabicycle 1.200 failed to react with 1,4-cis-butene diacetate (1.247) under conventional 
ROCM conditions (Scheme 1.74).  The starting material 1.200 unreactive even with 
microwave heating or in the presence of Ti(OiPr)4.  The only identifiable product was 10 
mol % of cinnamyl acetate (1.249), which was formed as a side product corresponding to 
the cross-product of Grubbs II catalyst with 1,4-cis-butene diacetate (1.247).  The 
isolation of 1.249 suggests that the allyl acetate alkylidine species 1.250 is being formed, 













Scheme 1.74: Absence of reactivity with 1,4-cis-butene diacetate cross-partner 
 
 
Figure 1.19: Likely allyl acetate intermediate alkylidine species 
 
 
 On the suspicion that the alkylidine species 1.250 was unreactive with 
oxabicycle 1.200, we envisioned that we might be able to encourage the ring-opening of 
1.200 by exchanging the alkylidine of 1.250 with a more reactive alkylidine such as a 




outlined in Scheme 1.75, would begin with either Grubbs II or Hoveyda Grubbs II 
catalyst reacting with 1,4-cis-butene diacetate (1.247) to give the unreactive alkylidine 
1.250 along with cross product 1.249.  Alkylidine 1.250 could then react with ethylene to 
form the highly reactive methylidine 1.251, which could allow for the loading of the 
ruthenium catalyst onto oxabicycle 1.200. Subsequent ring-opening to species 1.252 











Scheme 1.75: Proposed pathway to overcome unreactive alkylidine intermediates
 
 
Gratifyingly, when the ROCM with 1,4-cis-butene-diacetate (1.247) was 
conducted under an ethylene atmosphere, the desired product 1.248 was isolated in 33% 
yield as a single regio- and stereoisomer, along with 41% of the unreacted starting 
material 1.200, 11% of the ethylene cross product 1.253 and unreacted 1,4-cis-butene 




Scheme 1.76: Results of ring-opening cross metathesis under ethylene atmosphere 
 
 
Varying the catalyst, reaction temperature, solvent, equivalents of 1.247, rate of 
addition, and order of addition eventually lead to the optimal conditions that yielded 55% 
of 1.248 along with 21% of unreacted starting material 1.200 and 8% of ethylene cross 
product 1.253 (Scheme 1.77).  If more 1,4-cis-butene diacetate (1.247) was added, the 
reaction became sluggish; likewise, if less than six equivalents of 1.247 was used, the 
reaction slowed down.  Solvent changes had a negligible effect on the reaction.  Slow 









Scheme 1.77: Optimized cross-metathesis conditions under ethylene atmosphere 
 
 
If ethylene is aiding in the ring-opening process to access an intermediate such as 
1.252, a question arises as to whether that intermediate directly reacts with 1,4-cis-butene 
diacetate (1.247) or whether the system first reacts with ethylene to give 1.253, which 
then reacts with the olefin partner 1.247.  In order to probe this question, the ethylene 
ROCM product 1.253 was prepared in 76% yield (Scheme 1.78).  When 1.253 was 
exposed to standard cross metathesis conditions with 1,4-cis-butene diacetate (1.247) in 
the presence and absence of ethylene (Scheme 1.79), no 1.248 was formed.  The results 
of this experiment support a hypothesis that the carbene 1.252 reacts directly with 1,4-
cis-butene diacetate (1.247), but allyl acetate 1.240 does not. 
 






Scheme 1.79: Probing the reaction pathway  
 
 
To further probe the mechanism of the ROCM of 1.200 with 1,4-cis-butene 
diacetate (1.247), the unsubstituted oxabicycle 1.203 was prepared and exposed to 
Hoveyda Grubbs II catalyst and 1,4-cis-butene diacetate (1.247) under an argon 
atmosphere.  This less-substituted bicyclic substrate was extremely reactive under these 
conditions, giving a mixture of several products, including approximately 10% of 1.254 
and 35% of the double cross-product 1.255 (Scheme 190).  The fact that this system was 
much more reactive than 1.200 and did not require an ethylene atmosphere suggests that 
the bridgehead methyl groups of 1.200 impart a steric penalty that a less reactive 
alkylidine such as 1.250 is unable to load onto the oxabicycle.  When a highly reactive 
alkylidine such as 1.251 is present, it has sufficient reactivity to load onto the sterically 
congested oxabicycle 1.200, thus leading to ring-opened intermediate 1.252.  
Intermediate 1.252 can then react with 1,4-cis-butene diacetate (1.247), which may be 









Scheme 1.80: Further probing of the cross metathesis. 
 
 
High temperatures are detrimental to ring-opening cross metatheses conducted 
under an ethylene atmosphere, so we hypothesized that the methylidine alkylidine 1.251 
was decomposing at higher temperatures.  We hypothesized that we might improve the 
yield and the catalytic turnover of this reaction if we substituted ethylene with a 
substituted olefin such as 2-methylpropene.  The ruthenium alkylidine of this olefin 
might be more stable to the reaction conditions than the methylidine 1.251.  Whether 
1.256 or 1.257 was formed would be dependent upon the regioselectivity of the 
alkylidine formation with 2-methylpropene (Scheme 1.81).  Indeed, when 1.200 was 
exposed to Hoveyda-Grubbs II catalyst and cis-butene diacetate (1.247) under an 
atmosphere of 2-methyl propene gas, we did not see any formation of 1.256, and we 









Scheme 1.81: Probing the mechanism of the cross metathesis using methylpropene gas 
 
 
Presumably, 2-methylpropene reacted with alkylidine 1.250, which would have 
been generated by the cross metathesis of Hoveyda-Grubbs catalysts with 1,4-cis-butene 
diacetate (1.247).  This would have given the reactive methylidine species 1.251 along 
with allyl acetate cross product 1.257 (Scheme 1.82), though we did not specifically 
observe the formation of either.  Methylidine 1.251 may also arise from Hoveyda-Grubbs 
II (1.205) by a similar pathway. 
 






We queried whether we might use other olefins in place of ethylene in order to 
improve the yield and catalytic turnover of the ROCM of 1.200 and 1.247 to give 1.248.  
To test this hypothesis, we performed a number of experiments wherein we added 
different olefins to the ring-opening cross metathesis reaction of 1.200 in place of 
ethylene.  We added the olefins drop wise over a few hours as to avoid overloading the 
catalyst with multiple cross-partners and to facilitate a slow but constant generation of the 
presumed active species 1.251 (Scheme 1.83).  While we were pleased to see that we 
could generate the desired product 1.248 in such a manner, the yields were 
disappointingly low.  When 1.248 was formed, traces of the cross metathesis products 
with the unintended olefins were detected in all cases in low yield.  The most successful 
reaction was by the dropwise addition of allyltrimethylsilane to the reaction, which gave 
















Scheme 1.83: Addition of various simple olefins in place of ethylene 
 
 
In hopes that we might extend this ethylene atmosphere technique to 
functionalized cross-partners besides 1,4-cis-butene diacetate (1.247), we screened a 
number of functionalized olefins with oxabicycle 1.200 under similar conditions (Scheme 
1.84).  Unfortunately, all of the olefins screened failed to give a detectable amount of the 
desired products 1.258.  This is perhaps due to the importance of two factors when using 
functionalized olefins: (1) There must be a pathway to generate alkylidine 1.251 (2) The 
olefin cross partner must be reactive enough to undergo metathesis with the sterically 
hindered neopentyl alkylidine 1.252.   Functionalized cross partners without the strain 








Scheme 1.84: Failure of the ethylene atmosphere technique with other cross-partners 
 
 
We then examined the ROCM of the mono-substituted oxabicycle 1.202.  We 
found that sulfone 1.202 reacted with an excess of allyltrimethylsilane, in the presence of 
Hoveyda-Grubbs 2
nd
 generation catalyst 1.206, to give a mixture of regioisomers 1.259 
and 1.260 (Scheme 1.85).  Interestingly, the course of the reaction was temperature 
dependent.  Namely, when the reaction was performed at low temperature, regioisomer 
1.260 was favored over 1.259 in a 1:2 ratio.  When the reaction was run at room 
temperature, we observed a switch in the major product, giving 1.259 and 1.260 in a 3:1 
ratio.  Performing the reaction at 50 °C led to a 9:1 mixture of 1.259 and 1.260.  Finally, 
when the reaction temperature was raised to 70 °C, we observed a very selective reaction, 
favoring 1.259 over 1.260 in a 12:1 ratio in 76% yield. Further increases in the reaction 
temperature failed to improve this ratio.  The main regioisomer was characterized by an 





Scheme 1.85: ROCM of mono-substituted system 
 
 
To probe whether the temperature dependence of the ring opening cross-
metathesis of 1.202 with allyltrimethylsilane was due to an equilibration between 1.259 
and 1.260, we resubjected purified 1.259 and 1.260 to the reaction conditions; however, 
no equilibration was observed.  We speculate that this that the temperature dependence 
may be based on a kinetically formed alkylidine 1.261, which is formed initially at the 
less sterically hindered carbon (Scheme 1.86).  This kinetic preference is unique to the 
mono-substituted oxabicycle 1.202, and is not present with alkylidine 1.245.   At higher 
temperatures 1.261 can equilibrate to alkylidine 1.262, which is a more 
thermodynamically stable due to a stabilizing effect with the proximal sulfone.  Thus, at 
low temperatures alkylidine 1.261 reacts with allyltrimethylsilane to give 1.260 and at 








Scheme 1.86: Possible temperature dependent alkylidine formation 
 
 
Several other olefins were screened in order to expand the scope of ROCM 
reaction of 1.202 (Scheme 1.87) to give 1.263a-c, but it quickly became apparent that 
each case would be unique in terms of the regioselectivity and yield.  For example, the 
reaction of 1.202 with styrene (1.225) gave a complex mixture of what appears to be four 
different products by examination of the 
1
H NMR spectrum of the crude mixture in 
excellent yield.  While variations in the temperature altered the ratio of these four 
products, no temperature was found that favored a single product in a synthetically useful 




inseparable products in high yield.  These products were never characterized, so it was 
not possible to make regiochemical assignments.  Unfortunately, all attempts to improve 
this ratio by changing the temperature were unsuccessful.  Reaction of allyl phenylether 
(1.239) with 1.202 gave a mixture of two products in 1:1 ratio in >95% yield.   
 
Scheme 1.87: Screening of various metathesis cross-partners 
 
 
The ROCM of 1.202 with methylacrylate (1.235) in the presence of Hoveyda-
Grubbs II gave 1.264 as a single regioisomer (Scheme 1.88).  The structural assignment 
of tetrahydrofuran 1.264 was made on the basis of the nOe interaction between the 
vinylic protons and the tertiary methyl group.  The trans configurations were assigned 
based on the coupling constants (J = 15.7 Hz) of the vinylic protons.  The primary factors 
affecting the yield of 1.264 were reaction temperature and catalyst loading.  Increasing 




temperature had no effect.  Use of 5 mol% catalyst instead of 1% further improved the 
yield of 1.264 to 67%.  Surprisingly, the reaction of 1.202 with 1.268 gave solely the 
opposite regioisomer as had been seen in previous examples using 1.200.  The reasons 
behind this are unclear, but this might be because the alkylidine generated from 1.235 is 
electron deficient, and thus may prefer to open the ring at the opposite terminus of the 
olefin as with more electron rich olefins.   
 
Scheme 1.88: Optimized conditions for the ROCM with methylacrylate. 
 
 
 It was clear that mono-substituted cycloadduct 1.202 was a more challenging 
substrate for ROCM, due to a propensity for the formation of both regioisomers.  
However, after an extensive screening of olefin cross partners, we eventually found 
several olefins that did react with monosubstituted oxabicycle 1.202 in a highly selective 
manner (Table 1.9).  The regioisomers were characterized by the characteristic nOe 
interactions between the quaternary methyl group and proximal vinyl proton (see 







Table 1.9: Summary of successful ring-opening cross metathesis examples for 1.202 
 
 
A summary of the successful ROCM reactions with disubstituted cycloadduct 
1.200 is shown in Table 1.10.  The results from tables 1.9 and 1.10 constitute the 




























1.4.3. Development of the oxidative ring-opening 
As a complement to the ROCM, we examined the oxidative ring-opening of 1.194 
as an option that would allow access to other functionalized tetrahydrofurans from a 
single oxabicycle.  Specifically, an oxidative cleavage of 1.194 would allow access to 
aldehydes, carboxylic acids, and esters, none of which are directly accessible via 
ROCM.
86
   The oxidative cleavage of similar bicyclic systems has been reported using 
ozone or Pb(OAc)4 (Schemes 1.11-1.13).
32,36
   
We sought to develop conditions to prepare fuctionalized tetrahydrofurans, 
represented by 1.270 and 1.271 (Scheme 1.89) and a number of ozonolysis conditions 
were screened with oxabicyclic sulfoxide 1.194.
86 
 Exposure of 1.194 to ozone at low-
temperature followed by reductive workup with dimethylsulfide in dichloromethane gave 
no trace of desired bis-aldehyde 1.270.  In an attempt to access acetal 1.271 cycloadduct 
1.270 was allowed to react with ozone and the intermediate was treated with 
toluenesulfonic acid and then by sodium carbonate and dimethylsulfide.  No trace of 













Scheme 1.89: Failed attempts at oxidative ring-opening 
 
 
Since the sulfoxide moiety can be oxidized with ozone, we screened a number of 
common oxidative procedures in an attempt to synthesize compounds 1.272-1.275 from 
1.200 (Scheme 1.90).   Several ozonolysis conditions were modeled after the procedures 
published by Schreiber.
86
  In an attempt to prepare acetal 1.272, cycloadduct 1.200 was 
subjected to ozone then worked up with toluenesulfonic acid followed by sodium 
carbonate and dimethylsulfide; however, no trace of the desired acetal was detected.  
Attempts to access ester 1.273 or diol 1.274 by exposure to ozone in CH2Cl2/MeOH and 
workup using either acetic anhydride/triethylamine or sodium borohydride both failed to 
generate any of the desired products.  We also attempted to cleave the olefin of 1.202 
using the Johnson-Lemieux conditions, but exposure of 1.200 to osmium tetroxide and 









Scheme 1.90: Failed attempts to oxidize sulfone substituted cycloadduct 1.200 
 
 
The difficulties with the ozonolysis of 1.200 suggested that some intermediate 
might be unstable and decompose under the reaction conditions.  We were encouraged by 
a recently published procedure for the direct conversion of alkenes to aldehydes by 
performing the ozonolysis in wet acetone.
88
  The key feature of this technique was the 
presence of dissolved water, which intercepted the reactive carbonyl oxide intermediates 
to produce the dialdehyde.  Based on the mechanism proposed by the authors, we hoped 
that after the ozonolysis of 1.200, water would intercept the carbonyl oxide 1.276 and 
convert it into 1.277 which should collapse to intermediate dialdehyde 1.275 (Scheme 
1.91).  Gratifyingly, application of this protocol to 1.200 gave a product 1.278, which was 
presumably a complex mixture of aldehyde hydrates 1.279 based on analysis of LCMS 
data (Scheme 1.92).  Due to the complexity of the 
1
H NMR spectrum of 1.279, we were 










Scheme 1.91: Proposed mechanism for the ozonolysis with dissolved water  
 
Scheme 1.92: First successful oxidative cleavage  
 
Encouraged by this result, oxabicycle 1.200 was then subjected to ozonolysis, 
followed immediately by a reductive workup with sodium borohydride to give 







Scheme  1.93: Two-step oxidation and reduction sequence to give diol 1.280 
 
 
We subsequently found that ozonolysis of 1.200 in the presence of 2,6-lutidine 
improved the yield of the diol 1.280 from 62% to 84% (Scheme 1.94).  The reasons for 
this improvement are still unclear, but we believe that the lutidine may function as a 
general base promoting the addition of water to the carbonyl oxide 1.281, leading to 
intermediate 1.282 (Scheme 1.95).  Alternatively, 2,6-lutidine may also facilitate the 
breakdown of the intermediate secondary ozonide 1.282 to give dialdehyde 1.278 by 
release of hydrogen peroxide. 
 









Scheme 1.95: Possible mechanistic explanations for the improved yield with base  
 
We were also interested in the conversion of dialdehydes such as 1.278 into their 
corresponding diyne via the Ohira-Bestmann reaction.  The inspiration for this 
transformation was from our planned route to cortistatin A.
8 
 In the event, ozonolysis of 
1.200 followed by a double Ohira-Bestman reaction using dimethyl-1-diazo-2-
oxopropylphosphonate (1.283) delivered the di-yne 1.284 in 63% yield over two steps 
(Scheme 1.96).  The sulfonyl group epimerized under prolonged exposure to base, giving 
1.284 as a mixture (4:1) of isomers.  When the oxidation was performed without 2,6-
lutidine, the yield over two steps was only 47%.  At this point, we had developed two 
successful modes for the ring-opening cycloadducts such as 1.200, and our attention 











1.5. CLEAVAGE OF THE SULFONE AUXILIARY 
Early explorations into the reductive cleavage of the carbon-sulfur bond were 
focused upon the sulfoxide substituted tetrahydrofuran 1.209, after attempts to remove 
the sulfur from the oxabicyclic systems were unsuccessful.  We attempted the reductive 
cleavage of 1.209 by submitting it to a variety of well-known conditions (Scheme 
1.97).
89,95 
 However, all attempts to prepare tetrahydrofuran 1.285 from 1.209 were 
unsuccessful, and no trace of the desired product was ever detected.  The conditions that 
were attempted are summarized in Scheme 1.96.  The dissolving metal reductions with 
sodium or lithium in ammonia led to a mixture of unidentifiable products.  Na/Hg 
amalgam failed to react with 1.209, leading to only recovered starting material.
90
   When 
1.209 was exposed to lithium-naphthalenide, only trace amounts of over-reduced 1.286 
were isolated, along with an intractable mixture of side-products.
91
   Exposure of 1.209 to 
deactivated Raney nickel resulted in the reduction of the unsubstituted olefin, along with 
partial reduction of the sulfoxide giving tetrahydrofuran 1.287 in 84% yield.
92




1.209 with an excess of SmI2 gave partially reduced thioether 1.288 in 35% yield, along 




Scheme 1.97: Attempts at reductive cleavage of sulfoxide 1.209 
 
 
We then examined the reductive cleavage of the sulfone moiety from 1.223.  We 
chose this specific substrate because it was readily available in high yield, and, we 
believed the TMS group would be stable under harsh reductive conditions, thus limiting 
the possible side products.  The screening began with a survey of known reductive 
conditions for arylsulfonyl groups.
95
  A large number of reagents were tested, including 
dissolving metal reductions with sodium or lithium, samarium diiodide, and metal-
mercury amalgams.  Each reagent was examined using a range of solvents, temperatures, 
and pH’s (Scheme 1.98).  Unfortunately, all of the conditions failed to convert 1.223 to 




Noteworthy is that Na-Hg amalgam and Mg/MeOH gave low yields of 1.289 and the 
reactions were reasonably clean.  This prompted us to explore these reaction conditions 
further.   
 






Numerous attempts under many conditions were made to improve the yield of the 
desulfurization using either Na-Hg amalgam and Mg/MeOH.  Fortuitously, while 
examining various additives, we found that the addition of a small amount of water to 
methanol dramatically improved the yield of 1.289 when using Na-Hg amalgam (Scheme 
1.99).  A number of products were isolated from the reaction, including the desired 
product 1.289 in 42% yield, ring-opened material 1.290 in 6% yield, dehalogenated 
material 1.291 in 28% yield, and 17% of recovered starting material 1.292. 
 
Scheme 1.99: Distribution of products with sodium amalgam in wet methanol 
 
 
Having isolated and characterized the side products, we began to search for 
optimal conditions to give 1.289.  After extensive optimization, we found that use of Na-
Hg (10%) in a MeOH/H2O (8:1) at 0 °C gave the desulfurized product 1.289 in 78% yield 




yields.  Upon development of conditions for the cleavage of the sulfone, our 
methodology could now access the desired tetrahydrofuran substructure 1.1.   
 




1.5. SUMMARY AND CONCLUSIONS 
In summary, we have discovered a novel chiral vinyl sulfoxide 1.191, which is 
readily available in both enantiomeric forms, that undergoes highly diastereoselective 
[4+2] cycloadditions with several substituted furans.  This discovery represents the first 
examples of the use of substituted furans in enantioselective [4+2] cycloadditions with 
vinyl sulfoxides.  Additionally, vinyl sulfoxide 1.191 reacts with furan in the presence of 
TBSOTf in higher yield and diastereoselectivity than any previously reported chiral vinyl 
sulfoxide.  A one-pot cycloaddition/oxidation sequence represents a useful synthetic tool, 
which adds diversity to the vinyl sulfoxide dienophile by allowing facile conversion to 
the sulfone.  The cycloadducts obtained from the reaction of 1.191 with furans 1.46, 




manifolds, including a highly regioselective ring-opening cross metathesis or an 
ozonolysis in the presence of water to give facile access to 2,2,5-tri- and 2,2,5,5-
tetrasubstituted tetrahydrofurans, represented by 1.293, 1.280, and 1.284.  These 
heterocycles comprise structural subunits in a broad array of biologically active natural 















Chapter 2:  Synthesis of diketopiperazine containing natural products 
2.1. INTRODUCTION TO DIKETOPIPERAZINE CONTAINING ALKALOIDS 
2.1.1. Hexahydropyrroloindoline diketopiperazine alkaloids biological activity and 
structure 
 Hexahydropyrroloindoline alkaloids are a large family of secondary fungal 
metabolites that contain interesting structural features and exhibit a wide range of potent 
biological activities.
97
  Members of this class of natural products all contain a common 
tricyclic core structure represented by 2.1 (Figure 2.1).  Many of these alkaloids possess 
an additional cyclic dipeptide diketopiperazine substructure, represented by tetracycle 
2.2.  A particularly bioactive class of these compounds contains a bridged polysulfide 
linkage across the cyclic dipeptide diketopiperazine substructure as is illustrated by 2.3.
98
  
The polysulfide linker can range from one to four sulfur atoms in length.  Some of the 
toxicity of these sulfur containing molecules is attributed to the polysulfide bridge of the 
diketopiperazine subunit, which can either conjugate directly to cysteine residues or 
generate reactive oxygen intermediates.
99
   Molecules containing this polysulfide bridge 












Figure 2.1: Common core structures of hexahydropyrroloindoline alkaloids 
 
 
 Most ETP-containing hexahydropyrroloindoline natural products have either a 3-
indole substituted core such as 2.4 or a symmetrical dimeric structure shown by 2.5. 
Many hexahydropyrroloindoline natural products are thought to be biosynthetically 
derived from two molecules of tryptophan or tryptophan-containing peptides.
100
  Natural 
products such as 2.4 and 2.5 have attracted considerable interest from the synthetic 
community in recent years due to their promising and unique bioactivities, and their 
challenging molecular architectures.
101
  For instance gliocladin C (2.6)
102
 and leptosin D 
(2.7)
103,
 are cytotoxic against P-388 lymphocytic leukemia cell lines with ED50 values of 
240 ng/mL and 86 ng/mL, respectively (Figure 2.2).
104
 Similarly, T988 A (2.8) and T988 
B (2.9) exhibit cytotoxicity against P-388 cell lines with ED50 values of 0.25 µg/mL and 
2.18 µg/mL, respectively.
105
  Bionectins A (2.10) and B (2.11) exhibit antibacterial 
activity against methicillin-resistant S. aureus (MRSA) and quinolone-resistant S. aureus 
(QRSA) with MIC = 10-30 µM/mL.
106
  The novel alkaloid plectosphaeroic acid A (2.12) 




removing the ability of cancer cells to escape immunologically mediated cellular 
rejection.
107,108
  Plectosphaeroic acid A (2.12) inhibited recombinant human IDO with an 





Figure 2.2: 3-indole substituted hexahydropyrroloindoline natural products  
 
 
 Among the symmetrical, dimeric ETPs, chaetocin (2.14) has been one of the more 
synthesized natural products due to its early isolation, and wide-ranging bioactivity 
(Figure 2.3).
110
   Not only does it possess potent antibacterial and cytostatic activity,
111
 
but 2.14 is also known to be a potent inhibitor of histone methyl transferases (HMTs),  
enzymes that play important roles in controlling gene expression.
112
  WIN 64821 (2.15) is 






 and it is also an antagonist of the cholecystokinin type-B receptor.
114
 
Dideoxyverticillin (2.16) has significant inhibitory activity against topoisomerases I and 
II, and it exhibits cytotoxicity toward a number of human cancer cell lines.
115
 Both 
verticillins A (2.17) and B (2.12), along with ditryptophenaline (2.19) exhibit 





Figure 2.3: Symmetrical dimeric hexahydropyrroloindoline containing natural products  
 
 
 Given the powerful biological activities of nearly all hexahydropyrroloindoline 
natural products, they have attracted significant attention from synthetic chemists.
101,118 
While a number of innovative synthesis of these and related natural products have been 




members within this family.
119,120 
 In addition, we sought a route that would have the 
potential to access the entire family of natural products and for the synthesis of analogues 
for biological screening.
 121
  We selected plectosphaeroic acid A (2.12) and T998 A (2.8) 
and B (2.9) as our initial targets because they have not yet been synthesized, and we 
targeted gliocladin C (2.6) as it may be an intermediate in the route to 2.8 and 2.9. 
 
 
2.1.2. Previous synthetic studies toward hexahydropyrroloindoline diketopiperazine 
natural products 
2.1.2.1. Overman’s first total synthesis of gliocladin C 
The first total synthesis and structural confirmation of gliocladin C (2.6) was 
published in 2007 by Overman and co-workers.
122
  Their synthesis began with a 
diastereoselective Mukaiyama aldol reaction between 2-siloxyindole 2.20, which is 
available in four steps from isatin (2.21), and the serine derived aldehyde 2.22 in the 
presence of BF3OEt2 and 4-methyl-di-tert-butylpyridine (2.23) to give key intermediate 
2.24 in 75-89% yield as a mixture (80:1) of diastereostereomers (Scheme 2.1).  The 
oxazoline and Boc protecting groups were then cleaved under acidic conditions, and the 
resultant diol was protected using 2,2-dimethoxypropane to provide 1,3-dioxane 2.25.  
Reduction of 2.25 with LAlH4 and ionization of the hemiaminal with silica gel gave 
aminal 2.26 in 93% yield.  TMSOTf activated rearrangement of the dimethylketal of 2.26 
gave the protected primary alcohol 2.27 in 91% yield.  Protection of the amine with Boc-
anhydride followed by deprotection gave diol 2.28.  Further functional group 
manipulations allowed for the conversion of the secondary alcohol to the methyl ether 




Scheme 2.1: Overman’s total synthesis of gliocladin C 
 
 
 The primary alcohol 2.29 was then oxidized to a carboxylic acid that was coupled 
with methylamine, and the Boc group was removed to provide the amide 2.30 in 39% 
yield over four steps (Scheme 2.2).  Deprotection of the benzyl groups under reductive 




in a sealed tube with hexamethyldisilazane to furnish (+)-gliocladin C (2.6) in 73% yield.  
Additionally, the central step of the sequence featured an asymmetric Mukaiyama aldol 
reaction for the construction of the quaternary carbon of 2.24. 
 
Scheme 2.2: Completion of Overman’s synthesis of gliocladin C 
 
 
2.1.2.2. Overman’s second generation approach to gliocladin C 
As a follow-up to their 2007 total synthesis, Overman, DeLorbe, and co-workers 
shortened their route to gliocladin C (2.6) by assembling the molecule in a more 
convergent manner.
123
  Beginning with oxindole 2.32, which was available in one step 
from isatin and indole, the alcohol was reduced by exposure to acid in the presence of 
triethylsilane (Scheme 2.3). Protection of the intermediate using Boc-anyhydride, gave 
oxindole 2.33 in 68% yield over two steps.  In the next step, stereoinduction was 




followed by a Lewis acid catalyzed OC rearrangement catalyzed by 5 mol % of Fu’s 
(S)-(-)-4-pyrrolidinopyrindinyl-(pentamethylcyclopentadienyl) iron catalyst 2.35.  This 
asymmetric rearrangement leads to enantioenriched 3,3-disubstituted oxindole 2.36 in 
88% yield and a 98:2 enantiomeric ratio.
124
 The oxindole carbonyl group was then 
selectively reduced to the hemi-aminal with sodium borohydride and converted to 2.37 in 
67% yield over two steps using trimethylorthoformate.  A two-step reduction/oxidation 
sequence with lithium borohydride and Dess-Martin periodinane gave access to 






















Scheme 2.3: Overman’s second generation synthesis of gliocladin C 
 
 
 The trioxopiperazine nucleophile 2.39 was deprotonated with lithium 
diisopropylamide, and the intermediate anion was allowed to react with aldehyde 2.38 to 
provide 2.40 in 75% yield (Scheme 2.4).  Exposure of 2.40 to Sc(OTf)3 in acetonitrile at 
room temperature delivered gliocladin C (2.6) in 60% yield.  This approach constituted 
the most concise synthesis of gliocladin C to date and featured a novel asymmetric 
rearrangement to access enantioenriched 3,3-disubstituted oxindole 2.36.  Furthermore, 
the base induced coupling of 2.38 and 2.39 exemplifies their convergent approach to the 




Scheme 2.4: Completion of the enantioselective synthesis of (+)-gliocladin C 
 
 
2.1.2.3. Movassaghi’s total synthesis of gliocladin C 
 Recently Movassaghi and co-workers published a concise total synthesis of (+)-
gliocladin C (2.6) and the related natural product gliocladin B (Scheme 2.5).
126
  The route 
commences with the bromocyclization of diketopiperazine 2.42, which was synthesized 
in four steps from tryptophan, to give tetracycle 2.43 in 75% yield.  Ionization of the 
bromine with AgBF4 in the presence of 2,6-di-tert-butyl-4-methylpyridine (2.23) 
followed reaction with the bromoindole 2.44 gave the core structure 2.45 in good yield.  
Nucleophile 2.44 was used because it provided 2.45 in the highest yield during an 
extensive screening of a variety of substituted indoles, but reasoning for this yield 
enhancement was provided.  Removal of the extraneous indole bromide functionality, 
followed by oxidation of the diketopiperazine ring gave the somewhat unstable 2.46 in 
41% yield over two steps.  No reason for the stereoselectivity was given.  Selective 




sulfonyl protecting group under buffered photolytic conditions furnished 2.48 in excellent 
yield.
127
  The aryl amine was protected with trifluoroacetic anhydride that occurred with 
concomitant elimination of the tertiary alcohol, fluoride promoted removal of the TIPS-
group with HF•pyridine gave 2.49.   Oxidation of the secondary alcohol of 2.49 and 
removal of the N-protecting group gave (+)-gliocladine C in 48% yield over four steps.  
This synthetic strategy featured a novel Friedel-Crafts-based coupling of 2.43 and indole 





























2.1.2.4. Chaeotocin A  
 Movassaghi and co-workers have published a highly stereoselective route to the 
dimeric alkaloids epipolythiodiketopiperazines chaetocin A (2.13) and C (2.50)
128
 as well 
dideoxyverticillin A (2.15).
129
  This synthesis of 2.6 began with the bromine-induced 
cyclization of tryptophan-derived diketopiperazine 2.51, which was synthesized in three 
steps from N-Boc-tryptophan and serine methyl ester (Scheme 2.6), to give 2.52.  The 
tetracycle was N-methylated followed by removal of the silicon. O-acylation of the 
intermediate led to 2.53 in 73% yield.  The CoCl(PPh3)3-mediated reductive radical 
dimerization of 2.53 provided the dimeric diketopiperazine 2.54 in 49% yield.  The dimer 
was then oxidized to tetraol 2.55 with Py2AgMnO4 in 55% yield and subsequent  
exposure of tetraol 2.56 to trifluoroacetic acid and hydrogen sulfide generated a 
bisthiohemiaminal intermediate, which was then exposed to isobutyrylchloride to acylate 
the free alcohols and thiols.  The stereoinduction is suggested to be a directed by the 
approach of the oxidant from the less hindered face of the molecule.  Following 
photolytic deprotection of the N-sulfonyl group, they isolated advanced intermediate 2.56 

















The free thiols were revealed by a hydrazinolysis of thioesters, which were then 
sulfenylated to give 2.57 in 90% yield.  Subsequent ionization of the isobutyrates and 
efficient cyclization with concomitant loss of a triphenylmethyl cation produced the bis-
acetylated precursor to the natural product.  Deprotection using Otera’s catalyst and 
methanol gave chaetocin A (2.14) in 75% yield over the two steps.
130
  This total synthesis 
of (+)-chaetocin A represents an innovative approach the dimeric 
epipolythiodiketopiperazine alkaloids.  The route featured a novel cobalt catalyzed 
dimerization of bromide 2.53 and a challenging stereoselective manganese 
tetrahydroxylation of 2.54.  The stepwise construction of these sulfur-bridged 
diketopiperazine represents a novel and versatile method for the installation of the 
disulfide and trisulfide bridges. 
 
2.1.2.5. Gliocladine C  
 As an extension of their synthesis of gliocladin C (2.6) (vida supra), Overman and 
co-workers prepared the closely related epidithiodioxopiperazine gliocladine C (2.13).
123
  
The synthesis branched from intermediate 2.40 with the BF3OEt2 induced ring-closure 
and concomitant dimethylation to provide the tetracyclic structure 2.58 in 80% yield 
(Scheme 2.7).   Trioxopiperazine-fused pyrrolidinoindoline 2.58 was reacted with 
methylmagnesium chloride at -78 ºC, and the free alcohol was protected with TBSOTf to 
give a mixture of siloxy epimers 2.59 in 81% yield.  Catalytic dihydroxylation of the 
internal olefin using AD-mix-α gave diol 2.61 in 82% yield with good 
diastereoselectivity.  Use of AD-mix-β resulted in poorer diastereoselectivity.  Protection 




intermediate was then exposed to hydrogen sulfide and BF3OEt2 under ionizing 
conditions in a sealed tube, followed by exposure to oxygen to deliver the disulfide 2.63 
in 62% yield.  It was suggested that the selectivity was due to the approach of sulfur to 
the less sterically encumbered face of the molecule.  The addition of both thiols to the 
same face of the diketopiperazine ring was first documented by Kishi and co-workers, 
and it was suggested to be due the first thiol directing of the approach of second hydrogen 
sulfide molecule by hydrogen bonding.
131
  Deprotection with methanolic La(OTf)3 gave 
(+)-gliocladine C (2.13) in 75% yield.  This work featured the first total synthesis of 
glicladine C (2.13), and it featured a diastereoselective dihydroxylation and innovative 
Lewis acid catalyzed sulfur installation.  It should be noted that this synthesis was 























2.1.3. Dihydrooxepine epidithiodiketopiperazine natural products structure and 
biological activity. 
The oxepin moiety is a common substructure in a number of biologically active 
natural products.
132,133  
 There have been a number of methods reported regarding the 
synthesis of these seven-membered heterocycles.
134
  There is a specific subset of 
biologically potent oxepin containing alkaloids known as dihydrooxepine 
epidithiodiketopiperazine containing natural products (Figure 2.4).  These compounds are 
characterized by the presence of a 4,5-dihydrooxepine ring and a sulfur-bridged 
epidithiodiketopiperazine, both of which are linked via a pyrrolidine ring.  Included 





aranotin (2.66), acetylaranotin (2.67),
137




Figure 2.4: Dihydrooxepine epidithiodiketopiperazine containing natural products. 
 
 
 Compounds 2.64-2.68 exhibit an impressive array of biological activities, ranging 




 and apoptotic activity 
against various human cancer cell lines.
140




potent anticancer properties with in vitro activity against the DU145 prostate cancer cell 
line with an IC50 value of 9.3 nM.  The complex structure and impressive anticancer 
activity of these alkaloids make them attractive synthetic targets.  Despite this, 
acetylaranotin (2.66) has been the only member of the dihydrooxepine 
epidithiodiketopiperazine class of natural products to have been synthesized.
141
  When 
exploring the potential for the total synthesis of MPC1001, we discovered that there was 
a paucity of methodology to access dihydrooxepine cores, such as the ones present in 
structures 2.64-2.68.  This lack methodology inspired our interest in the development of 
methodology for the construction of the dihydrooxepin core, specifically those 
substituted only at the 3-, 4-, and 5-carbon atoms, as shown by 2.69 (Figure 2.5), because 
we wished to create a route that would be directly applicable toward the synthesis of the 
core structure of dihydrooxepine ETP alkaloids, represented by 2.70. 
 






2.1.4. Synthetic methods to access substituted 4,5-dihydrooxepins 
2.1.4.1. Stepwise ring construction using nucleophilic ring-closure and elimination 
A survey of the literature revealed a limited number of methods for the 
construction of 4,5,6-substituted dihydrooxepines such as 2.69.  One such technique 
involves the stepwise construction of the oxepin core structure by the intramolecular 
cyclization of 1,6-ene-ol or 1,6-yne-ol, giving the seven-membered oxepin ring.  A 
surrogate leaving group was then eliminated to reveal the final dihydrooxepin structure.  
This stepwise approach was reported by Clive and co-workers in their synthesis of the 




late stage intermediate 2.71 
was first elaborated to the vinylogous amide 2.72 in 70% yield using dimethylformamide 
dimethyl acetal in THF.  The intramolelcular cyclization was induced upon exposure to 
trifluoroacetic acid in toluene, to provide the oxepin ring 2.73 in 77% yield.  Selenoxide 
oxidation and elimination with sodium periodate furnished the dihydrooxepin 2.74 in 














Scheme 2.8: Clive’s approach to the MPC1001 core structure 
 
 
A similar oxacyclization was used by the Reisman lab in their total synthesis of 
acetylaranotin (2.67) (Scheme 2.9).
141
  Starting from advanced yneol 2.75, they 
successfully applied a rhodium-catalyzed cycloisomerization to create the oxepine 2.76 in 
88% yield.  Sequential protecting group removal with TBAF, followed by elimination 
using lithium carbonate afforded the dihydrooxepine 2.77 in 55% yield over two steps.  A 
peptide coupling with related amino acid 2.78 using standard coupling conditions yielded 
87% of dimer 2.79, which was elaborated to acetylaranotin (2.67) in four steps.  This 
synthesis is the only total synthesis of a dihydrooxepine epidithiodiketopiperazine natural 
product.  While both Clive’s synthesis of 2.74 and Reisman’s synthesis of 2.67 by 
oxacyclization successfully accessed core structures such as 2.70, each did so at the cost 




We aimed to design a method that avoids the synthesis of complex starting materials in 
order to reduce the overall step count. 
 
Scheme 2.9: Synthesis of the dihydrooxepine core of acetylaranotin 
 
 
2.1.4.2. Epoxidation of cyclobutenes and ring expansion to oxepins 
 The Snapper group reported the synthesis of functionalized bicyclic oxepins by a 
thermal rearrangement of highly strained cyclobutanes (Scheme 2.10).
144
  Epoxidation of 
cyclobutene 2.80 using meta-chloroperoxybenzoic acid (m-CPBA) gave the tetracycle 
2.81 in 93-98% yield.     Heating 2.81 in benzene at 200 ºC in a sealed tube furnished 




limited substrate scope to only ester or aryl R-groups and diastereoselectivity tended to 
be low (9-75%). 
 
Scheme 2.10:  Ring expansion of strained cyclobutanes 
 
 
2.1.4.3. Constructions of oxepins by Cope rearrangement of divinyl epoxides 
 One attractive approach to oxepins is features the Cope rearrangement of divinyl 
epoxides.
145
  White and co-workers initiated a four-carbon ring expansion of trans-
divinyloxirane 2.83 at 230 ºC to give partial conversion to 4,5-dihydrooxepine (2.84) in 
30% conversion along with dihydrofuran 2.85 in 70% conversion (equation 2.1).
146
   
Notably, they discovered that the trans-divinyl epoxide 2.86 underwent complete 
conversion to oxepine 2.84 at 50 ºC (equation 2.2), no trace of furan 2.85 was detected.  
It has been suggested that this difference in reactivity between cis-epoxide 2.86 and trans-
epoxide 2.3 is due to a favorable orbital overlap for the ring expansion to the seven-
membered ring.
147







The Cope rearrangement of substituted cis-2,3-divinyl epoxides was also explored 
by the White lab.
148
  They reported the synthesis of 4,6-disubstituted dihydrooxepins by 
first constructing  methyl ketone substituted vinyl epoxide 2.87, which they converted to 
the trans-substituted enol derivative 2.88 by kinetic deprotonation and acylation with 
acetic anhydride (Scheme 2.11).  Divinyl epoxide 2.88 underwent the Cope 
rearrangement to give oxepin 2.89 after 12 hours at 135 ºC.  When using a cis-2,3-divinyl 
epoxide 2.91, which lacks substitution at the terminus of the diene, the rearrangement 
required only 100 ºC to generate oxepine 2.92 in 80% yield.  They proposed that the 
additional substituent added steric strain to the transition state.  Furthermore, they found 
that the trans-isomers related to 2.88 and 2.91 did not undergo any reaction at 
temperatures as high as 180 ºC.  The Cope rearrangement of divinyl epoxides has never 
been applied in the context of a total synthesis, possibly due to the lack of methodology 













2.1.4.4. Oxepin synthesis via the retro-homo Diels-Alder reaction of epoxides 
 
White and co-workers reported a novel approach to the dihydrooxepin core by a 
retro-homo Diels-Alder reaction driven by the extrusion of nitrogen gas.  The endo-
epoxide 2.93 was synthesized by a cycloaddition between benzene oxide and 
bis(trichloroethyl)azodicarboxylate,
149
  followed oxidation using copper in ammonium 
hydroxide to reveal the diaza-oxotricyclononene intermediate 2.94 (equation 2.3).  The 
strained intermediate 2.94 was warmed to 10 ºC, whereupon nitrogen gas was liberated 
revealing 4,5-dihydrooxepin (2.84) as the sole product.  In contrast, exo-epoxide 2.95 was 
converted to 2.96, which was easily handled at room temperature (equation 2.4).  This 
intermediate was found to be thermally stable up to 180 ºC, at which point 2.96 
rearranged to the undesired cyclohexanone 2.97.  This reaction is presumed to occur 









Nicolaou and co-workers applied the retro-homo Diels-alder oxepin construction 
to their synthesis of the monomeric unit of aranotin 2.66 (Scheme 2.12).
150
  They used 
trichloroethyl nitrosoformate (2.98), which was generated from TrocNHOH and NaIO4, 
as the dienophile and bicyclic diene 2.99, to give cycloadduct 2.100.  Oxidation of 2.100 
with methyl(trifluoromethyl)dioxirane afforded the oxepin core structure 2.101 in 40% 
yield.  The reaction was assumed to proceed through fleeting intermediate 2.102, which 
rapidly underwent a retro-homo Diels-Alder cyclization and regenerated dienophile 2.98.  
The use of retro-homo Diels-Alder cycloadditions is a promising candidate for the 
synthesis of substituted oxepins; however, the necessity to use endo-epoxides renders the 












2.2. PROPOSED ROUTES TOWARD DIKETOPIPERAZINE CONTAINING NATURAL 
PRODUCTS AND PRECEDENT 
2.2.1. Retrosynthesis of hexahydropyrroloindoline diketopiperazine alkaloids  
We envisioned a route to access several hexahydropyrroloindoline natural 
products that was both concise and novel.  We chose to target T998B (2.9) and 
plectosphaeroic acid A (2.12), because these alkaloids have never before been 
synthesized despite their promising bioactivities.  A total synthesis of these natural 
products would serve as a useful tool for further exploration of their interesting biological 
properties by way of analogue synthesis.  Furthermore, we saw an opportunity to access 
gliocladin C (2.6), which has been synthesized by several groups.
123,126
  A more concise 
synthesis of gliocladin C would serve to showcase the efficiency and generality of our 




Our original retrosynthetic analysis of 2.9, 2.12, and 2.6 led to the diene core 
structure 2.103 (Scheme 2.13).  We envisioned this substructure a branching point, 
wherefrom we could either access epidithiodiketopiperazine alkaloids such as 2.7-2.12 or 
simpler hexahydropyrroloindoline alkaloids, such as 2.6.  The hexacyclic core 2.103 
would arise from the intramolecular reductive ring-closure of oxindole 2.104, 3,3-
disubstituted oxoindole 2.104 would arise using an ionic coupling of hydroxyoxindole 
2.105 and didehydro diketopiperazine 2.106. 
 
Scheme 2.13: Retrosynthetic analysis of 2.9, 2.12, and 2.6 
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The key step involves the ionization of 3-hydroxyoxindole 2.107 under Lewis 




trapped by the enamide
154
 functionality of diketopiperazine 2.107 and to provide the 
oxindole 2.109 (Scheme 2.14).  Use of a dehydrodiketopiperazine as a nucleophile has 
very little precedent, and it has never been used in total synthesis.
151
  Thus, our initial 
focus will be the development of this coupling.  Upon validation of this step, we 
envisioned that an asymmetric variant could be developed using either a chiral Lewis or 
Brønsted acid.  
 
Scheme 2.14: Key ionic coupling between π-cation 2.108 and nucleophile 2.106
 
 
2.2.2. Precedent for the synthesis of hexahydropyrroloindoline alkaloids 
2.2.2.1. Ionization and nucleophilic capture of 3-hyrdoxyoxoindoles 
 The crucial transformation of 2.107 to 2.109 was inspired by a number of 




indolylinolin-2-ones.  These reactive substrates are generally synthesized by the 
nucleophilic addition of an indole to isatin.  For example, Ji and Wang found that ceric 
ammonium nitrate efficiently catalyzed the reaction of isatins 2.110 with indoles (Scheme 
2.15).
151
  The cerium was thought to act as a Lewis acid that activated the isatin carbonyl 
group toward nucleophilic attack by π-nucleophiles such as indole, to give intermediate 
2.111.  The alcohol moiety 2.111 then ionized to generate a cation that was quenched 
with a second equivalent of indole, giving disubstituted oxindoles such as 2.112 in 83-
95% yield.   
 
Scheme 2.15: Cerium catalyzed double addition of indole to isatin 
 
 
The asymmetric addition of indole to isatin has recently been reported by Chimni 
and co-workers,
152
  who describe the use of cinchona alkaloid-derived catalysts such as 
2.113 to catalyze the formation of 3-hydroxyoxindoles 2.114 by the addition of indole 
into isatin derivatives such as 2.115 (Scheme 2.16).  The enantioselective addition 
proceeded in excellent yields and enantioselectivities.  The ability to control the 
enantioselectivity at the 3-position of oxindoles with chiral ligands is relevant to our own 




Scheme 2.16: Bifunctional cinchona alkaloid controlled asymmetric addition to isatins 
 
 
 Further promising developments came from the lab of Franz and co-workers,
153
  
who treated isatin 2.21 to N-methylindole (2.116) in the presence of scandium triflate or 
copper triflate and chiral ligand 2.117 to form 3-hydroxyoxindole 2.118 in 98% yield and 
99% enantiomeric excess (Scheme 2.17).  If the reaction is warmed above -20 ºC they 
observed a second ionization of 2.118 to give the disubstituted oxindole 2.119 in 84% 
yield.  These results suggest that we might be able to use a chiral Lewis-acid to control 














2.2.2.2. Nucleophilic attack using didehydro diketopiperazines 
 A much less precedented step in our route is the use of unsaturated 
diketopiperazines as nucleophiles.  There is very limited information regarding the 
reactivity of the enamide functionality of unsaturated diketopiperazines such as 2.106.  
To our knowledge, the closest literature precedent comes from Matsunari and co-
workers,
154
 who explored the reactivity of bis-unsaturated diketopiperazine 2.120 under a 
variety of conditions.  For example, methyl chlorosulfide reacted with the enamide 
groups of 2.120 leading to the putative iminium salt 2.121, which either underwent 
elimination to give 2.122 in 52% yield, or reaction with H2O to afford diol 2.123 in 42% 







Scheme 2.18: Rare example of di-dehydro diketopiperazines acting as nucleophiles 
 
 
2.2.2.3. Intramolecular reductive ring closure 
 The intramolecular reductive ring closure of an oxoindole with a pendant an 
amide function is a well precedented procedure.
155
  Stoltz has shown that methyl amide 
2.124 may be reduced with lithium aluminum hydride in THF to give pyrrolidinoindoline 
2.125 (Scheme 2.19).
156
  No over reduction of the amide carbonyl group was reported.  
 
Scheme 2.19: Reduction of methyl amide to the tricyclic aminal with LiAlH4 
 
 
 Similarly, in their total synthesis of asperazine, Overman and co-workers 
demonstrated an effective intramolecular reductive coupling of the Boc- protected amine 
2.126 (Scheme 2.20).
157




triethylborohydride furnished an intermediate that underwent acid catalyzed cyclization 
to give the pyrrolidine ring.  Selective cleavage of the carbonates yielded 2.127 in 79% 
yield over two steps.   
 
Scheme 2.20:  Two-step reductive coupling with lithium triethylborohydride and HCl 
 
 
Buchwald and co-workers synthesized 3,3-disubstituted oxindoles, such as 2.128, 
by a palladium-catalyzed arylation/alkylation sequence.
158
  When 2.128 was reduced with 
alane-dimethylethylamine complex, pyrroloindoline cores like 2.129 were obtained 
(Scheme 2.21).   Control of temperature was critical, because over reduction to 2.130 can 
occur if the reaction was performed at room temperature. 
 





 Another example of this type of cyclization was reported by Rodrigo and co-
workers in their total synthesis of folicanthine.
159
  Although 2.131 could not be converted 
to 2.132 under a variety of the standard conditions, they discovered that deprotonation of 
2.131 with lithium diisopropylamide to give dianion 2.133, followed by reduction gave 
2.132 in 52% yield (Scheme 2.22).   
 
Scheme 2.22: Sequential de-activation of reactive free-amides and reductive coupling 
 
 
2.2.2.4. Oxidation of the internal enamide double bond 
 We proposed a late stage oxidation of the internal olefin of the hexacyclic 
pyrroloindoline 2.103, leading to our final targets 2.6, 2.9, and 2.12 (Scheme 2.8).  The 
most applicable precedent for this transformation is from the aforementioned total 
synthesis of (+)-gliocladine C 2.13 by Overman and co-workers (Scheme 2.7).
123
  




desmethoxy-verruculogen TR-2 (2.134) (Scheme 2.23) by Boyd.
160
  Exposure of 2.135 to 
a slight excess of osmium tetroxide in pyridine, followed by reductive workup, delivered 
the natural product 2.134 in 75% yield as a single diastereomer.  The approach of the 
oxidant is thought to be directed by the steric factors around the C10 and C15 carbons.   
 
Scheme 2.23:  Late-stage oxidation to give desmethoxy-verrucluogen TR-2 (2.134) 
 
 
 In pursuit of the closely related alkaloid (+)-fumitremorgin B, Hino and co-
workers oxidized 2.136 to the trans-diol 2.137 using NBS and H2O in 85% yield.  
(Scheme 2.24).
161
  The mechanism presumably went through the bromohydrin 2.138, 
which was then converted to the diol by ionization of the bromide to give the iminium ion 











Scheme 2.24: Oxidative conditions using NBS and water 
 
 
The direct oxidation of exocyclic olefins of diketopiperazines using 
dimethyldioxirane has been reported for the conversion of ylidenepyrazine-2,5-dione 
2.140 to diol 2.141 (Scheme 2.25).
162
  The methodology required the use of ‘wet’ solvent 
to provide water as a nucleophile to capture the iminium intermediate 2.142, which was 
presumably in equilibrium with epoxide 2.143.  The reaction gave syn-diol 2.141 in 80% 








Scheme 2.25:  Oxidation of exocyclic enamides with dimethyldioxirane  
 
 
In a similar example, Yates and Hoare found that they could oxidize the 
tetrasubstituted exocyclic olefin of 2.144 using mCPBA, giving isolable epoxide 2.145 in 
90% yield (Scheme 2.26).
163
  Further elaboration of 2.145 involved ionization with 
toluenesulfonic acid, and trapping of the resultant cation with water, to furnish diol 2.146, 
as well as tosylate 2.147. 
 






2.2.2.5. Installation of the disulfide 
 The construction of the sulfur bridge onto the diketopiperazine ring has been 
explored and developed in a number of seminal papers.
164,165
 Epidithiodiketopiperazines 
represented by 2.148 or 2.149 can generally be prepared by two general pathways.  One 
pathway involves deprotonation of the diketopiperazines, such as 2.150, followed by 
trapping the anion 2.151 (equation 2.5).  A more common method features ionization of a 
leaving group at the α-position of the amide 2.152, followed by nucleophilic capture of 






 This route has been used in a number of applications, including the 
aforementioned total syntheses of gliocladine C (2.13) (Scheme 2.7) and chaetocin A 
(2.14) (Scheme 2.6).  A similar ionization was developed by Overman and co-workers 
during their study of methodology to access epidithiodiketopiperazines.
168
  In that study, 
they synthesized intermediate 2.154, which was exposed to scandium triflate and 
hydrogen sulfide followed by oxygen to provide the disulfide 2.155 in 37% yield 




influenced by the nearby acetate functionality, which directed the hydrogen sulfide to the 
same face through hydrogen bonding. 
 
Scheme 2.27: Overman’s model study toward the synthesis of epidithiodiketopiperazines 
 
 
 The Sodeoka group utilized a similar strategy to transform tetraol 2.156 to bis-













2.2.3. Proposed route to substituted oxepins by sequential pyrone cycloaddition and 
retro-homo Diels-Alder cycloaddition  
2.2.3.1. Proposed model study 
We became interested in synthetic methodology for preparing 4,5-dihydrooxepins 
due to our pursuit of a total synthesis of MPC1001 (2.65).  We desired a simple 
procedure to generate the oxepin moiety under conditions that would not affect sensitive 
functionality.  Upon retrosynthetic analysis of the dihydrooxepin moiety, we formulated 
an approach that involved a Diels-Alder cycloaddition of substituted pyrones such as 
2.158 with substituted dienophiles 2.159 to give bicyclic lactones 2.160 (Scheme 2.29).  
This bicycle could then be epoxidized, giving 2.161 and setting up a retro-homo Diels-
Alder cycloaddition to reveal the oxepin 2.162.  This model study was envisioned to 
demonstrate the practicality of the chemistry. 
 













2.2.3.2. Precedent for model system 
 
Pyrones such as 2.158 are well known to undergo inter- and intramolecular 
inverse electron demand Diels-Alder cycloadditions.
170
  These [4+2] cycloadditions are 
generally highly regio- and diastereoselective, favoring bicyclic lactones such as 2.160 
with the X-group oriented opposite of the lactone bridge and proximal to the carbonyl 
group.  Cycloadditions of this type typically require the presence of a mild Lewis acid or 
high pressure to go to completion,
171
 whereas the intramolecular variant can occur 
spontaneously at room temperature.
172
  
One example is the enantioselective cycloaddition of 3-carbomethoxy pyrone 
(2.163) and phenyl vinyl sulfide (2.164) using Yb(OTf)3 and (S)-BINOL to give 
cycloadduct 2.165 in 91% yield and 95% enantiomeric excess (Scheme 2.30).
173
  This 
methodology was generally applicable to a wide range of vinyl ethers and sulfides.   
 
Scheme 2.30: Inverse electron demand Diels-Alder reaction with pyrones 
 
 
Noguchi and co-workers reported an intramolecular pyrone Diels-Alder reaction 
by mixing acid chloride 2.166 and the benzylamide 2.167 in the presence of triethylamine 
to provice intermediate 2.168 (Scheme 2.31).
172
  The cyclization of 2.168 occurred 




resultant cycloadduct at 60 ºC quantitatively converted 2.169 to diene 2.170 by extrusion 
of carbon dioxide.   
 
Scheme 2.31: Intramolecular pyrone Diels-Alder followed by loss of carbon dioxide 
 
 
After the cycloaddition, our plan was to oxidize the olefin moiety in 2.171 to both 
exo-epoxide 2.172 and endo-epoxides 2.173 (Scheme 2.32).  Several examples of the 
epoxidation of systems similar as 2.171 are known.
174,175
  Using traditional electrophilic 
oxidants the epoxidation is expected to occur proximal to the lactone bridge to give the 
exo-isomer 2.172, as this is the less hindered face of the molecule.  In order to oxidize the 
opposite face of bicyclic system 2.171, we planned to form the halohydrin 2.174 followed 
by a base promoted ring closure of 2.173, which is a known sequence to form epoxides 
on the more hindered face 2.171.
176
  We planned to screen both epoxides 2.172 and 2.173 
under thermal conditions for conversion to substituted oxepin 2.175.  However, based on 
the aforementioned precedent, we expected endo-epoxide 2.173 to undergo the retro-














2.2.4. Route to MCP1001 core structure by Cope rearrangement of divinyl epoxide 
2.2.4.1. Proposed route to MCP1001 core structure 2.176 
Additionally, we proposed a concise route to access the core structure of 
MPC1001 2.176 by the Cope rearrangement of a divinyl epoxide.  We hoped to access 
the divinyl epoxide 2.177 by a Corey-Chaykovski-type epoxidation of an unsaturated 
aldehyde represented by 2.178 (Scheme 2.33).
177
  The epoxidation was expected to 
furnish a mixture of cis and trans isomers, both of which would be evaluated, although 











Scheme 2.33: Proposed route to substituted bicyclic oxepin cores related to MPC1001 
 
 
2.2.4.2. Precedent for the conversion of 2.178 to divinyl epoxide 2.177 
There are a number of reported conditions for the conversion of simple aldehydes 
to vinyl epoxides.  One of the most commonly used methods was reported by Murphy 
and co-workers during their construction vinyl-substituted epoxide 2.179 (Scheme 
2.34).
178
  The preformed sulfonium salt 2.180 was deprotonated to form ylide 
intermediate 2.181, which underwent reaction with alkyl aldehyde 2.182 giving epoxide 
2.179 in 83% yield as a mixture (1.4:1) of cis- and trans-isomers.  Reactions of this class 
have been rendered enantioselective by the use of chiral sulfur groups.
179
  Sulfonium salts 
with additional substitution on the olefin have been successfully implemented.
180
 NaOH 
and KOH are the most commonly used bases under biphasic conditions, although the use 
of K2CO3, DBU and NaH has been reported under anhydrous conditions.
181








Scheme 2.34: Epoxidation by addition of a vinyl sulfonium ylide  
 
 
 An alternative method for the formation of vinyl substituted epoxides is by the 
nucleophilic addition of a vinyl-metal nucleophile followed by a basic workup.  In a 
report by Auge and Serge, dichloropropene 2.183 premixed with tin chloride was added 
to unsaturated aldehyde 2.184 leading to chlorohydrin 2.185 (Scheme 2.35).
182
  Exposure  
of 2.185 to sodium methoxide formed the epoxide 2.186 in 51% yield as a mixture (9:1) 















 A alternative method, which was originally pioneered by the Oehlschlager group, 
involves the Brown-type allylation of a vinyl-borane and an aldehyde (Scheme 2.36).
186
   
A vinyl borane species was generated by the deprotonation of allyl chloride (2.187) with 
LDA and methoxy boronate 2.188 and when aldehyde 2.189 was added the chlorohydrin 
2.190 was formed.  The intermediate can then be cyclized with base to give vinyl 
substituted epoxides 2.191 in 60-65% yield and excellent selectivity for the cis-isomer 
(>9:1).  The method can be rendered enantioselective by the use of chiral boronates (R= 
isopinocampheyl), leading to epoxides 2.191 in as high as 98% enantiomeric excess.  




Scheme 2.36: Brown-type allylation of aldehydes to generate chlorohydrins 
 
To our knowledge, Corey-Chaykovsky type transformations have never been 
reported with an unsaturated aldehyde such as 2.178.  We hope to adapt one of the 
aforementioned methodologies to such a system, seeing as there is precedent for 
nucleophilic additions to similar vinylogous systems.
189,190
 There is not, however, 





2.3. MARTIN GROUP SYNTHETIC EFFORTS TO DIKETOPIPERAZINE CONTAINING 
ALKALOIDS 
2.3.1. Synthetic efforts toward the synthesis of hexahydropyrroloindoline alkaloids 
2.3.1.1. Exploration of the cation capture using diketopiperazine 2.106 as a 
nucleophile 
Initial synthetic efforts were focused on the synthesis of the 3,3-disubstituted 
oxoindole 2.109.  We envisioned this intermediate could arise by a coupling of 3-hydroxy 
oxoindole 2.107 with the diketopiperazine 2.106 (Scheme 2.37), so we sought an efficient 
method to prepare both starting materials.  
 
Scheme 2.37: Starting materials required for the key bond construction  
 
 
 Following a known procedure, isatin (2.21) and indole (2.192) were mixed in the 
presence of a catalytic amount of piperidine to provide the oxindole 2.107 in 73% yield 
after crystallization (Scheme 2.38).  This procedure allows for the facile synthesis of 
large amounts of 2.107, but because 2.107 discolors upon prolonged exposure to light it 








Scheme 2.38: Piperidine catalyzed synthesis of 3-hydroxy oxoindole 2.107. 
 
 
 In order to prepare the bis-unsaturated diketopiperazine 2.106, we first converted 
serine (2.193) to 2.194 with methanol and thionyl chloride (Scheme 2.39).   The free-base 
slowly dimerized to form the diketopiperazine 2.195 in 80% yield according to a known 
literature procedure.
191
  The diol was then acylated using a known protocol by dissolving 
2.195 in hot acetic acid followed by the dropwise addition of acetyl chloride to give
192
 the 
bis-acetylated product 2.196 in 86% yield.  The acyl groups were envisioned to act as 
leaving groups for elimination under basic conditions.  After screening a number of 
alkoxide and amine bases, it was found that sodium tert-butoxide in DMF effected the 
elimination, giving complete conversion of 2.196 into 2.106.  Despite the excellent 
conversion, we isolated didehydro diketopiperazine 2.106 in only 45%, despite efforts to 
optimize the reaction.  The low yield of 2.106 is most likely due to its poor solubility in 










Scheme 2.39: Dimerization of serine and elimination to access nucleophile 2.106 
 
 
 With starting materials 2.106 and 2.107 in hand, we set out to test the key bond 
formation to give 3,3-disubstituted oxindole 2.109 (Scheme 2.40).  Our strategy was to 
mix the starting materials together and expose them to a variety of Lewis acids 
[Sc(OTf)3, CeCl3, cerium ammonium nitrate, and ZnBr2] and protic acids (CSA, TFA, 
AcOH).  The poor solubility of 2.106 was a constant problem, limiting our solvent choice 
to DMF, DMSO, glyme, or MeOH.  A variety of conditions were screened with multiple 
combinations of Lewis and protic acids, solvents, temperatures, concentrations, and 









Scheme 2.40: Initial failed attempts to form disubstituted oxindole 2.109 
 
 
When the reaction was run in non-nucleophilic solvents, bis-enamide 2.106 was 
recovered unchanged; however, hydroxyoxindole 2.107 slowly decomposed to an 
intractable mixture of products.  When the reaction was run in methanol, we observed no 
reaction involving 2.106; however, we did observe the quantitative conversion of alcohol 
2.107 to 2.197.  No polymerization was detected under these conditions.  This is evidence 
that we are indeed ionizing 2.107, but diketopiperazine does not appear to react as a 
nucleophile with 2.198.  During experimentation we observed that the solubility of 




in alkaline solutions (Figure 2.6).  This led us to believe that the enamide protons are 
quite acidic, and that, deprotonation might lead to a more reactive nucleophile. 
 
Figure 2.6: Observations during the course of the condition screening 
 
 
2.3.1.2. Re-worked forward synthesis of 2.104 using base promoted nucleophilic 
addition 
 When considering the use of 2.106 as a nucleophile under basic conditions, we 
encountered a potential problem with our approach: we required acidic conditions to 
ionize the tertiary alcohol of 2.107 but basic conditions may be needed to activate 2.106 
as a nucleophile.  This analysis led to a revision of out synthetic approach (Scheme 2.41).  
We thus envisioned a resequencing of the steps, wherein protected isatin 2.199 would 
first react with 2.106 under basic conditions to give the intermediate allylic alcohol 2.200 
that would undergo ionization in the presence of a Lewis acid and indole to give our key 







Scheme 2.41: Reworked forward synthesis of 2.104 
  
To explore the feasibility of this new route, N-benzyl protected isatin 2.201 and 
bis-enamide 2.106 were dissolved in DMF or DMSO and exposed to a variety of bases, 
temperatures, times, and concentrations (Scheme 2.42).  The isatin was protected to avoid 
competitive deprotonation from the amide proton.  A variety of amine bases were 
screened, and we eventually discovered that exposure of 2.106 gave 2.202 in 30% yield.  
Similarly, oxide and hydride bases were screened, with NaOtBu in DMF giving 1.202 in 
30-40% yield.  Carbonate bases K2CO3 and Cs2CO3 in DMF also lead to 2.202 in 13% 











Scheme 2.42: Base screening to access 3-hydroxyoxoindole 2.202 
 
 
 The low yield during each of the base promoted nucleophilic additions was 
attributed to formation of the major side product 2.203 (Figure 2.7).  We attribute this 
side product to the over-reaction of the initially formed product 2.202 with a second 
molecule of isatin 2.201.  The bis-alkylated substrate 2.203 was isolated as a mixture 
(1:1) of diastereomers.  While this problematic side-reaction was disappointing, it did 
produce enough of mono-alkylated product 2.202 to allow us to test the ionization/indole 
addition step.   
 





 Using a small amount of 3-hydroxyindole 2.202, we screened two ionization 
conditions in the presence of indole to access the 3,3-disubstituted oxindole 2.204.  
Unfortunately, exposure of 2.202 to scandium triflate or camphorsulfonic acid failed to 
produce any of the desired addition product 2.204 (Scheme 2.43).    Both reactions did, 
however, produce 2.205 in 30-55% yield as a mixture (1.6:1.0) of diastereomers.  A 
single isomer 2.206 was isolated from this mixture and its structure was determined by 
X-ray crystallography (Figure 2.8). Despite not isolating any of the desired product, the 
synthesis of hydroxyoxindole 2.202 and side product 2.205 were critical results that 
served as a proof-of-principal for future improvement.   
 












 generation synthesis of 2.209 by base induced nucleophilic attack 
 In light of these problems, we redesigned the route in order to avoid over-reaction 
during the ionization/indole trapping sequence and to improve the yields of the 
nucleophilic diketopiperazine addition (Scheme 2.44).  By replacing symmetrical 
diketopiperazine 2.106 with mono-methyl nucleophile 2.207 we felt that we could avoid 
the formation of the double addition products such as 2.203 because only one of the 
enamides would be nucleophilic under basic conditions.  Furthermore, we hoped that by 
activating the resultant tertiary alcohol by transformation to acetate 2.208, we could 
synthesize oxoindole 2.209.  The reasoning for this hypothesis is that under acidic 
conditions the tertiary acetate 2.208 would be a much better leaving group, thus it would 
ionize selectively before external enamide, thus avoiding the formation of side products 






Scheme 2.44: Redesigned route using mono-methyl diketopiperazine nucleophile 2.132 
 
 An early challenge in the development of this second generation route was the 
synthesis of unsymmetrical diketopiperazine 2.207.  Common strategies for the synthesis 
of unsymmetrical heterocycles such as 2.207 require that the individual amino acids be 
prepared separately, coupled, and cyclized.
193,194 
Accordingly, we prepared N-methyl 
amino acid 2.210.  Following an approach first developed by Hughes and co-workers,
195
 
the free hydroxyl group of serine (2.193) was first protected using acetyl chloride under 
acidic conditions (Scheme 2.45).  This O-acetylated amino acid was then N-protected 
with N-(benzyloxycarbonyloxy)succinimide to give bis-protected serine derivative 2.211 
in 74% yield over the two steps.  Exposure of 2.211 to paraformaldehyde and catalytic 
camphor sulfonic acid gave cyclic oxazolidinone 2.212 in 85% yield.  Reductive cleavage 
of 2.212 using trifluoroacetic acid and triethylsilane, gave 2.210 in 85% yield.  This 
sequence requires no chromatography and allowed us efficiently produce considerable 









Scheme 2.45: Synthesis of N-methyl serine derivative 2.210. 
 
 
The other half of 2.207 originated from acetylated serine methyl ester 
hydrochloride salt 2.194 (Scheme 2.46).  The synthesis of 2.213 was accomplished in by 
N-Boc protection of 2.194 using Boc-anhydride and triethylamine followed by hydroxyl 
protection with acetic anhydride.  Formation of the HCl salt with concomitant 
deprotection of the N-Boc group gave 2.213 in 77% overall yield. 
 
Scheme 2.46: Three step synthesis of acetyl-serine methyl ester 2.213.  
 
 
The coupling of 2.210 and 2.213 was then explored.  Disappointingly, all attempts 
to couple the peptides under a variety of common conditions failed to give dipeptide 
2.214 in appreciable yield.  The reactions consistently gave mixtures of multiple 




appears to be associated with the labile acetate groups, which are prone to elimination 
even under mildly basic conditions.  The route was then redesigned to avoid this problem. 
 
Scheme 2.47: Failed coupling of 2.210 and 2.213 due to labile acetates  
 
 
Exposure of 2.210 to HCl in dioxane cleanly produced the deprotected serine 










 The coupling of peptides 2.217 and 2.194 proceeded without event on large scale 
using commercially available Castro’s reagent (2.218) and diisopropylethylamine to 
furnish dipeptide 2.219 in 76% yield after flash chromatography on silica gel (Scheme 
2.49).  This represents the first time that chromatography was used in the route.  Other 
coupling reagents were not evaluated due to our desire to test the downstream chemistry.   
The cyclization of 2.219 to diketopiperazine 2.221 was initially problematic.  The 
N-deprotection proceeded cleanly under standard conditions using palladium on carbon 
under an atmosphere of hydrogen to give 2.220, together with desired product 2.221. 
Because 2.220 and 2.221 are only soluble in highly polar solvents such as DMF, MeOH, 
and DMSO purification was a problem.  In order to avoid the need for a chromatographic 
purification procedure, we required cyclization conditions that cleanly gave 2.221. We 
screened numerous basic conditions, including the use of amines, alkoxides, and amide 
bases.  While many of these conditions gave significant amounts of desired heterocycle 
2.221, this product was invariably contaminated with polypeptide side products or 












Scheme 2.49: Coupling of peptides 2.217 and 2.194, and failed cyclization conditions 
 
 
We eventually found that we could limit side reactions and get full conversion of 
2.219 to 2.221 by running the cyclization in the presence of 7.5 wt% ammonium 
hydroxide (37% NH3/H2O) in dilute methanol to give 2.221 in 98% yield (Scheme 
2.50).
196
  The formation of a single product and complete consumption of starting 
material allowed us to simply filter and concentrate the solution, rendering solid 2.221 








Scheme 2.50: Successful deprotection and cyclization sequence 
 
 
The next step required the elaboration of dieketopiperazine 2.221 into bis-
unsaturated nucleophile 2.207, but the poor solubility of 2.221 was problematic.  We 
found that we could improve the solubility of 2.221 and activate the alcohols toward 
elimination by first silylating the hydroxyl groups with TBSCl in DMF (Scheme 2.51).  
Exposure of the crude product to sodium t-butoxide afforded the bis-enamide 2.207 in 
35% yield over two steps.  We suspected that the low yield can be attributed to the poor 
solubility profile of bis-unsaturated diketopiperazine 2.207, which made isolation 
difficult.  Despite the difficulties in preparing and handling 2.207, we were able to access 
small quantities of pure 2.207 for screening in the next step.  When a solution of 2.207 
and isatin 2.201 in DMF was treated with anhydrous potassium carbonate, 3-
hydroxyoxindole 2.202 was isolated in 34% yield as a single cis/trans isomer.  The 
difficulties associated with the handling of 2.207 prompted us to explore the possibility of 
developing a modified procedure that would avoid isolation of intermediate 2.207 thereby 
increasing the overall yield of 2.202.  After some experimentation, we found that the 
alcohols of 2.221 could be activated with mesyl chloride in DMF and eliminated with 
triethylamine a single synthetic operation.  Once all starting materials were converted to 
bis-unsaturated nucleophile 2.207, N-benzylisatin (2.201) and potassium carbonate were 




temperature for two days, the reaction was worked up, giving the desired product 2.202 
was obtained in 71% yield from 2.221 after chromatography.   The structure of 2.202 was 
confirmed by X-ray crystallography (Figure 2.9). This streamlined procedure allowed us 
to access preparative amounts of hydroxyindole 2.202. 
 











Figure 2.9: X-ray crystal structure of 2.202 
 
 
 With significant quantities of 2.202 in hand, we set out to explore conditions to 
activate the tertiary alcohol of 2.202.  After some initial experiments, it became apparent 
that the product formed by acetylation of 2.202 was unstable, and we were never able to 
characterize 2.208 (Scheme 2.52). We then explored a one-pot synthesis of 2.209 without 
first derivatizing the alcohol 2.202.  When 2.202 was treated with various Lewis acids in 
the presence of indole and di-tert-butyl-pyridine (1.182), the 3,3-disubstituted oxindole 
2.209 was obtained in 10-40% yield.  From these experiments, we determined that the 









Scheme 2.52: Ionization and indole trapping to access 3,3-disubstituted oxoindole 2.209 
 
 Optimization of the reaction sequence led to identifying the conditions shown in 
Scheme 2.53.  By increasing the amount of TMSOTf to two equivalents, we were able to 
lower the reaction temperature from 100 ºC to 75 ºC and increase the yield of 2.209 to 
80%.  The structure of 2.209 was confirmed by X-ray crystallography (Figure 2.10). 
 







Figure 2.10 Structure confirmation of 2.209 with X-ray crystallography 
 
 
2.3.1.4. Development of the reductive ring-closure of 2.209 
 In order to access the core hexacyclic structure, we sought to develop conditions 
for the reductive ring closure of 2.209 to 2.222.  While we were aware of precedent for 
this type of reaction, there were some major concerns.
155
  Oxindole 2.209 and aminal 
2.222 contain a number of reducible functional groups that increase the possibility for 
side reactions.  Besides the carbonyl group of the oxindole, there is the possibility of 
reducing the carbonyl groups of the diketopiperazine ring, as well as the potential for 1,4-
reduction of the enamide functions.   
 In initial experiments, we examined the use of AlH3•NEtMe2, AlH(OtBu)3, and 
LiBHEt3.  Discouragingly, when 2.209 was exposed to these reducing agents at -50 °C, 
the starting material decomposed into a complex mixture of products (Scheme 2.54).  In 
the reaction of alane-dimethylethylamine complex with 2.209, we detected trace amounts 





Scheme 2.54: Failed reductive coupling of 2.209 with common reducing agents 
 
 
Attempts to use lithium aluminum hydride for the reductive cyclization of 2.209 
were also not successful.  When 2.209 was exposed to lithium aluminum hydride at cold 
temperatures in THF, no trace of 2.222 was detected (Scheme 2.55).  Instead, we 
observed the rapid formation of a complex mixture of products.  The major product was 
the methyl substituted diketopiperazine 2.223 which was isolated in near 30% yield.  We 
suspected that this product arose by the deprotonation of the free enamide of 2.209 to 
give the coordinated aluminum hydride 2.224, which then undergoes hydride addition via 














Scheme 2.55: 1,4-Reduction of the external olefin using lithium aluminum hydride 
 
 
In order to circumvent this deleterious side reaction, we sought to deactivate the 
free enamide of 2.209 by deprotonation prior to exposure to the reducing agent.  To this 
end, we first treated 2.209 with one equivalent of freshly prepared lithium 
diisopropylamide in THF at -78 ºC prior to the addition of either lithium aluminum 
hydride or alane-N,N-dimethyelthylamine complex at -30 ºC (Scheme 2.56).  In both 
cases, we failed to detect any trace of the desired product 2.222, and we consistently 
observed the formation of the fragmentation product 2.225 in as much as 10% yield.  No 







Scheme 2.56: Deprotonation of 2.209 with LDA prior to addition of hydride sources 
 
 
We suspected that 2.225 arises via the mechanistic pathway shown in Scheme 
2.48.   Disubstituted oxoindole 2.209 was first deprotonated to give the anion 2.226.  
Upon addition of hydride, the internal olefin of 1.226 was reduced by 1,4-addition, 
leading to an unstable dianion 2.227 that collapses by a retro-Michael addition to 












Scheme 2.48: Possible mechanistic explanation for the fragmentation of 2.209.  
 
 
 We envisioned an alternative approach in which the free enamide of 2.209 might 
first be protected as an intermediate such as 2.230 in situ prior to the reduction, thus 
deactivating that portion of the molecule (Scheme 2.57).  To test this theory, oxoindole 
2.209 was exposed to TMSOTf in the presence of di-tert-butylpyridine.  The reaction 
mixture was cooled to 0 ºC, and lithium aluminum hydride was added.  While the 
reaction generated a complex mixture of products, we were for the first time able to 
isolate and identify the desired cyclized product 2.222 in 11% yield.  Questions persisted 
regarding how the TMSOTf was enabling the synthesis of 2.222.  Namely, was the 
reaction indeed proceeding via intermediate 2.230, or was the effect due to the 
coordination of a Lewis acid to the oxoindole, allowing for a more selective reduction by 






Scheme 2.57: First successful reductive coupling of 2.209 to give core structure 2.222 
 
 In order to probe these important questions, oxoindole 2.209 was mixed with an 
assortment of Lewis acids, including BF3•OEt2, AlEt3, and TMSOTf, and a reducing 
agent was added.   The reducing agents screened were AlH3•Me2NEt, AlH3, LiBHEt3, 
and LAH (Scheme 2.58).  From these experiments, it appears that the addition of a Lewis 
acid is critical to gaining selectivity for the reductive coupling.  The presence of BF3OEt2, 
AlEt3 or TMSOTf led to the production of isolable quantities of 2.222.  The best 
condition involved premixing oxindole 2.209 and BF3OEt2 followed by adding 
AlH3•Me2NEt at -50 ºC to give 2.222 in 41% yield.  Use of AlEt3 and TMSOTf as Lewis 
acids gave 2.222 in lower yields and if no Lewis acid was present, no trace of 2.222 was 
observed.  When BF3OEt2 or AlEt3 was used, the reaction was generally clean, leading 
mostly to 2.222 and recovered starting material 2.209.  The reaction always halts between 
15-40% conversion as judged by TLC.  The product 2.222 slowly decomposes under the 
reaction conditions, so it was necessary to quench the reaction once the conversion 







Scheme 2.58: Screening of various Lewis acids and reducing agents to access 2.222 
 
 
 We identified conditions for reductive cyclization of 2.209 by careful 
optimization of reaction variables (Scheme 2.59).  Namely, 2.209 was premixed with 1.5 
equivalents of BF3OEt2 in THF and AlH3•Me2NEt was added dropwise at 0 °C when the 
reaction was quenched with dilute acetic acid after 1 minute, we could reproducibly 
isolate the key hexacyclic core structure 2.222 in 54-58% yield.  We also isolated 21% 
yield of the over-reduced product 2.231 as a mixture of diastereomers; the starting 
material was present in 10% yield.  A more comprehensive screening of Lewis acids may 











Scheme 2.59: Optimized reductive coupling conditions 
 
 
 At this point, we were reasonably confident that the compound isolated was 





were somewhat ambiguous. The high-resolution mass spectrum was consistent with 
2.222, but the possibility that this compound was a related structural isomer was a 
concern.  All attempts to recrystallize 2.222 were unsuccessful.  Thus, we tried to 
derivatize 2.222 in such a way that would confirm its structure.  The putative tetracycle 
2.222 was hydrogenated using palladium on carbon under an atmosphere of hydrogen.  
Over the course of 12 h, a number of products were isolated and characterized (Scheme 
2.60).  The first reduction occurred at the exocyclic olefin, leading to a mixture (3:1) 
diastereomers 2.232 and 2.233.  Prolonged exposure of 2.232 and 2.233 to the reaction 
conditions led to the reduction of the internal olefin.  Substrate 2.233 was reduced 




giving isomer 2.234 as the sole product, whereas 2.232 was reduced without any facial 
selectivity, giving a mixture (1:1) of isomers 2.235 and 2.236.  The structure of isomer 
2.234 was established by X-ray crystallography, thus confirming that we began with the 
hexacyclic starting material 2.222 (Figure 2.11).   
 






Figure 2.11: X-ray crystal structure of hydrogenated derivative 2.234. 
 
 
2.3.1.5. Oxidation of diene 2.222 
With core structure 2.222 in hand, we began to explore methods to effect the 
double dihydroxylation of the two olefins of 2.222.   The first conditions that we screened 
were similar to those developed by Overman in his total synthesis of gliocladine C.
123
  By 
mixing diene 2.222 with K2OsO4, quinuclidine, K3Fe(CN)6, K2CO3, and MeSO2NH2 
under biphasic conditions at 0 ºC, we saw rapid oxidation of the external olefin leading to 
diol 2.237 as a mixture (3:2) of two isomers (Scheme 2.61).  Continued stirring led to 
tetraol 2.238 in 26% yield as a mixture of three isomers, along with 10-15% of the mono-
oxidized product 2.237.  A mixture of unidentified side products was also isolated from 
the reaction accounting for 25-50% of the mass recovery.  If the reaction was halted after 
the first oxidation, diol 2.237 can be isolated in 30-60% yield depending on the 
conditions.  Upon continued exposure to the oxidizing conditions, the diol 2.237 and 
tetraol 2.238 degrade into an intractable mixture of unidentified side products, most likely 




better yields by modifying the pH of the reaction, changing the solvents, and using 
different oxidants, but all modified conditions resulted in lower yields of tetraol 2.238.  
 
Scheme 2.61: Double dihydroxylation of 2.222 
 
 
When monitoring this oxidation by TLC, it appeared that the initially formed diol 
2.237 was stable to the reaction conditions, whereas the tetra-hydroxylated product 2.238 
was not.  We hypothesized that one potential side reaction might involve fragmentation 
of the tetrahydroxylated compound 2.238 to give bis-indole 2.239 and aldehyde 2.240 
(Scheme 2.62).
197
  Masses consistent with 2.240 and 2.239 were observed by LCMS; but 




Scheme 2.62: Possible fragmentation pathway leading to the instability of 2.238. 
 
 
 In an effort to prevent this presumed side-reaction, we were inspired by a protocol 
developed by Narasaka and later improved by Sharpless, wherein the dihydroxylation is 
carried out under anhydrous conditions in the presence of phenylboronic acid.
198,199 
 The 
boronic acid hydrolyzes the intermediate osmate ester, forming a boronic ester 2.242 
rather than a diol.  When we applied similar conditions to 2.222, we observed an increase 
in the rate of consumption of 2.222 (Scheme 2.63), but, 2.238 was isolated in only 13% 














Scheme 2.63: Attempted in-situ protection during the oxidation procedure 
 
 
We were unable to isolate any boronate esters intermediates, thus we 
hypothesized that that the difficulties with the reaction may be due to the instability of 
intermediates such as 2.241 to hydrolysis.  We sought a more stable boronic ester by 
screening similar reaction conditions, using the more electron-rich ortho-methoxy 
substituted boronic acid 2.242, as we hoped that boronic esters would be more stable to 
hydrolysis because of a less electrophilic boron center (Scheme 2.44).  Unfortunately, the 
results using boronic acid 2.242 were even worse, giving the desired hydroxylated 







Scheme 2.64: In-situ boronic ester formation using alternate boronic acid 2.242. 
 
 We also tried to oxidize 2.222 to 2.238 via the epoxide intermediate 2.243,  
thinking that bis-epoxide 2.243 would be prone to spontaneous ring-opening to a reactive 
iminium species such as 2.244, which would be trapped by water to give 2.238.  
However, nucleophilic epoxidation conditions using tert-butyl hydroperoxide and DBU 
led to an intractable mixture of products (Scheme 2.65), whereas oxidation using mCPBA 
with buffer in biphasic conditions resulted in what we believe to be oxidation of the 
indole ring based on LCMS and 
1
HNMR.  In both cases, we failed to detect even trace 










Scheme 2.65: Attempted epoxidations to access 2.238 
 
 
 It was previously observed that the external olefin of 2.222 oxidizes much more 
rapidly than the internal olefin (Scheme 2.61).  This finding led to us to explore the 
oxidative cleavage of the exocyclic olefin of 2.222 to access the gliocladin C skeleton 
2.245.  However, attempted selective ozonolysis led to over oxidation of the starting 







Scheme 2.66: Attempted oxidative cleavage of 2.222 using ozone 
 
 
 When diene 2.222 was exposed to Johnson-Lemieux conditions in the presence of 
2,6-lutidine, 2.245 was isolated in 7% yield, along with 55% recovered starting 
material.
200,201
  However, oxidative cleavage of 2.222 was accomplished by using 
osmium tetraoxide (2 mol %), phenyl iodoacetate, N-methylmorpholine oxide, and 2,6-
lutitdine, giving 2.245 in 84% yield (Scheme 2.67).
202
   Hexacyclic compound 2.245 was 




CNMR, and HRMS. 
 






 With the oxidative cleavage conditions developed, we could explore tactics to 
elaborate 2.245 into gliocladin C (2.6) by the removal of the N-benzyl group.  It should 
be noted that the synthesis was originally planned to target only the oxidized 
epipolythiodiketopiperazine containing natural products such as 2.9 and 2.12, so we did 
not anticipate the need for removal of the N-benzyl group in the presence of a 
trisubstituted olefin.  Subjecting 2.245 to hydrogenative conditions with Pd/C or Pd(OH)2 
failed to produce isolable amounts of gliocladin C.  Under all conditions screened, the 
first product formed was 2.246 as identified by LCMS monitoring of the reaction mixture 
(Scheme 2.68).  Continued reaction time led to varying amounts of the reduced  
debenzylated product 2.247 as identified by LCMS monitoring of the reaction mixture.  
Use of Pd(OH)2 led to faster hydrogenation of both the internal olefin and the benzyl 
group.  Addition of protic acids such as AcOH, TFA, and HCl did not affect the rate of 
benzyl group hydrogenolysis versus olefin hydrogenation. Preliminary attempts to 














Scheme 2.68: Attempted benzyl group removal under hydrogenolysis conditions 
 
 
 In summary, the synthesis of N-benzyl gliocladin C (2.6) was accomplished in 9 
total steps and 13.4% overall yield from commercially available 2.11 by a novel and 
concise route, starting from simple and readily available starting materials.  If 2.245 were 
elaborated to Gliocladin C (2.6), this route would compare favorably to the routes from 
Overman (14 steps, 14.4% yield) and Movassaghi (14 steps, 10.7% yield).   
  The overall sequence is summarized in Scheme 2.269-2.271. Commercially 
available protected serine derivative (2.211) was converted in 3 simple steps to N-methyl-
amino acid 2.217 (Scheme 2.69).  This sequence required no chromatography and is 









Scheme 2.69: Five step route from serine protected N-methyl-amino acid 2.217.   
 
 
A coupling procedure was developed for coupling of 2.217 and 2.194 using 
Castro’s reagent to give 2.219 in 76% yield.  Dipeptide 2.219 was deprotected and 
cyclized in a high-yielding transformation to give diketopiperazine 2.221 (Scheme 2.70).  
One of the featured steps in the route to 2.245 is the unprecedented one-pot activation, 
elimination, and nucleophilic addition of 2.221 to isatin 2.201 that was initiated by 
treatment of 2.221 with MsCl and K2CO3 in DMF to furnish 3-hydroxyindole 2.202 in 
71% yield.  The use of unsaturated diketopiperazines as nucleophiles is a valuable new 
synthetic tool for the construction of diketopiperazine containing natural products 
because of it is a short and convergent approach that uses readily available starting 
materials.  Additionally, this step serves as a potential branching point to introduce 
diversity for the synthesis of analogues by replacing 2.201 with a variety of isatin 
derivatives.   
The Lewis acid promoted ionization of 2.202 presence of indole gave the 




expansion over the previously reported ionization of tertiary bromide 2.43 to give 2.45.  
A system for the selective reductive cyclization were eventually discovered by using a 
reducing agent in the presence of a Lewis acid activator, allowing for the construction of 
the key hexahydropyrroloindoline core skeleton 2.222 in five steps from peptide 2.217 
and commercially available serine methyl ester 2.194.  This novel set of conditions may 
find future applications in the reductive cyclization of substrates with sensitive 
functionality such as unsaturated amides, esters, and ketones. 
 






The core structure 2.222 can be elaborated in two ways.  One is by the double 
dihydroxylation to give tetraol 2.238.  This transformation has been accomplished by 
using a modified version of the Sharpless conditions to give 2.238 in 26% yield as a 
mixture of isomers (Scheme 2.71).  If 2.238 could be accessed more selectively it would 
be an estimated 3-5 steps removed from a number of natural products within the 
epipolythiodiketopiperazine containing natural product family that have never before 
synthesized, including T998B (2.9) and plectosphaeroic acid A (2.12).  
Furthermore, the exocyclic olefin of 2.222 can be oxidatively cleaved to give N-
benzyl-gliocladin C (2.245).  Upon development of the debenzylation conditions, this 
will constitute a total synthesis of gliocladin C (2.6).  In the instance that the N-benzyl 
group of 2.245 cannot be removed, the route can be modified slightly to use an alternate 
isatin electrophile with a more suitable protecting group such as PMB or SEM.  
Additional advancement may include the development of an enantioselective variant, 


























2.3.2. RESULTS AND DISCUSSION: MPC1001 CORE STRUCTURE VIA RETRO HOMO-
DIELS-ALDER CYCLOADDITION OR BY COPE REARRANGEMENT OF DIVINYL EPOXIDES 
2.3.2.1. Sequential pyrone cycloaddition and retro-homo Diels-Alder cycloaddition 
 Our interest in the dihydrooxepine epipolythiodiketopiperazine alkaloids inspired 
efforts directed toward developing new methods for the construction of fused 
dihydrooxepins.  We envisioned two potential approaches to access the dihydrooxepin 
core of these alkaloids. The first of these would involve a sequential pyrone cycloaddition 
and retro-homo Diels-Alder cycloaddition (Scheme 2.29) and the second by a Cope 
rearrangement of a divinyl epoxide (Scheme 2.33).  We initiated work on a model system 
for the retro homo-Diels-Alder reaction by reacting carbomethoxy pyrone 2.163 with 
vinyl n-butylether (2.248).   Pyrone 2.163 was selected for this study because it is 
commercially available, or it can be synthesized in two steps from inexpensive starting 
materials.
203
  Additionally, 2.163 was well-known to undergo Diels-Alder reactions with 
a variety of olefinic partners with high selectivity.
204
 In the event, we found that the 
Diels-Alder of 2.163 with 2.248 gave 2.249 in 78% yield as a single isomer (Scheme 
2.72).  The structural assignment was made basis on the nOe interactions of the C7 nbutyl 
group protons (3.34 ppm) and the proximal C2 vinylic proton (6.79 ppm).  The selectivity 
that we observed matches what is reported for similar systems.
204
   
 





Attempts to epoxidize 2.249 to 2.250 with mCPBA, DMDO, and 
trifluoroperacetic acid failed consume the starting material (Scheme 2.73).  After 
prolonged heating, the starting material began to decompose to a complex mixture of 
side-product.  The unreactive nature of the olefin may be due to its electron deficiency.  
 




 After an extensive screening of conditions in attempts to form halohydrin 2.251, 
we found that 2.249 was consumed by exposure to trichloroisocyanuric acid (TCCA) 
(2.253) or tribromoisocyanuric acid (TBCA) (2.254) in the presence of triflic acid 
(Scheme 2.74).  However, the reaction of 2.249 with TCCA in dioxane/H2O gave a 
mixture (1:1) of the rearranged chlorohydrins 2.255 and 2.256 in 70% yield (equation 
2.7).  Similarly, reaction of 2.249 with TBCA in the presence of triflic acid gave the 
unexpected bromohydrin 2.257 in 83% yield (equation 2.8).  The structures of 2.255 and 

































 The formation of products 2.255, 2.256 and 2.257 can be explained by the 
cyclization displacement of the initially formed halonium ion 2.258 with the adjacent 
ether oxygen atom to give an oxonium intermediate 2.259 that was susceptible to 





Scheme 2.75: Mechanistic explanation for the observed products. 
 
 
 In order to avoid this undesired rearrangement during the halohydrin formation, 




the molecule (Scheme 2.76).  An intramolecular Diels-Alder reaction with allylamide 
2.260 would provide the tricyclic ester 2.261, epoxidation of which thermal extrusion of 
carbon dioxide might allow us access bicyclic oxepins such as 2.262.   
 
Scheme 2.76: Proposed model system to avoid unwanted rearrangements 
 
 
 Given this plan, the known pyrone acid chloride 2.263 was added to a solution of 
allyl amine 2.264 and triethylamine to give amide 2.265 in 77% yield (Scheme 2.77).  
Pyrone 2.265 was then heated in toluene at 75 ºC to provide the exo-cycloadduct 2.266 in 
60% yield and the endo-cycloadduct 2.267 in 21% yield after separation by flash 
chromatography.  The endo and exo structural designations for 2.266 and 2.267 were 
retroactively assigned based on X-ray crystal structure of 2.268 (Figure 2.13).  The exo-
isomer 2.266 and endo-isomer 2.267 can be distinguished by the characteristic shifts of 
their C4 protons at 2.24 ppm and 2.60 ppm, respectively.  Efforts to improve the 
diastereoselectivity of the cycloaddition with Lewis or Brønsted acid catalysis failed to 







Scheme 2.77: Intramolecular [4+2] cycloaddition  
 
 
 The exo-cycloadduct 2.266 was subjected to TBCA and triflic acid in an 
acetone/water mixture to furnish bromohydrin 2.268 in 78% yield (equation 2.9). The 
structure of 2.268 was confirmed by X-ray crystallography (Figure 2.13).    Endo-
cycloadduct 2.267 was reacted under identical conditions to give the bromohydrin 2.269 
in 19% yield (equation 2.10).  The regio- and stereochemical structural assignments of 
2.269 were made based on analogy to those observed with 2.268. The stereochemistry of 
the bromohydrin reflects the formation of the bromonium on the less hindered face of the 
double bond proximal to the lactone bridge, followed by nucleophilic attack of water 
from opposite face.  The regiochemistry of the bromohydrin results from the nucleophilic 
addition of water to the more electropositive carbon of the bromonium, proximal to the 








Figure 2.13: X-ray crystal structure of 2.268 
 
 
 Bromohydrins 2.268 and 2.269 were subjected to a variety of basic conditions in 
attempts to access endo-epoxide 2.270 (Scheme 2.78), but they were unreactive, even 
under forcing conditions.  When 2.268 and 2.269 were heated, the starting material 




detected.   We suspected that the failure of bromohydrins 2.268 and 2.269 to react may be 
due to the highly strained nature of tetracycle 2.270. 
 
Scheme 2.78: Failed epoxide formation 
 
 
 We hoped that the halohydrin 2.271 would allow for the closure to the epoxide 
2.272 due to a lower amount of strain in the tricyclic product.  In order to test this 
hypothesis, we examined an approach wherein we would synthesize a bicyclic ester 
shown by 2.273.  We speculated that the acyl group oxygen atom may participate during 
the bromination through a cyclic oxonium species such as 2.274, which may hydrolyze to 
give 2.271 (Scheme 2.79).  Exposure to base would lead to epoxide 2.272 and then Cope 








Scheme 2.79: Synthesis of bicyclic bromohydrin 2.271 
 
 Efforts to synthesize a bicyclic ester such as 2.273 began with a screening of vinyl 
acetate 2.276 and N-acyl vinyl amides 2.277 and 2.278 in the cycloaddition with 2-
carbomethoxy pyrone (2.263) (Scheme 2.80); only N-Vinyl pyrrolidone 2.278 underwent 
a [4+2] cycloaddition with 2.263 in the presence of catalytic Yb(OTf)3 (1 mol %) at room 
temperature to give the cycloadduct 2.279,  the structure of which was confirmed by X-
ray crystallography (Figure 2.14).   
 





Figure 2.14: X-ray crystal structure of 2.279 
 
 
 We then explored the direct oxidation of cycloadduct 2.279 using a number of 
oxidants including mCPBA, trifluoroperacetic acid, and methyl trifluoromethyl 
dioxirane, all of which gave recovered 2.279 (Scheme 2.81).  Heating the reactions 
generally resulted in the decomposition of the starting material to a complex mixture of 
products.  Similarly, exposure of 2.279 to TBCA under acidic conditions with either HCl 
or triflic acid gave mostly recovered 2.279.  No trace of the desired bromohydrin 2.281 










Scheme 2.81: Attempted oxidation of electron deficient olefin 2.279 
 
 
 In an effort to make the olefin in 2.279 less electron deficient, we explored the 
reduction of the exocyclic methylester to an alcohol.  However, attempts to reduce the 
exocyclic ester of 2.279 failed to give any trace of the desired product (Scheme 2.82).  
Accordingly, we were compelled to pursue a more circuitous approach to synthesize the 
alcohol. The acid chloride 2.282 was thus esterified with tert-butanol to give pyrone 
2.283 in 68% yield.
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  Diels-Alder cycloaddition of 2.283 with vinyl pyrrolidone 2.275 
in the presence of a catalytic amount of Yb(OTf)3 furnished cycloadduct 2.276 in 82% 
yield.  Exposure of 2.276 to trifluoroacetic acid cleanly gave the free acid 2.277 in 88% 
yield.  The mixed anhydride obtained by reaction of 2.277 with isobutyl chloroformate 
was reduced with sodium borohydride to furnish the alcohol 2.278 in 82% yield.  
Protection of the hydroxyl group with TIPSCl and imidazole provided TIPS-ether 2.279 
in 98% yield.  When 2.279 was then exposed to mCPBA, trifluoroperacetic acid, and 




After prolonged exposure to the reaction conditions or heating, loss of the –TIPS group 
was observed, but no epoxide was isolated. 
 
Scheme 2.82: Synthetic route to access 2.280. 
 
 
 On the other hand iodohydrin 2.281 was formed in 90% yield by the action of N-
iodosuccinimide and trifluoroacetic acid (Scheme 2.83); no conversion was observed 
without the addition of acid.  The structure of 2.281 was confirmed by X-ray 





Scheme 2.83: Synthesis of iodohydrin 2.281. 
 
 
Figure 2.15: X-ray crystal structure of 2.281. 
 
 
 A variety of hydride, amide, amine, and carbonate bases were screened to form 
the epoxide 2.282 from the iodohydrin 2.281 (Scheme 2.84).  In general, we found that 
there was simply no reaction with all bases in THF but when DMF was used, we 
observed some consumption of the starting material, although, no epoxide was isolated.  
When acetonitrile was used in combination with NaOtBu or CsCO3, we were able to 




2.282 was found to be water sensitive, so the reaction was concentrated and 
chromatographed without aqueous workup.  The structure of 2.282 was confirmed by X-
ray crystallography (Figure 2.16).   
 
Scheme 2.84: Successful epoxide formation from the iodohydrin 
 
 






 We then screened a variety of conditions to induce the retro-homo Diels-Alder 
reaction of 2.282 (Scheme 2.85).  Heating 2.281 in toluene, tetraglyme, 
hexafluoroisopropanol gave only recovered starting material, even at temperatures as 
high as 330 ºC.  No change was observed under microwave heating in toluene at 200 ºC.  
Heating 2.282 under vacuum to encourage the extrusion of carbon dioxide gas also 
resulted in only recovered starting material.  Exposure of 2.281 to Lewis acids TMSOTf, 
ZnBr2, and Ti(OiPr)4 led only to recovered 2.282;  no trace of desired oxepin 2.282 was 
detected.  The failure of 2.281 to undergo the retro-homo Diels-Alder reaction may be 












2.3.2.2. Cope rearrangement of divinyl epoxides 
 In order to explore the possibilty of inducing the ring expansion of divinyl 
epoxides, we tried to convert the vinylogous formamide 2.283 into epoxide 2.284 
(Scheme 2.86).  Unsaturated aldehyde 2.283 was available in four steps from 





focused on the use of the preformed sulfonium salt 2.285 to transform aldehyde 2.283 
into vinyl substituted epoxide 2.284.
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screened, but no conditions were identified that to produced detectable amounts of 
desired epoxide 2.284.  Instead, we observed a slow decomposition of sulfoxonium salt 
2.285 along with recovered aldehyde 2.283.  The N-Boc protecting group was exchanged 
with an N–benzyl group and an N-sulfonyl group and the substrates 2.286 and 2.287 were 
re-submitted to the reaction conditions, all of which failed to generate the epoxide. 
 
 





We also investigated the use of an organo-titanate nucleophile derived from the 
anion of phenyl allyl sulfide (2.288) to generate the alcohol 2.289 without success 
(Scheme 2.87).   
 
Scheme 2.87: Attempted use of organo-titanate nucleophiles to form alcohol 2.286. 
 
In another unsuccessful attempt to generate a precursor of the epoxide 2.284, 
chloro-iodopropene 2.290 was premixed with tin chloride prior to the addition of 
aldehyde 2.283 (Scheme 2.88).
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Scheme 2.88: Attempted tin promoted addition of allyl chloride 
 
 
A Brown-type allylation of and aldehyde 2.283 was also briefly examined using a 
vinyl-borane generated from the anion of allylchloride (2.292),
186




chlorohydrin 2.294 or epoxide 2.284 was detected (Scheme 2.89).  Aldehydes 2.286 and 
2.287 also failed to give any desired epoxide under the reaction conditions. 
 





2.3.2.3. Summary and Conclusions 
Our unsuccessful attempts to construct dihydrooxepins by the retro-homo Diels-
Alder cycloaddition (Scheme 2.85) or by the Cope rearrangement of divinyl epoxides 
(Scheme 2.33) highlights the difficulties associated with the synthesis of this structural 
motif.  Despite the failure to form dihydrooxepin 2.282 by loss of carbon dioxide, we 
speculate that perhaps the route can be redesigned to be more reactive through extrusion 
of nitrogen gas
149
 or a nitroso group.
150
 Our explorations into this route led to the 
development of epoxidation conditions for electronically deactivated olefins, which may 
be useful to future work toward this methodology (Scheme 2.84). 
We were unable to attempt the Cope-rearrangement of divinyl epoxides due to the 




may be due to the vinylogous nature of the formamide, which is not precedented to 
undergo nucleophilic additions from allyl anion equivalents.  The route will need to be 
redesigned to avoid this transformation.  If epoxides such as 2.284 could be easily 
accessed by alternative methods, Cope-rearrangement may serve as a rapid means for the 






















Chapter 3: Experimental Section 
 
General Methods: Nuclear magnetic resonance spectra were recorded on a 600, 500 or 
400 MHz spectrometer.  Chemical shifts are reported in parts per million (δ) and are 
referenced to the indicated deuterated solvent.  Coupling constants (J) are reported in 
Hertz (Hz) and the splitting abbreviations used are: s, singlet; d, doublet; t, triplet; q, 
quartet; dt, doublet of triplets; ddd, doublet of doublets of doublets; dtd, doublet of 
triplets of doublets; dq, doublet of quartets; m, multiplet; comp, overlapping multiplets of 
non-magnetically equivalent protons; br, broad.  Infrared (IR) spectra were obtained with 
a Nicolet IR100 FT-IR spectrometer, either neat on sodium chloride or as solutions in the 
solvent indicated.  Band positions are given in reciprocal centimeters (cm
-1
).  Melting 
points were determined using a Thomas-Hoover Uni-melt capillary melting point 
apparatus and are uncorrected. All optical rotations were taken on an Atago AP-300 
automatic polarimeter.  Thin layer chromatography (TLC) was performed on glass-
backed precoated silica gel plates (0.25 mm thick with 60 F254) and were visualized using 
one or both of the following manners: UV light (254 nm) and staining with basic aqueous 
KMnO4 or p-anisaldehyde.  Column chromatography was performed using glass columns 
and “medium pressure” silica gel (Sorbent Technologies, 45-70μ).  Tetrahydrofuran and 
diethyl ether were dried by filtration through two columns of activated, neutral alumina 
according to the procedure described by Grubbs (Pangborn, A. B.; Giardello, M. A.; 
Grubbs, R. H.; Rosen, R. K.; Timmers, F. J., Organometallics 1996, 15, 1518-1520).  
Toluene was additionally deoxygenated by passing through activated Q5.  Triethylamine, 




distilled from CaH2 prior to use.  Furans were distilled from KOH immediately prior to 
use.  All reagents were purchased and used as received unless otherwise stated.  
Glassware used in the reactions was dried overnight in an oven at 120 ºC.  All reactions 
were performed under an atmosphere of argon unless otherwise noted.  Our thanks to 




 3-(Vinylsulfonyl)oxazolidin-2-one (1.133) (nb-2-164).  A solution of 2-
oxazolidinone (1.136) (1.94 g, 22.31 mmol) and Et3N (12.44 mL, 89.24 mmol) in dry 
CH2Cl2 (200 mL) was cooled to -30 ºC (dry-ice/acetone bath), and to this solution was 
added 2-chloroethanesulfonyl chloride (1.137) (4.00 g, 24.54 mmol, 2.56 mL) dropwise 
over 45 min with stirring.  After the addition was completed, the mixture was stirred for 
1.5 h at -30 ºC.  After this time, the reaction became cloudy and slightly orange in color.  
H2O (100 mL) was added, and the mixture was extracted with CH2Cl2 (4 x 100 mL).  The 
combined organics were washed with brine (1 x 100 mL) and dried (MgSO4), filtered, 
and concentrated under reduced pressure to give 1.91 g of crude 1.333, which was 
recrystallized from EtOAc/hex to provide 2.37 g (55%) of 1.333 as white crystals: mp 82-
84 ºC; 
1
H NMR for 1.333 (500 MHz, CDCl3) δ 6.85 (dd, J = 16.56, 9.90 Hz, 1H), 6.55 
(dd, J = 16.6, 0.6 Hz, 1H), 6.24 (dd, J = 9.9, 0.7 Hz, 1H), 4.49-4.40 (AA’BB’, J = 7.66, 
7.91, 2H), 4.03 (AA’BB’, J = 7.91, 7.65, 2H); 
13




152.3, 131.4, 132.8, 62.7, 44.5; IR (neat) 1162.9, 1778.0; Mass Spectrum (CI) m/z 
178.0172 [C5H8NO4S (M+1) requires 178.0174], 178 (base), 355. 
 
NMR ASSIGNMENTS FOR 3-(Vinylsulfonyl)oxazolidin-2-one (1.133):  
 1
H NMR for 1.333 (500 MHz, CDCl3) δ 6.85 (dd, J = 16.6, 9.9 Hz, 1H, C2-H), 6.55 
(dd, J = 16.6, 0.6 Hz, 1H, C1-H), 6.24 (dd, J = 9.9, 0.7 Hz, 1H, C1-H), 4.49-4.40 
(AA’BB’, 2H, C4-H), 4.03 (AA’BB’, 2H, C3-H); 
13
C NMR for 1.333 (125 MHz, CDCl3) 





Procedure for the Asymmetric Diels-Alder Reaction with 2,5-dimethylfuran 
to furnish 1.161 and 1.162 (nb-2-155).  To a solution of the sulfonium salt 1.82 (20 mg, 
0.06 mmol) in anhydrous CH2Cl2 (200 µL) was added 2,5-dimethylfuran (29 mg, 0.29 
mmol, 31 μL) via syringe at –78 ˚C.  The reaction mixture was stirred at –78 ˚C for 1 h 
then placed in a -20 ˚C refrigerator for 11 h.  KOH (0.2 M, 0.5 mL) was added to the 
solution and the reaction mixture was warmed to room temperature, with stirring for an 
additional 30 min at room temperature.  The reaction mixture was extracted with CH2Cl2 
(3 x 2 mL), washed with brine (4 mL), dried (MgSO4), and concentrated under reduced 




1:0.18, endo d.e. = 90%, exo d.e. = 84%, established by 
1
H NMR).  Crude material 
purified by reverse phase HPLC using a semi-prep gemini 10μ C18 column, 0-95% 
H2O/CH3CN increasing gradient over 60 min, 10 mL/min flow rate.  
1
H NMR for 1.161 
(500 MHz, CDCl3) δ 7.61 – 7.47 (comp, 2 H), 7.26 (dd, J = 8.5, 0.6  Hz, 2 H), 6.50 (d, J 
= 5.6 Hz, 1 H), 6.33 (d, J = 5.6 Hz, 1 H), 3.19 (dd, J = 8.8 Hz, 3.9 1 H), 2.38 (s, 3 H), 
1.81 (s, 3 H), 1.61 (dd, J = 12.2, 9.0 Hz, 1 H), 1.51 (s, 3 H), 1.15 (dd, J = 12.3, 3.9 Hz, 1 
H); 
13
C NMR for 1.161 (125 MHz, CDCl3) δ 142.25, 140.88, 140.74, 136.82, 130.2, 
125.3, 88.6, 85.6, 71.3, 36.2, 21.6, 19.9, 18.8; MS (CI) m/z 263.1109 [C15H19O2S (M+1) 
requires 263.1106], 263 (base), 267. 
1
H NMR for 1.162 (500 MHz, CDCl3) δ 7.65 – 7.54 (comp, 2 H), 7.27 (d, J = 7.8 
Hz, 2 H), 6.19 (d, J = 5.5 Hz, 1 H), 6.13 (d, J = 5.5 Hz, 1 H), 2.88 (dd, J = 8.0, 4.6  Hz, 1 
H), 2.38 (s, 3 H), 1.93 (s, 3 H), 1.52 (s, 3 H), 1.27 (dd, J = 12.5, 8.0 Hz, 1 H), 1.07 (dd, J 
= 12.5, 4.6 Hz, 1 H);
 13
C NMR for 1.162 (125 MHz, CDCl3) δ 142.40, 140.83, 140.48, 
139.25, 130.09, 126.14, 87.92, 85.46, 70.91, 37.76, 21.68, 18.65, 17.62; MS (CI) m/z 
263.1110 [C15H19O2S (M+1) requires 263.1106], 263 (base). 
 
NMR ASSIGNMENTS FOR 1.161:  
1
H NMR for 1.161 (500 MHz, CDCl3) δ 7.61 – 7.47 (comp, 2 H, C10-H), 7.26 
(dd, J = 8.5, 0.6 Hz, 2 H, C11-H), 6.50 (d, J = 5.6 Hz, 1 H, C2-H), 6.33 (d, J = 5.6 Hz, 1 
H, C1-H), 3.19 (dd, J = 8.8, 3.9  Hz, 1 H, C4-H), 2.38 (s, 3 H, C13-H), 1.81 (s, 3 H, C7-
H), 1.61 (dd, J = 12.2 9.0 Hz, 1 H, C5-H endo), 1.51 (s, 3 H, C8-H), 1.15 (dd, J = 12.3, 
3.9 Hz, 1H, C5-H exo); 
13
C NMR for 1.161 (125 MHz, CDCl3) δ 142.25 (C9), 
140.88(C12), 140.74(C1), 136.82(C2), 130.2(C11), 125.3(C10), 88.6(C3), 85.6(C6), 





NMR ASSIGNMENTS FOR 1.162:  
1
H NMR for 1.162 (500 MHz, CDCl3) δ 7.65 – 7.54 (comp, 2 H, C10-H), 7.27 (d, 
J = 7.8 Hz, 2 H, C11-H), 6.19 (d, J = 5.5 Hz, 1 H, C1-H), 6.13 (d, J = 5.5 Hz, 1 H, C2-
H), 2.88 (dd, J = 8.0, 4.6 Hz, 1 H, C4-H), 2.38 (s, 3 H, C13-H), 1.93 (s, 3 H, C8-H), 1.52 
(s, 3 H, C7-H), 1.27 (dd, J = 12.5, 8.0 Hz, 1 H, C5-H endo), 1.07 (dd, J = 12.5, 4.6 Hz, 1 
H, C5-H exo);
 13
C NMR for 1.162 (125 MHz, CDCl3) δ 142.4 (C9), 140.8 (C12), 140.5 
(C2), 139.3 (C1), 130.1 (C11), 126.1 (C10), 87.9 (C6), 85.5 (C3), 70.9 (C4), 37.8 (C5), 






Procedure for AlMe3 mediated the Diels-Alder Reaction with 2,5-
dimethylfuran to furnish 1.139a and 1.139b (nb-2-69).   AlMe3 (2 M in hexane) (120 
µL, 0.238 mmol) was added dropwise to a dry, argon-purged, vial containing vinyl 
sulfone 1.126 (20 mg, 0.119 mmol) in CH2Cl2 (200 µL) with stirring at 0º C.  The 
solution was stirred for 20 min at 0 ºC, and 2,5-dimethylfuran (freshly distilled from 
KOH) (57.2 mg, 63 µL, 0.595 mmol) was added dropwise over 1 min with rapid stirring.  
The reaction was then stirred at 5 ºC (refrigerator) for 36 h.   The reaction was allowed to 




filtrate was then concentration by rotary evaporation to yield 35 mg of pale yellow oil.   
The crude material was purified via column chromatography eluting with Et2O/Pentane 
(2:3) to provide 26 mg of 1.139a (top spot) and 3 mg of 1.139b (lower spot) (95%), both 
as white crystals.
 1
H NMR for 1.139a (500 MHz, CDCl3) δ 7.89-7.82 (comp, 2 H), 7.69-
7.61 (m, 1 H), 7.59-7.52 (comp, 2 H), 6.38-6.30 (comp, 2 H), 3.54 (dd, J = 8.9, 4.5 Hz, 1 
H), 1.98 (dd, J = 11.8, 8.9 Hz, 1 H), 1.91 (dd, J = 11.8, 4.5 Hz, 1 H), 1.69 (s, 3 H), 1.57 
(s, 3 H); 
13
C NMR for 1.139a (125 MHz, CDCl3) δ 140.7 , 140.2, 135.7, 133.6, 129.3, 
127.9, 87.6, 86.2, 69.9, 38.5, 19.0, 18.6; IR (neat) 1147.9, 2931.3; MS (CI) m/z 265.0895 
[C14H17O3S (M+1) requires 263.0898], 169, 265 (base), 377. 
 
NMR ASSIGNMENTS FOR 1.139a:  
1
H NMR for 1.139a (500 MHz, CDCl3) δ 7.89-7.82 (comp, 2 H, C10-H), 7.69-
7.61 (comp, 1 H, C12-H), 7.59-7.52 (comp, 2 H, C11-H), 6.38-6.30 (app.s, ab pattern, 2 
H, C1-H, C5-H), 3.54 (dd, J = 8.9, 4.5 Hz, 1 H, C3-H), 1.98 (dd, J = 11.8, 8.9 Hz, 1 H, 
C4-H), 1.91 (dd, J = 11.8, 4.5 Hz, 1 H, C5-H), 1.69 (s, 3 H, C8-H), 1.57 (s, 3 H, C7-H);
  
13
C NMR for 1.140 (125 MHz, CDCl3) δ 140.7 (C9), 140.2 (C1), 135.7 (C5), 133.6 










1-Chloro-4-(vinylsulfinyl)benzene (1.191) (nb-3-60).  4-Chlorophenyl vinyl 
sulfide  (10.14 g, 170.66 mmol) was dissolved in AcOH (20 mL) and cooled to 0 °C, and 
H2O2 (30% aq.) (8.42 g, 8.42 mL, 34.01 mmol) was added dropwise with rapid stirring.  
The reaction was stirred at 0 °C for 1 h after which time the solution was warmed to 
room temperature and stirred for 12 h.  The now homogenous solution was diluted with 
H2O (30 mL) and extracted with Et2O (3 x 30 mL).  To the combined organics was added 
solid NaHCO3 followed by saturated aqueous NaHCO3 (ca. 15 mL) until all of the acid 
was neutralized.  The organic layer was then separated and dried (MgSO4), filtered, and 
concentrated by rotary evaporation.  The crude oil was then purified by flash 
chromatography (1:1 EtOAc/Hex to 2:1 EtOAc/Hex) to yield the product 1.191 (10.07 g, 




C NMR spectra were consistent with those 













methylcyclohexyloxy)ethylsulfinyl)benzene (1.197, 1.198) (nb-2-290).  (-)-Menthol 
(1.09 g, 6.96 mmol) in THF (3 mL) was added to a suspension of NaH (60% dispersion 
in mineral oil) (278 mg, 6.96 mmol) in THF (9 mL) at rt.  The suspension was stirred for 
30 min. and vinyl sulfoxide 1.191 (1 g, 5.36 mmol) in THF (3 mL) was added, 
immediately followed by a catalytic amount of KH.  Upon addition of KH, the reaction 
became brown in color.  The reaction was stirred for 4 h until all starting material was 
consumed by TLC.  The reaction was quenched by dilution with Et2O (15 mL) followed 
by the slow addition of brine until all bubbling had ceased.  The mixture was extracted 
with Et2O (3 x 15 mL), dried (MgSO4), filtered, and concentrated under reduced pressure.  
The crude oil was then purified by column chromatography (15% EtOAc/Hex to 30% 
EtOAc/Hex) to yield 1.197 and 1.198 (1.50 g, 81% yield) as a mixture (1:1) of 
diastereomers as a yellow oil.  This mixture was then dissolved in Et2O and cooled to 5 
°C, whereupon 1.197 crystallized as x-ray quality white spikes (mp 102-105 °C).  The 
mother liquor was diluted with pentane and cooled to -20 °C overnight, resulting in a 
second crop of 1.197 (741 mg total, 40% yield, >95% de by NMR). The mother liquor 
was then concentrated under reduced pressure and purified by column chromatography 
(15% EtOAc/Hex to 30% EtOAc/Hex) to yield 1.198 (609 mg, 33% yield, >95% de by 
NMR) as an off-white solid.  
1
H NMR for 1.197 (500 MHz, CDCl3) δ 7.60-7.59 (comp, 2 
H), 7.51-7.49 (comp, 2 H), 4.09-4.06 (m, 1 H), 3.60-3.56 (m, 1 H), 3.09-3.05 (m, 1 H), 




(m, 1 H), 0.99-0.82 (m, 9 H), 0.76 (d, J = 7.0 Hz, 3 H);
 13
C NMR for 1.197 (125 MHz, 
CDCl3) δ 143.0, 137.1, 129.5, 125.4, 79.8, 61.1, 59.2, 48.1, 40.2, 34.4, 31.5, 25.6, 23.3, 
22.2, 20.9, 16.3; IR (neat) 2953, 1475, 1051 cm
-1
; HRMS (CI) m/z calculated for 
C18H28O2SCl (M+1) 343.1499; found, 343.1504; mass spectrum, 326, 343 (base), 345. 
1
H NMR for 1.198 (500 MHz, CDCl3) δ 7.62-7.57 (comp, 2 H), 7.52-7.48 (comp, 
2 H), 3.96-3.86 (m, 1 H), 3.76 (ddd, J = 10.4, 9.3, 4.2 Hz, 1 H), 3.16 (dt, J = 10.6, 4.2 
Hz, 1 H), 2.95 (comp., 2 H), 2.27 (dtd, J = 13.95, 6.96, 2.77 Hz, 1 H), 2.08 (comp, 2 H), 
1.65 (comp, 2 H), 1.45-1.30 (m, 1 H), 1.23 (tdd, J = 13.38, 10.35, 3.18 Hz, 1 H), 1.06-
0.95 (m, 1 H), 0.95-0.89 (dd, J = 6.6, 3.6 Hz, 6 H), 0.84 ( comp., 5 H);
  13
C NMR for 
1.198 (125 MHz, CDCl3) δ 143.1, 137.0, 129.5, 125.3, 80.2, 60.8, 59.4, 48.3, 40.2, 34.5, 
31.4, 25.7, 23.3, 22.3, 20.9, 16.3; ; IR (neat) 2953, 1475, 1091 cm
-1
; ; HRMS (CI) m/z 













(-)-1-Chloro-4-(vinylsulfinyl)benzene ((-)-1.191) (nb-3-53).  A solution of 
LiHMDS (1M in THF) (1.63 g, 1.83 mL, 1.823 mmol) was added to a solution of 
diastereomerically pure sulfoxide 1.197 (500 mg, 1.458 mmol) in THF (10 mL) at -78 
°C.  The reaction was stirred for 45 sec. after which time it was quenched by the rapid 
addition of NH4Cl (sat. aq. soln.) and then allowed to warm to room temp.  The mixture 
was then extracted with CH2Cl2 (3 x 10 mL), dried (MgSO4), filtered, and concentrated 
under reduced pressure.  The crude oil was purified by column chromatography (30% 





NMR spectra were consistent with those reported in the literature.208 The purified (-)-
1.191 was separated via HPLC on a Chiral OB column in >99% ee (1 mL/min, 0% to 
30% iPrOH/hexanes gradient over 30 min) in >99% ee, the two enantiomers eluting at 
21.24 min. and the minor at 25.32 min.; [α]
27










(+)-1-Chloro-4-(vinylsulfinyl)benzene ((+)-1.191) (nb-3-51).  A solution of 
LiHMDS (1M in THF) (1.63 g, 1.83 mL, 1.823 mmol) was added to a solution of 
diastereomerically pure sulfoxide 1.198 (500 mg, 1.458 mmol) in THF (10 mL) at -78 
°C.  The reaction was stirred for 45 sec. after which time it was quenched by the rapid 
addition of NH4Cl (sat. aq. soln.) and then allowed to warm to room temp.  The mixture 
was then extracted with CH2Cl2 (3 x 10 mL), dried (MgSO4), filtered, and concentrated 
under reduced pressure.  The crude oil was purified by column chromatography (30% 





NMR spectra were consistent with those reported in the literature.208 The purified (+)-
1.191 was separated via HPLC on a Chiral OB column (1 mL/min, 0% to 30% 
iPrOH/hexanes gradient over 30 min) in >99% ee, the two enantiomers eluting at 21.24 
min. and the major at 25.32 min.; [α]
27











(nb-4-58).  TBSOTf (123 µL, 0.536 mmol) was added dropwise to a solution of p-
chlorophenyl-vinylsulfoxide (-)-1.191 (100 mg, 0.54 mmol) and 2,6-di-tert-butylpyridine 
(12 µL, 0.06 mmol) in CH3CN (200 µL) at 0 °C.  The mixture was stirred for 15 min, 
whereupon furan (364 mg, 195 µL, 2.68 mmol) was added dropwise.  The reaction was 
stored for 24 h at 0 °C (refrigerator).  Saturated aqueous NaHCO3 (1 mL) was then added, 
and the layers were separated.  The aqueous layer was extracted with CH2Cl2 (3 x 5 mL), 
and the combined organic layers were dried (MgSO4) and concentrated under reduced 
pressure.  The residue was purified by flash chromatography eluting with EtOAc/hexanes 
(66% to 100%) to give 137.5 mg (99%) of 1.195 as a mixture of endo:exo isomers (1.8:1) 
and as a clear oil.  Endo-1.195 was separated via HPLC using a Chiral OB column (1 
mL/min, 0% to 30% iPrOH/hexanes over 30 min) with the two diastereomers eluting at 
28.28 min and 40.85 min in 90% de. Exo-1.195 was separated via HPLC using a Chiral 
OB column (1 mL/min, 0% to 30% iPrOH/hexanes over 30 min) with the two 
enantiomers eluting at 30.35 min and 35.30 min in 88% ee.  The product major endo 
isomer was recrystallized via slow evaporation from Et2O to give X-ray quality crystals 
(mp: 104-105 °C);  
1
H NMR for endo-1.195 (400 MHz, CDCl3) δ 7.63-7.56 (comp, 2 H), 
7.56-7.51 (comp, 2 H), 6.58 (dd, J = 5.9, 1.7 Hz, 1 H), 6.37 (dd, J = 5.9, 1.5 Hz, 1 H), 
5.12-5.06 (m, 1 H), 4.75 (ddd, J = 4.2, 1.5, 0.7 Hz, 1 H), 3.42-3.35 (m, 1 H), 2.13 (ddd, J 
= 13.3, 8.5, 4.3 Hz, 1 H), 1.79 (dd, J = 12.3, 3.8 Hz, 1 H); 
13




MHz, CDCl3) δ 142.5, 137.9, 137.6, 131.1, 129.8, 125.5, 79.1, 78.2, 64.9, 25.9;
 
IR (neat) 
3011, 1045; HRMS (CI) m/z calculated for C12H12O2SCl
+
 (M+1), 255.0247; found, 
255.0243; mass spectrum, 237 (base), 239, 268. 
 1
H NMR for exo-1.195 (400 MHz, CDCl3) δ 7.68-7.61 (comp, 2 H), 7.55-
7.49 (comp, 2 H), 6.45 (dd, J = 5.8, 1.6 Hz, 1 H), 6.24 (dd, J = 5.8, 1.8 Hz, 1 H), 5.16-
5.10 (m, 1 H), 4.96 (dd, J = 1.8, 0.7 Hz, 1 H), 2.75 (dd, J = 7.9, 3.6 Hz, 1 H),  2.29 (app. 
dt, J = 12.3, 4.0, 1 H), 1.56 (dd, J = 12.4, 7.9 Hz, 1 H);
 13
C NMR for exo-1.195 (100 
MHz, CDCl3) δ 141.9, 138.4, 137.7, 133.6, 129.7, 126.2, 79.0, 78.5, 64.7, 26.7; IR (neat) 
3009, 1046; HRMS (CI) m/z calculated for C12H12O2SCl
+
 (M+1), 255.0247; found, 
255.0247; mass spectrum, 237 (base), 269. 
 
NMR ASSIGNMENTS FOR endo-1.195:  
1
H NMR for endo-1.195 (400 MHz, CDCl3) δ 7.63-7.56 (comp, 2 H, C8-H), 7.56-
7.51 (comp, 2 H, C9-H), 6.58 (dd, J = 5.9, 1.7 Hz, 1 H, C1-H), 6.37 (dd, J = 5.9, 1.5 Hz, 
1 H, C5-H), 5.12-5.06 (m, 1 H, C2-H), 4.75 (ddd, J = 4.2, 1.5, 0.7 Hz, 1 H, C6-H), 3.42-
3.35 (m, 1 H, C3-H), 2.13 (ddd, J = 13.3, 8.5, 4.3 Hz, 1 H, C4-H), 1.79 (dd, J = 12.3, 3.8 
Hz, 1 H, C4-H); 
13
C NMR for endo-1.195 (100 MHz, CDCl3) δ 142.5 (C7), 137.9 (C1), 










NMR ASSIGNMENTS FOR exo-1.195:  
 1
H NMR for exo-1.195 (400 MHz, CDCl3) δ 7.68-7.61 (comp, 2 H, C8-H), 7.55-7.49 
(comp, 2 H, C9-H), 6.45 (dd, J = 5.8, 1.6 Hz, 1 H, C1-H), 6.24 (dd, J = 5.8, 1.8 Hz, 1 H, 
C5-H), 5.16-5.10 (m, 1 H, C2-H), 4.96 (dd, J = 1.8, 0.7 Hz, 1 H, C6-H), 2.75 (dd, J = 
7.9, 3.6 Hz, 1 H, C3-H),  2.29 (app. dt, J = 12.3, 4.0, 1 H, C4-H), 1.56 (dd, J = 12.4, 7.9 
Hz, 1 H, C4-H);
 13
C NMR for exo-1.195 (100 MHz, CDCl3) δ 141.9 (C7), 138.4 (C1), 





 (1S,2S,4S)-2-(4-chlorophenylsulfonyl)-7-oxabicyclo[2.2.1]hept-5-ene (1.203) (nb-
4-48).  TBSOTf (123 µL, 0.536 mmol) was added dropwise to a solution of p-
chlorophenyl-vinylsulfoxide (-)-1.191 (100 mg, 0.54 mmol) and 2,6-di-tert-butylpyridine 
(12 µL, 0.06 mmol) in CH3CN (200 µL) at 0 °C.  The mixture was stirred for 15 min, 
whereupon furan (195 µL, 2.68 mmol) was added dropwise.  The reaction was stored for 
24 h at 0 °C (refrigerator), whereupon 20% TEA in MeOH (500 µL) was added followed 
by Oxone (600 mg, 1.95 mmol).  The suspension was stirred for 6 h and H2O (4 mL) was 
added.  The mixture was extracted with Et2O (4 x 5 mL), and the combined organic 
layers were dried (MgSO4) and concentrated under reduced pressure.  The residue was 




143.5 mg (98%) of 1.203  as a (1.8:1) mixture of endo:exo isomers and as a white solid: 
endo-1.203 mp: 151-152 °C (clear needles by slow evaporation from Et2O), exo-1.203 
mp: 138-140 °C (white needles by slow evaporation from Et2O); endo-1.203 was 
separated via HPLC using a Chiral AD column (1 mL/min, 0% to 30% iPrOH/hexanes 
over 15 min) with the two enantiomers eluting at 30.73 min and 40.76 min in 88% ee; 
The endo-1.203 was recrystallized by slow evaporation from Et2O to give X-ray crystal 
77; 
1
H NMR for endo-1.203 (400 MHz, CDCl3) δ 7.86-7.75 (comp, 2 H), 7.61-7.51 
(comp, 2 H), 6.58 (dd, J = 5.6, 1.5 Hz, 1 H), 6.48 (dd, J = 5.8, 1.5 Hz, 1 H), 5.18-5.02 
(comp., 2 H), 3.76-3.64 (app. pent, J = 4.4 Hz, 1 H), 2.19 (ddd, J = 17.6, 9.1, 4.8,  1 H), 
1.67 (dd, J = 11.7, 4.5 Hz, 1 H); 
13
C NMR for endo-1.203 (125 MHz, CDCl3) δ 140.6, 
138.9, 137.5, 131.6, 129.8, 129.3, 79.6, 78.3, 62.8, 28.8; IR (neat) 1310, 1149 cm
-1
; 
HRMS (CI) m/z calculated for C12H12O3SCl
+
 (M+1), 271.0196; found, 271.0193; mass 
spectrum, 269, 271 (base), 273; [α]
27
D -27.6° (c 0.2, CH2Cl2). 
 1
H NMR for exo-1.203 (600 MHz, CDCl3) δ 7.86-7.82 (comp, 2 H), 7.55-7.51 (comp, 
2 H), 6.44 (dd, J = 5.8, 1.7 Hz, 1 H), 6.33 (dd, J = 5.8, 1.8 Hz, 1 H), 5.32 (dd, J = 1.8, 
0.8 Hz, 1 H),  5.05 (ddd, J = 4.6, 1.5, 0.8 Hz, 1 H), 3.11 (dd, J = 8.2, 4.2 Hz, 1 H), 2.17-
2.09 (m, 1 H), 1.64 (dd, J = 8.2, 12.3, 1 H); 
13
C NMR for exo-1.203 (125 MHz, CDCl3) δ 
140.6, 138.5, 136.8, 134.2, 130.2, 129.6, 78.9, 78.1, 64.1, 28.1; IR (neat) 2921.1, 1311.9, 
1149.3 cm
-1
; HRMS (CI) m/z calculated for C12H12O3SCl
+
 (M+1), 271.0196; found, 
271.0201; mass spectrum, 269, 271 (base); [α]
27






NMR ASSIGNMENTS FOR endo-1.203:  
 1
H NMR for endo-1.203 (400 MHz, CDCl3) δ 7.86-7.75 (comp, 2 H, C8-H), 7.61-
7.51 (comp, 2 H, C9-H), 6.58 (dd, J = 5.6, 1.5 Hz, 1 H, C1-H), 6.48 (dd, J = 5.8, 1.5 Hz, 
1 H, C5-H), 5.18-5.02 (comp, 2 H, C2-H and C6-H), 3.76-3.64 (app pent, J = 4.4 Hz, 1 
H, C3-H), 2.19 (ddd, J = 17.6, 9.1, 4.8,  1 H, C4-H), 1.67 (dd, J = 11.7, 4.5 Hz, 1 H, C4-
H); 
13
C NMR for endo-1.203 (125 MHz, CDCl3) δ 140.6 (C10), 138.9 (C7), 137.5 (C8), 
131.6 (C9), 129.8 (C1), 129.3 (C2), 79.6 (C2), 78.3 (C6), 62.8 (C3), 28.8 (C4). 
 
NMR ASSIGNMENTS FOR exo-1.203:  
 1
H NMR for exo-1.203 (600 MHz, CDCl3) δ 7.86-7.82 (comp, 2 H, C8-H), 7.55-7.51 
(comp, 2 H, C9-H), 6.44 (dd, J = 5.8, 1.7 Hz, 1 H, C1-H), 6.33 (dd, J = 5.8, 1.8 Hz, 1 H, 
C5-H), 5.32 (dd, J = 1.8, 0.8 Hz, 1 H, C2-H),  5.05 (ddd, J = 4.6, 1.5, 0.8 Hz, 1 H, C6-
H), 3.11 (dd, J = 8.2, 4.2 Hz, 1 H, C3-H), 2.17-2.09 (m, 1 H, C4-H), 1.64 (dd, J = 8.2, 
12.3, 1 H, C4-H); 
13
C NMR for exo-1.203 (125 MHz, CDCl3) δ 140.6 (C10), 138.5 (C8), 











(1.196) (nb-4-101).  TBSOTf (37 µL, 0.16 mmol) was added dropwise to a solution of p-
chlorophenyl-vinylsulfoxide (-)-1.191 (40 mg, 0.21 mmol) and 2,6-di-tert-butylpyridine 
(3.4 mg, 4 µL, 0.02 mmol) in CH3CN (100 µL) at -30 °C.  The mixture was stirred for 15 
min, whereupon 2-methylfuran (36.4 mg, 40 µL, 0.43 mmol) was added dropwise.  The 
reaction was stored for 24 h at -30 °C (freezer).  Saturated aqueous NaHCO3 (800 µL) 
was then added with rapid stirring, and the mixture was allowed to warm to room 
temperature.  CH2Cl2 (2 mL) was added, and the layers were separated.  The aqueous 
layer was then extracted with CH2Cl2 (3 x 4 mL), and the combined organic layers were 
dried (MgSO4) and concentrated under reduced pressure.  The residue was purified by 
flash chromatography eluting with EtOAc/hexanes (50% to 66%) to give 51 mg (89%) of 
1.196 as a (25:1) mixture of endo:exo isomers and as a clear oil; Endo-1.196 was 
separated via HPLC using a Chiral AD column (1 mL/min, 0% to 20% iPrOH/hexanes 
over 30 min) with the two diastereomers eluting at 28.09 min and 31.61 min in 99% de; 
The product endo-1.196 was then recrystallized via slow evaporation from Et2O to give 
X-ray quality crystals  (mp: 76-78 °C); 
1
H NMR for endo-1.196 (600 MHz, CDCl3) δ 
7.55-7.41 (comp, 4 H), 6.48 (d, J = 5.7 Hz, 1 H), 6.18 (d, J = 5.6 Hz, 1 H), 4.94-4.86 (m, 
1 H), 2.82 (dd, J = 8.6, 3.9 Hz, 1 H), 1.97-1.91 ( m, 1 H) 1.83-1.75 (m, 1 H), 1.61 (s, 3 
H); 
13
C NMR for endo-1.196 (125 MHz, CDCl3) δ 142.7, 137.9, 137.0, 134.0, 129.5, 
125.3, 86.3, 78.3, 68.8, 26.6, 17.8; IR (neat) 2975, 1475, 1388 cm
-1






 (M+1), 269.0403; found, 271.0406; mass spectrum, 251 
(base), 269; [α]
21
D +182.3° (c 1.0, CH2Cl2). 
 
NMR ASSIGNMENTS FOR endo-1.196:  
1
H NMR for endo-1.196 (600 MHz, CDCl3) δ 7.55-7.41 (comp, 4 H, C9-H and 
C10-H), 6.48 (d, J = 5.7 Hz, 1 H, C1-H), 6.18 (d, J = 5.6 Hz, 1 H, C5-H), 4.94-4.86 (m, 
1 H, C6-H), 2.82 (dd, J = 8.6, 3.9 Hz, 1 H, 3-H), 1.97-1.91 ( m, 1 H, C4-H) 1.83-1.75 (m, 
1 H, C4-H), 1.61 (s, 3 H, C7-H); 
13
C NMR for endo-1.196 (125 MHz, CDCl3) δ 142.7 
(C8), 137.9 (C1), 137.0 (C11), 134.0 (C5), 129.5 (C10), 125.3 (C9), 86.3 (C2), 78.3 (C6), 





ene (1.202) (nb-4-102).  TBSOTf (37 µL, 0.16 mmol) was added dropwise to a solution 
of p-chlorophenyl-vinylsulfoxide (-)-1.191 (40 mg, 0.21 mmol) and 2,6-di-tert-
butylpyridine (3.4 mg, 4 µL, 0.02 mmol) in CH3CN (100 µL) at -30 °C.  The mixture was 
stirred for 15 min, whereupon 2-methylfuran (36.4 mg, 40 µL, 0.43 mmol) was added 
dropwise.  The reaction was stored for 24 h at -30 °C (freezer), whereupon 20% TEA in 




was stirred for 6 h and H2O (3 mL) was added.  The mixture was extracted with Et2O (4 x 
3 mL) and the combined organic layers were dried (MgSO4) and concentrated under 
reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/hexanes (10% to 30%) to give 48.4 mg (81%) of 1.202 as a mixture of endo:exo 
isomers (>25:1) as a white solid. Endo-1.202 was separated via HPLC using a Chiral AD 
column (1 mL/min, 0% to 20% iPrOH/hexanes over 30 min) with the two enantiomers 
eluting at 28.62 min and 31.91 min in 99% ee;  The major endo isomer was recrystallized 
from Et2O/pentane: mp: 89-91 °C; 
1
H NMR for endo-1.202 (400 MHz, CDCl3) δ 7.57-
7.51 (comp, 2 H), 7.82-7.76 (comp, 2 H), 6.52 (dd, J = 5.7, 1.7 Hz, 1 H), 6.35 (d, J = 5.7 
Hz, 1 H), 4.94 (dd, J = 4.7, 1.8 Hz, 1 H), 3.37 (dd, J = 9.1, 4.4 Hz, 1 H), 2.31-2.24 ( m, 1 
H), 1.77-1.71 (comp, 4 H); 
13
C NMR for endo-1.202 (100 MHz, CDCl3) δ 140.4, 139.1, 
137.5, 135.1, 129.7, 129.4, 87.7, 78.2, 67.3, 32.5, 18.8; IR (neat) 3090, 1582, 1317 cm
-1
; 
HRMS (CI) m/z calculated for C13H14O3SCl
+
 (M+1), 285.0352; found, 285.0352;  mass 
spectrum, 269, 285 (base), 287; [α]
28
D -20.4° (c 0.2, CH2Cl2). 
 
NMR ASSIGNMENTS FOR endo-1.202:  
  1
H NMR for endo-1.202 (400 MHz, CDCl3) δ 7.57-7.51 (comp, 2 H. C9-H), 7.82-
7.76 (comp, 2 H, C10-H), 6.52 (dd, J = 5.7, 1.7 Hz, 1 H, C1-H), 6.35 (d, J = 5.7 Hz, 1 H, 
C5-H), 4.94 (dd, J = 4.7, 1.8 Hz, 1 H, C6-H), 3.37 (dd, J = 9.1, 4.4 Hz, 1 H, C3-H), 2.31-
2.24 ( m, 1 H, C4-H), 1.77-1.71 (comp., 4 H, C4-H and C7-H); 
13
C NMR for endo-1.202 
(100 MHz, CDCl3) δ 140.4 (C8), 139.1 (C11), 137.5 (C1), 135.1 (C5), 129.7 (C9), 129.4 







5-ene (1.194) (nb-4-98).  TBSOTf (25 µL, 0.11 mmol) was added dropwise to a solution 
of p-chlorophenyl-vinylsulfoxide (-)-1.191 (40 mg, 0.21 mmol) and 2,6-di-tert-
butylpyridine (4.3 mg, 5 µL, 0.02 mmol) in CH3CN (100 µL) at -30 °C.  The mixture was 
stirred for 15 min, whereupon 2,5-dimethylfuran (41.5 mg, 46 µL, 0.43 mmol) was added 
dropwise.  The reaction was stored for 24 h at -30 °C (freezer).  Saturated aqueous 
NaHCO3 (800 µL) was then added, with rapid stirring and the mixture was allowed to 
warm to room temperature.  CH2Cl2 (2 mL) was added, and the layers were separated.  
The aqueous layer was then extracted with CH2Cl2 (3 x 4 mL), and the combined organic 
layers were dried (MgSO4) and concentrated under reduced pressure.  The residue was 
purified by flash chromatography eluting with EtOAc/hexanes (30% to 66%) to give 57 
mg (94%) of 1.194 as a mixture of endo:exo isomers (>25:1) as a clear oil; endo-1.194 
was separated via HPLC using a Chiral AD column (1 mL/min, 0% to 30% 
iPrOH/hexanes over 30 min) with the two enantiomers eluting at 18.35 min and 19.27 
min in 98% de; 
1
H NMR for endo-1.194 (500 MHz, CDCl3) δ 7.49-7.40 (comp, 4 H), 
6.31 (d, J = 5.6 Hz, 1 H), 6.16 (d, J = 5.6 Hz, 1 H), 2.96 (dd, J = 8.6, 4.1 Hz, 1 H), 1.93 
(dd, J = 12.0, 4.1 Hz, 1 H), 1.64 (dd, J = 11.9, 8.7 Hz, 1 H), 1.56 (s, 3 H), 1.51 (s, 3 H); 
13
C NMR for endo-1.194 (125 MHz, CDCl3) δ 142.7, 140.6, 136.9, 134.5, 129.4, 129.2, 
86.3, 86.3, 71.5, 32.6, 18.6, 18.0; IR (neat) 3078, 1090 cm
-1






 (M+1) 283.0560; found, 283.0558; mass spectrum, 269, 283 (base), 
285; [α]
21
D -178.9° (c 1.5, CH2Cl2). 
 
NMR ASSIGNMENTS FOR endo-1.194:  
1
H NMR for endo-1.194 (500 MHz, CDCl3) δ 7.49-7.40 (comp, 4 H, C10-H, 
C11-H), 6.31 (d, J = 5.6 Hz, 1 H, C1-H), 6.16 (d, J = 5.6 Hz, 1 H, C5-H), 2.96 (dd, J = 
8.6, 4.1 Hz, 1 H, C3-H), 1.93 (dd, J = 12.0, 4.1 Hz, 1 H, C4-H), 1.64 (dd, J = 11.9, 8.7 
Hz, 1 H, C4-H), 1.56 (s, 3 H, C7-H), 1.51 (s, 3 H, C8-H); 
13
C NMR for endo-1.194 (125 
MHz, CDCl3) δ 142.7 (C9), 140.6 (C5), 136.9 (C12), 134.5 (C1), 129.4 (C10), 129.2 





ene (1.200) (nb-3-77).  TBSOTf (25 µL, 0.11 mmol) was added dropwise to a solution of 
p-chlorophenyl-vinylsulfoxide (-)-1.191 (40 mg, 0.21 mmol) and 2,6-di-tert-
butylpyridine (4.3 mg, 5 µL, 0.021 mmol) in CH3CN (100 µL) at -30 °C.  The mixture 
was stirred for 15 min, whereupon 2,5-dimethylfuran (41.4 mg, 46 µL, 0.43 mmol) was 




TEA in MeOH (300 µL) was added followed by Oxone (300 mg, 0.98 mmol).  The 
suspension was stirred for 6 h, and H2O (3 mL) was added.  The mixture was extracted 
with Et2O (4 x 3 mL) and the combined organic layers were dried (MgSO4) and 
concentrated under reduced pressure.  The residue was purified by flash chromatography 
eluting with EtOAc/hexanes (15% to 50%) to give 56 mg (88%) of 1.200 as a mixture of 
endo:exo isomers (>25:1) as a white solid; endo-1.200 was separated via HPLC using a 
Chiral OB column (1 mL/min, 0% to 20% iPrOH/hexanes over 30 min) with the two 
enantiomers eluting at 20.99 min and 25.11 min in 98% ee  The major endo isomer was 
recrystallized by slow evaporation from Et2O to give X-ray quality crystals  (mp: 108-
110 °C); 
1
H NMR for endo-1.200 (500 MHz, CDCl3) δ 7.80-7.75 (comp, 2 H), 7.55-7.50 
(comp, 2 H), 6.35-6.32 (m, 2 H), 3.51 (dd, J = 8.9, 4.5 Hz, 1 H), 1.97 (dd, J = 11.7, 8.9 
Hz, 1 H), 1.86 (dd, J = 11.7, 4.5 Hz, 1 H), 1.72 (s, 3 H), 1.57 (s, 3 H); 
13
C NMR for 
endo-1.200 (125 MHz, CDCl3) δ 140.3, 140.3, 139.1, 135.7, 129.6, 129.4, 87.6, 86.2, 
69.9, 38.5, 19.0, 18.6; IR (neat) 2976, 1316 cm
-1
; HRMS (CI) m/z calculated for 
C14H16O3SCl
+
 (M+1) 299.0509; found, 299.0511; mass spectrum, 123, 203 (base), 299; 
[α]
28
D +33.5° (c 0.2, CH2Cl2). 
 
NMR ASSIGNMENTS FOR endo-1.200:  
 1
H NMR for endo-1.200 (500 MHz, CDCl3) δ 7.80-7.75 (comp, 2 H, C10-H), 7.55-
7.50 (comp, 2 H, C11-H), 6.35-6.32 (m, 2 H, C1-H and C5-H), 3.51 (dd, J = 8.9, 4.5 Hz, 
1 H, C3-H), 1.97 (dd, J = 11.7, 8.9 Hz, 1 H, C4-H), 1.86 (dd, J = 11.7, 4.5 Hz, 1 H, C4-
H), 1.72 (s, 3 H, C7-H), 1.57 (s, 3 H, C8-H); 
13




CDCl3) δ 140.3 (C9), 140.3 (C11), 139.1 (C12), 135.7 (C10), 129.6 (C1), 129.4 (C5), 
87.6 (C2), 86.2 (C6), 69.9 (C3), 38.5 (C4), 19.0 (C7), 18.6 (C8). 
 
NMR ASSIGNMENTS FOR exo-1.200:  
 1
H NMR for exo-1.200 (400 MHz, CDCl3) δ 7.87-7.78 (m, 2H, C10-H), 7.56-7.47 
(m, 2H, C11-H), 6.24 (d, J = 5.44 Hz, 1H, C1-H), 6.17 (d, J = 5.45 Hz, 1H, C5-H), 3.21 
(dd, J = 8.1, 4.9 Hz, 1H, C3-H), 1.93 (s, 3H, C7-H), 1.84 (dd, J = 11.9, 4.8 Hz, 1H, C4-
H), 1.61 (m, 4H, C4-H and C8-H); 
13
C NMR for exo-1.200 (100 MHz, CDCl3) δ 141.7 
(C9), 140.2 (C11), 139.4 (C12), 139.0 (C10), 129.6 (C1), 129.5 (C5), 88.0 (C2), 85.4 





vinyltetrahydrofuran (1.213) (nb-2-291).  Grubbs II catalyst (14 mg, 0.017 mmol) was 
added to a solution of oxanorbornene 1.194 (31 mg, 0.166 mmol) was in dichloroethane 
(500 µL) immediately followed by styrene (344.3 mg, 380 µL, 3.320 mmol).  The 
reaction was stirred for 12 h at room temperature after which time the starting material 




for 1 h before being concentrated under reduced pressure.  The crude black semi-solid 
was purified via column chromatography (30% EtOAc/Hex) to yield 1.213 (40.5 mg, 
63% yield) as a tan oil. 
1
H NMR for 1.213 (500 MHz, CDCl3) δ 7.58-7.54 (comp, 2 H), 
7.52-7.48 (comp, 2 H),  7.43-7.36 (comp, 2 H),  7.36-7.31 (comp, 2 H), 7.27-7.23 (m, 1 
H), 6.69-6.63 (d, J = 15.9 Hz, 1 H), 6.34 (d, J = 15.9, 1 H), 6.16-6.09 (dd, J = 17.6, 10.8 
Hz, 1 H), 5.30-5.25 (dd, J = 17.6, 1.0 Hz, 1 H),  5.12-5.08 (dd, J = 10.8, 1.0 Hz, 1 H), 
3.27-3.19 (dd, J = 11.3, 7.1 Hz, 1 H), 2.76 (dd, J = 12.9, 11.4 Hz, 1 H), 1.89-1.81 (dd, J = 
13.0, 7.1 Hz, 1 H), 1.51 (s, 3 H), 1.33 (s, 3 H); 
13
C NMR for 1.213 (125 MHz, CDCl3) δ 
143.8, 142.1, 137.5, 136.6, 131.0, 130.1, 129.6, 128.5, 127.8, 126.8, 126.0, 112.7, 83.3, 
81.7, 74.8, 34.3, 28.2, 27.7; IR (neat) 2974.7, 1091.3; Mass Spectrum (CI) m/z 387.1185 
[C22H24O2SCl (M+1) requires 287.1186], 380, 387 (base), 389. 
 
NMR ASSIGNMENTS FOR 1.213:  
1
H NMR for 1.213 (500 MHz, CDCl3) δ 7.58-7.54 (comp, 2 H, C17-H), 7.52-7.48 
(comp, 2 H, C16-H),  7.43-7.36 (comp, 2 H, C12-H),  7.36-7.31 (comp, 2 H, C13-H), 
7.27-7.23 (m, 1 H, C14-H), 6.69-6.63 (d, J = 15.9 Hz, 1 H, C10-H), 6.34 (d, J = 15.9 Hz, 
1 H, C8-H), 6.16-6.09 (dd, J = 17.4, 10.8 Hz, 1 H, C7-H), 5.30-5.25 (dd, J = 17.4, 1.0 Hz, 
1 H, C9-H),  5.12-5.08 (dd, J = 10.8, 1.0 Hz, 1 H, C9-H), 3.27-3.19 (dd, J = 11.3, 7.1 Hz, 
1 H, C2-H), 2.76 (dd, J = 12.9, 11.4 Hz, 1 H, C3-H), 1.89-1.81 (dd, J = 13.0, 7.1 Hz, 1 H, 
C3-H), 1.51 (s, 3 H, C6-H), 1.33 (s, 3 H, C5-H); 
13
C NMR for 1.213 (125 MHz, CDCl3) δ 
143.8 (C7), 142.1 (C15), 137.5 (C18), 136.6 (C11), 131.0 (C8), 130.1 (C10), 129.6 
(C16), 128.5 (C13), 127.8 (C14), 126.8 (C12), 126.0 (C17), 112.7 (C9), 83.3 (C1), 81.7 








vinyltetrahydrofuran-2-yl)allyl)trimethylsilane (1.223) (nb-3-116).  Hoveyda-Grubbs 
II catalyst (53 mg, 0.08 mmol) was added to a solution of oxanorbornene 1.200 (1.0 g, 
3.35 mmol) in 1,2-dichloroethane (10 mL) immediately followed by allyltrimethylsilane 
(5.74 mg, 7.99 mL, 50.25 mmol).  After 4 h DMSO (300 µL) was added and stirring 
continued for 12 h.  The solution was concentrated under reduced pressure and the 
residue was purified by flash chromatography with hexane/EtOAc (15%) to give 1.301 g 
(94%) of 1.223 as a clear oil: mp: 84-86 °C (clear rectangles from hexanes/EtOAc); 
1
H 
NMR for 1.223 (500 MHz, CDCl3) δ 7.85-7.79 (comp, 2 H), 7.57-7.51 (comp, 2 H), 6.03 
(dd, J = 17.4, 10.8 Hz, 1 H), 5.75 (td, J = 15.3, 8.1, 8.1 Hz, 1 H), 5.62 (td, J = 15.2, 1.0, 
1.0 Hz, 1 H), 5.18 (dd, J = 17.4, 1.0 Hz, 1 H), 5.05 (dd, J = 10.8, 0.9 Hz, 1 H), 3.58 (dd, 
J = 12.9, 6.3 Hz, 1 H), 2.54 (t, J = 12.5 Hz, 1 H), 1.93 (dd, J = 12.1, 6.3 Hz, 1 H), 1.53 
(s, 3 H), 1.51 (m, 2 H), 1.23 (s, 3 H), 0.02 (s, 9 H);
 13
C NMR for 1.223 (125 MHz, 
CDCl3) δ 143.5, 140.6, 138.6, 130.0, 130.5, 128.4, 128.1, 112.8, 83.9, 80.3, 72.1, 39.1, 
29.2, 27.8, 22.9, -1.8; IR (neat) 2954.1, 1090.37 cm
-1
; HRMS (CI) m/z calculated for 





NMR ASSIGNMENTS FOR 1.223: 
1
H NMR for 1.223 (500 MHz, CDCl3) δ 7.85-7.79 (comp, 2 H, C16-H), 7.57-7.51 
(comp, 2 H, C17-H), 6.03 (dd, J = 17.4, 10.8 Hz, 1 H, C7-H), 5.75 (td, J = 15.3, 8.1, 8.1 
Hz, 1 H, C10-H), 5.62 (td, J = 15.2, 1.0, 1.0 Hz, 1 H, C8-H), 5.18 (dd, J = 17.4, 1.0 Hz, 1 
H, C9-H), 5.05 (dd, J = 10.8, 0.9 Hz, 1 H, C9-H), 3.58 (dd, J = 12.9, 6.3 Hz, 1 H, C2-H), 
2.54 (t, J = 12.5 Hz, 1 H, C3-H), 1.93 (dd, J = 12.1, 6.3 Hz, 1 H, C3-H), 1.53 (s, 3 H, 
C6-H), 1.51 (m, 2 H, C11-H), 1.23 (s, 3 H, C5-H), 0.02 (s, 9 H, C12-H); 
13
C NMR for 
1.223 (125 MHz, CDCl3) δ 143.5 (C7), 140.6 (C19), 138.6 (C15), 130.0 (C16), 130.5 
(C17), 128.4 (C8), 128.1 (C10), 112.8 (C9), 83.9 (C4), 80.3 (C1), 72.1 (C2), 39.1 (3), 













vinyltetrahydrofuran (1.221) (nb-3-109).  Grubbs II catalyst (21 mg, 0.025 mmol) was 
added to a solution of oxanorbornene 1.200 (150 mg, 0.502 mmol) in dichloroethane (4 
mL) immediately followed by styrene (52.1 mg, 575 µL, 5.02 mmol).  The reaction was 
stirred for 4 h at room temperature after which time the starting material had been 
consumed by TLC.  The reaction was quenched with DMSO (50 µL) and stirred for 1 h 
before being concentrated under reduced pressure.  The crude black semi-solid was 
purified via column chromatography (15% EtOAc/Hex) to yield 1.221 (188 mg, 93% 
yield) as a gray oil.
 1
H NMR for 1.221 (500 MHz, CDCl3) δ 7.82-7.77 (comp, 2 H), 7.50-
7.45 (comp, 2 H), 7.39 (comp, 2 H), 7.34 (comp, 2 H), 7.26-7.22 (m, 1 H), 6.64 (d, J = 
15.8 Hz, 1 H),  6.49 (d, J = 15.8 Hz, 1 H), 6.11 (dd, J = 17.4, 10.8 Hz, 1 H), 5.26-5.21 
(dd, J = 17.4, 0.7 Hz, 1 H), 5.14-5.08 (dd, J = 10.8, 0.8 Hz, 1 H), 3.74 (dd, J = 12.9, 6.4 
Hz, 1 H), 2.59 (t, J = 12.6 Hz, 1 H), 2.04-1.98 (dd, J = 12.2, 6.4, 1 H),  1.63 (s, 3 H), 1.31 
(s, 3 H); 
13
C NMR for 1.221 (125 MHz, CDCl3) δ 143.1, 140.7, 138.0, 137.9, 136.7, 
130.1, 130.0, 130.0., 129.5, 128.5, 127.6, 126.8, 113.2, 83.8, 80.8, 72.5, 39.0, 28.9, 27.6; 
IR (neat) 2976, 1089 cm
-1
; HRMS (CI) m/z calculated for C22H24O3SCl (M+1) 403.1135; 





NMR ASSIGNMENTS FOR 1.221:  
 1
H NMR for 1.221 (500 MHz, CDCl3) δ 7.82-7.77 (comp, 2H. C16-H), 7.50-7.45 
(comp, 2 H, C17-H), 7.39 (comp, 2 H, C12-H), 7.34 (comp, 2 H, C13-H), 7.26-7.22 (m, 1 
H, C14-H), 6.64 (d, J = 15.8 Hz, 1 H, C10-H),  6.49 (d, J = 15.8 Hz, 1 H, C8-H), 6.11 
(dd, J = 17.4, 10.8 Hz, 1 H, C7-H), 5.26-5.21 (dd, J = 17.4, 0.7 Hz, 1 H, C9-H), 5.14-
5.08 (dd, J = 10.8, 0.8 Hz, 1 H, C9-H), 3.74 (dd, J = 12.9, 6.4 Hz, 1 H, C2-H), 2.59 (t, J 
= 12.6 Hz, 1 H, C3-H), 2.04-1.98 (dd, J = 12.2, 6.4, 1 H, C3-H),  1.63 (s, 3 H, C6-H), 
1.31 (s, 3 H, C5-H); 
13
C NMR for 1.221 (125 MHz, CDCl3) δ 143.1 (C7), 140.7 (C15), 
138.0 (C18), 137.9 (C11), 130.1 (C10), 130.0 (C8), 130.0 (C16), 129.5 (C17), 128.5 
C(13), 127.6 (C14), 126.8 (C12), 113.2 (C9), 83.8 (C6), 80.8 (C5), 72.5 (C2), 39.0 (C3), 











enyl)-5-vinyltetrahydrofuran (1.226) (nb-3-97).  Grubbs II catalyst (2.5 mg, 0.003 
mmol) was added to a solution of oxanorbornene 1.200 (20 mg, 0.067 mmol) in 1,2-
dichloroethane (500 µL) immediately followed by allylbenzene (79.4 mg, 89 µL, 0.67 
mmol).  After 12 h DMSO (50 µL) was added and stirring continued for 1 h. The solution 
was concentrated under reduced pressure and the residue was purified by flash 
chromatography eluting with hexanes/EtOAc (15%) to give 25.9 mg (89%) of 1.226 as a 
clear oil.  
1
H NMR for 1.226 (400 MHz, CDCl3) δ 7.79-7.72 (comp., 2 H), 7.50-7.43 
(comp., 2 H), 7.34-7.27 (comp., 2 H), 7.25-7.17 (comp., 3 H), 6.00 (dd, J = 17.4, 10.8 
Hz, 1 H), 5.92-5.80 (comp., 2 H), 5.16 (dd, J = 17.4, 0.9 Hz, 1 H), 5.02 (dd, J = 10.8, 0.9 
Hz, 1 H), 3.63 (dd, J = 12.9, 6.4 Hz, 1 H), 3.42 (d, J = 5.3 Hz, 2 H),  2.60 (t, J = 12.6 Hz, 
1 H), 1.45 (d, J = 8.4 Hz, 1 H), 2.00 (s, 3 H), 1.26 (s, 3H);
 13
C NMR for 1.226 (125 MHz, 
CDCl3) δ 143.2, 140.7, 140.0, 138.2, 131.5, 130.0, 129.9, 129.5, 128.7, 128.3, 126.0, 
113.0, 83.4, 80.5, 72.2, 38.8, 38.8, 28.6, 27.7; IR (neat) 2978, 1310, 1150 cm
-1
; HRMS 
(CI) m/z calculated for C23H29O3SCl (M+1) 434.15512; found, 434.15503; mass 










vinyltetrahydrofuran-2-yl)allyl acetate (1.248) (nb-3-270).  Hoveyda-Grubbs II 
catalyst (6.3 mg, 0.01 mmol) in DCE (200 µL) was added dropwise over 1 h to a solution 
of sulfone 1.200 (30 mg, 0.10 mmol), 1,4-cis-butene diacetate (103.7 mg, 96 µL, 0.600 
mmol), and DCE (100 µL) under and atmosphere of ethylene.  After 12 h DMSO (50 µL) 
was added and stirring continued for 3 h.  The solution was concentrated under reduced 
pressure to and the residue was purified by flash chromatography with pentane/Et2O 
(30%) followed by a second flash chromatography with hexanes/EtOAc (25%) to give 
21.7 mg (55%) 1.248 as a clear oil;
 1
H NMR for 1.248 (500 MHz, CDCl3) δ 7.86-7.79 
(comp, 2 H), 7.58-7.52 (comp, 2 H), 6.11 (td, J = 15.4, 1.5, 1.5 Hz, 1 H), 6.04 (dd, J = 
17.4, 10.8 Hz, 1 H), 5.91-5.82 (td, J = 15.4, 5.7, 5.7 Hz  1 H), 5.19 (dd, J = 17.4, 0.8 Hz, 
1 H), 5.09 (dd, J = 10.8, 0.8 Hz, 1 H), 4.66-4.56 (m, 2 H), 3.68-3.58 (dd, J = 12.9, 6.4 
Hz, 1 H), 2.52 (t, J = 12.57, 12.57 Hz, 1 H), 2.09 (s, 3 H), 1.94 (dd, J = 12.2, 6.4 Hz, 1 
H), 1.54 (s, 3 H), 1.24 (s, 3 H); 
13
C NMR for 1.248 (125 MHz, CDCl3) δ 170.7, 143.0, 
140.8, 138.2, 134.1, 125.1, 113.2, 129.9, 129.6, 83.2, 80.8, 72.1, 64.1, 38.9, 28.9, 27.6, 
20.9; IR (neat) 2979.0, 1738.0 cm
-1
; HRMS (CI) m/z calculated for C19H24O5SCl (M+1) 





NMR ASSIGNMENTS FOR 1.248: 
 1
H NMR for 1.248 (500 MHz, CDCl3) δ 7.86-7.79 (comp, 2 H, C12-H), 7.58-7.52 
(comp, 2 H, C13-H), 6.11 (td, J = 15.4, 1.5, 1.5 Hz, 1 H, C9-H), 6.04 (dd, J = 17.4, 10.8 
Hz, 1 H, C8-H), 5.91-5.82 (td, J = 15.4, 5.7, 5.7 Hz, 1 H, C7-H), 5.19 (dd, J = 17.4, 0.8 
Hz, 1 H, C10-H), 5.09 (dd, J = 10.8, 0.8 Hz, 1 H, C10-H), 4.66-4.56 (m, 2 H, C15-H), 
3.68-3.58 (dd, J = 12.9, 6.4 Hz, 1 H, C2-H), 2.52 (t, J = 12.57, 12.57 Hz, 1 H, C3-H), 
2.09 (s, 3 H, C18-H), 1.94 (dd, J = 12.2, 6.4 Hz, 1 H, C3-H), 1.54 (s, 3 H, C6-H), 1.24 (s, 
3 H, C5-H); 
13
C NMR for 1.248 (125 MHz, CDCl3) δ 170.7 (C17), 143.0 (C8), 140.8 
(C14), 138.2 (C11), 134.1 (C9), 129.9 (C12), 129.6 (C13), 125.1 (C7), 113.2 (C10), 83.2 














vinyltetrahydrofuran (1.228) (nb-3-108).  Hoveyda-Grubbs II catalyst (1.9 mg, 0.003 
mmol) was added to a solution of oxanorbornene 1.200 (20 mg, 0.067mmol) in 1,2-
dichloroethane (500 µL) immediately followed by 1-hexene (56.3 mg, 83 µL, 0.67 
mmol).  After 12 h DMSO (50 µL) was added and stirring continued for 1 h.  The 
solution was concentrated under reduced pressure and the residue was purified by flash 
chromatography with hexanes/EtOAc (15%) to give 20.1 mg (82%) of 1.228 as a clear 
oil; 
1
H NMR for 1.228 (500 MHz, CDCl3) δ 7.87-7.77 (comp, 2 H), 7.61-7.51 (comp, 2 
H), 6.04 (dd, J = 17.4, 10.8 Hz, 1 H), 5.81-5.67 (comp, 2 H), 5.18 (dd, J = 17.4, 0.9 Hz, 
1 H), 5.07 (dd, J = 10.8, 0.9 Hz, 1 H), 3.61 (dd, J = 12.9, 6.4 Hz, 1 H), 2.54 (t, J = 12.5 
Hz, 1 H), 2.11-2.03 (m, 2 H), 1.95 (dd, J = 12.1, 6.4 Hz, 1 H), 1.51 (s, 3 H), 1.42-1.28 
(m, 4 H), 1.25 (s, 3 H), 0.90 (t, J = 7.0 Hz, 3 H);
 13
C NMR for 1.228 (125 MHz, CDCl3) δ 
143.4, 140.6, 139.4, 131.7, 130.0, 129.9, 129.5, 112.9, 83.6, 80.5, 72.2, 39.0, 32.0, 31.2, 
28.9, 27.7, 22.3, 12.9; IR (neat) 2927.9, 1089.72 cm
-1
; HRMS (CI) m/z calculated for 






NMR ASSIGNMENTS FOR 1.228: 
1
H NMR for 1.228 (500 MHz, CDCl3) δ 7.87-7.77 (comp, 2 H, C16-H), 7.61-7.51 
(comp, 2 H, C17-H), 6.04 (dd, J = 17.4, 10.8 Hz, 1 H, C7-H), 5.81-5.67 (comp, 2 H, C8-
H and C9-H), 5.18 (dd, J = 17.4, 0.9 Hz, 1 H, C9-H), 5.07 (dd, J = 10.8, 0.9 Hz, 1 H, C9-
H), 3.61 (dd, J = 12.9, 6.4 Hz, 1 H, C2-H), 2.54 (t, J = 12.5 Hz, 1 H, C3-H), 2.11-2.03 
(m, 2 H, C11-H), 1.95 (dd, J = 12.1, 6.4 Hz, 1 H, C3-H), 1.51 (s, 3 H, C6-H), 1.42-1.28 
(m, 4 H, C13-H and C12-H), 1.25 (s, 3 H, C5-H), 0.90 (t, J = 7.0 Hz, 3 H, C14-H);
 13
C 
NMR for 1.228 (125 MHz, CDCl3) δ 143.4 (C7), 140.6 (C17), 139.4 (C16), 131.7 (C10), 
130.0 (C16), 129.9 (C18), 129.5 (C17), 112.9 (C9), 83.6 (C1), 80.5 (C4), 72.2 (C2), 39.0 












divinyltetrahydrofuran (1.253) (nb-3-213).  A solution of Hoveyda-Grubbs II catalyst 
(3 mg, 0.005 mmol) in DCE was sparged with ethylene gas for 5 min whereupon 
oxabicycle 1.200 (29.6 mg, 0.099 mmol) was added and the solution was stirred under an 
ethylene atmosphere.  After 6 h DMSO (50 µL) was added and stirring continued for 3 h.  
The solution was concentrated under reduced pressure and the residue was purified by 
flash chromatography with hexanes/EtOAc (15%) to give 25.2 mg (78%) of 1.253 as 
white crystals: mp: 117-120 °C (clear needles by Et2O evaporation); 
1
H NMR for 1.253 
(500 MHz, CDCl3) δ 7.90-7.76 (comp, 2 H), 7.69-7.45 (comp, 2 H), 6.23 (dd, J = 17.0, 
10.7 Hz, 1 H), 6.05 (dd, J = 17.4, 10.8 Hz, 1 H), 5.39 (dd, J = 17.0, 1.5 Hz, 1H), 5.21 
(comp, 2 H), 5.08 (dd, J = 10.8, 0.8 Hz, 1 H), 3.62 (dd, J = 13.0, 6.3 Hz, 1 H), 2.55 (t, J 
= 12.6, 12.6 Hz, 1 H), 1.91 (dd, J = 12.1, 6.3 Hz, 1 H), 1.56 (s, 3 H), 1.25 (s, H); 
13
C 
NMR for 1.253 (125 MHz, CDCl3) δ 143.0, 140.7, 138.3, 138.2, 129.8, 129.7, 115.4, 
113.2, 83.9, 80.7, 72.0, 38.9, 28.7, 27.6; IR (neat) 2979.0, 1146.0 cm
-1
; HRMS (CI) m/z 








NMR ASSIGNMENTS FOR 1.253: 
1
H NMR for 1.253 (500 MHz, CDCl3) δ 7.90-7.76 (comp, 2 H, C13-H), 7.69-7.45 
(comp, 2 H, C12-H), 6.23 (dd, J = 17.0, 10.7 Hz, 1 H, C7-H), 6.05 (dd, J = 17.4, 10.8 
Hz, 1 H, C8-H), 5.39 (dd, J = 17.0, 1.5 Hz, 1 H, C9-H), 5.21 (comp, 2 H, C9-H and C10-
H), 5.08 (dd, J = 10.8, 0.8 Hz, 1 H, C10-H), 3.62 (dd, J = 13.0, 6.3 Hz, 1 H, C2-H), 2.55 
(t, J = 12.6, 12.6 Hz, 1 H, C3-H), 1.91 (dd, J = 12.1, 6.3 Hz, 1 H, C3-H), 1.56 (s, 3 H, 
C6-H), 1.25 (s, 3 H, C5-H); 
13
C NMR for 1.253 (125 MHz, CDCl3) δ 143.0 (C8), 140.7 
(C14), 138.3 (C11), 138.2 (C7), 129.8 C13, 129.7 (C12), 115.4 (C9), 113.2 (C10), 83.9 





2-yl)allyl)trimethylsilane (1.259 and 1.260) (nb-4-206).  Hoveyda-Grubbs 2
nd
 
generation catalyst (440 µg, 0.0007 mmol) in 1,2-dichloroethane (100 µL) was added to a 
solution of oxanorbornene 1.202 (20 mg, 0.07 mmol) and allyltrimethylsilane (79.8 mg, 




70 °C for 2 min, whereupon DMSO (40 µL) was added and stirring continued for 12 h.  
The solution was concentrated under reduced pressure and the residue was purified by 
flash chromatography with EtOAc/hexanes (10%) to give 19.5 mg (76%) of 1.259 and 
1.260 as a mixture of regioisomers (12.3:1) as a clear oil; 
1
H NMR for 1.259 (400 MHz, 
CDCl3) δ 7.87-7.77 (comp, 2 H), 7.57-7.48 (comp, 2 H), 5.88 (ddd, J = 17.1, 10.3, 7.0 
Hz, 1 H), 5.79 (dt, J = 15.2, 8.2 Hz, 1 H), 5.67 (dt, J = 15.2, 1.0 Hz, 1 H), 5.25 (dt, J = 
17.1, 1.2 Hz, 1 H), 5.17 (dt, J = 10.6, 0.9 Hz, 1 H), 4.39-4.31 (m, 1 H), 3.46 (dd, J = 
12.2, 6.3 Hz, 1 H), 2.28 (dt, J = 12.2, 10.6 Hz, 1 H), 2.10 (m, 1 H), 1.54-1.52 (m, 2 H), 
1.52 (s, 3 H), 0.06-0.02 (m, 9 H); 
13
C NMR for 1.259 (150 MHz, CDCl3) δ 140.5, 138.6, 
137.5, 129.9, 129.4, 128.6, 128.1, 117.4, 83.3, 77.6, 72.7, 35.0, 28.5, 22.8, -1.8; IR (neat) 
2953, 1149, 1089 cm
-1
; HRMS (CI) m/z calculated for C19H28O3SiSCl (M+1) 399.1217; 
found, 399.1213; mass spectrum, 383 (base), 385, 399. 
 1
H NMR for 1.260 (400 MHz, CDCl3) δ 7.86-7.79 (comp., 2 H), 7.58-7.51 (comp., 2 
H), 6.29 (dd, J = 16.9, 10.6 Hz, 1 H), 5.74-5.63 (m, 1 H), 5.45 (dd, J = 16.9, 1.7 Hz, 1 
H), 5.33 (tdd, J = 15.1, 8.0, 1.2 Hz, 1 H), 5.27 (dd, J = 10.6, 1.7 Hz, 1 H), 4.34 (ddd, J = 
10.4, 8.0, 5.0 Hz, 1 H), 3.47 (dd, J = 12.3, 6.2 Hz, 1 H), 2.24 (dt, J = 12.3, 10.6 Hz, 1 H), 
2.04-1.98 (m, 1 H), 1.52 (s, 3 H), 1.50-1.46 (dd, J = 8.2, 1.2 Hz, 1 H),  -0.01 (s, 9 H); 
13
C 
NMR for 1.260 (150 MHz, CDCl3) δ 140.6, 138.8, 138.5, 132.2, 129.8, 129.6, 127.4, 
115.4, 82.9, 78.2, 72.8, 35.2, 28.0, 22.9, -2.0; IR (neat) 2954, 1149, 1088 cm
-1
; HRMS 
(CI) m/z calculated for C19H28O3SiSCl (M+1) 399.1217; found, 399.1219; mass 






NMR ASSIGNMENTS FOR 1.259:  
1
H NMR for 1.259 (400 MHz, CDCl3) δ 7.87-7.77 (comp, 2 H, C14-H), 7.57-7.48 
(comp, 2 H, C13-H), 5.88 (ddd, J = 17.1, 10.3, 7.0 Hz, 1 H, C6-H), 5.79 (dt, J = 15.2, 8.2 
Hz, 1 H, C9-H), 5.67 (dt, J = 15.2, 1.0 Hz, 1 H, C8-H), 5.25 (dt, J = 17.1, 1.2 Hz, 1 H, 
C7-H), 5.17 (dt, J = 10.6, 0.9 Hz, 1 H, C7-H), 4.39-4.31 (m, 1 H, C4-H), 3.46 (dd, J = 
12.2, 6.3 Hz, 1 H, C2-H), 2.28 (dt, J = 12.2, 10.6 Hz, 1 H, C3-H), 2.10 (m, 1 H, C3-H), 
1.54-1.52 (m, 2 H, C10-H), 1.52 (s, 3 H, C5-H), 0.06-0.02 (m, 9 H, C11-H); 
13
C NMR for 
1.259 (150 MHz, CDCl3) δ 140.5, 138.6, 137.5, 129.9, 129.4, 128.6, 128.1, 117.4, 83.3, 
















  (E)-Methyl 3-((2S,3S,5S)-3-(4-chlorophenylsulfonyl)-2-methyl-5-
vinyltetrahydrofuran-2-yl)acrylate (1.264) (nb-4-140).  Hoveyda-Grubbs 2
nd
 
generation catalyst (440 µg, 0.0007 mmol) was added to a solution of oxanorbornene 
1.202 (20 mg, 0.07 mmol) in neat methylacrylate (301.1 mg, 315 µL, 3.50 mmol) at 70 
°C.  The reaction was stirred at 70 °C for 2 min, whereupon DMSO (40 µL) was added 
and the reaction was removed from the oil bath and stirring continued for 12 h.  The 
solution was concentrated under reduced pressure and the residue was purified by flash 
chromatography with Et2O/pentane (50%) to give 17.3 mg (67%) of 1.264 as a single 
isomer as a clear oil; 
1
H NMR for 1.264 (600 MHz, CDCl3) δ 7.85-7.80 (comp, 2 H), 
7.56-7.52 (comp, 2 H), 6.90 (dd, J = 15.6, 5.7 Hz, 1 H), 6.30-6.23 (dd, J = 17.0, 10.7, 1 
H), 6.04 (dd, J = 15.7, 1.4 Hz, 1 H), 5.43 (dd, J = 17.0, 1.4 Hz, 1 H), 5.28 (dd, J = 10.7, 
1.4, 1 H), 4.58-4.52 (m, 1 H), 3.74 (s, 3 H), 3.53 (dd, J = 8.6, 6.4, 1 H), 2.31 (dt, J = 12.1, 
10.7 Hz, 1 H), 2.19 (m, 1 H), 1.54 (s, 1 H); 
13
C NMR for 1.264 (150 MHz, CDCl3) δ 
166.3, 145.4, 140.9, 138.1, 137.9, 129.9, 129.7, 122.0, 115.8, 83.9, 75.2, 72.5, 51.8, 34.6, 
27.7; IR (neat) 2952, 1724, 1278 cm
-1
; HRMS (CI) m/z calculated for C17H20O5SCl 





NMR ASSIGNMENTS FOR 1.264:  
1
H NMR for 1.264 (600 MHz, CDCl3) δ 7.85-7.80 (comp, 2 H, C13-H), 7.56-7.52 
(comp, 2 H, C14-H), 6.90 (dd, J = 15.6, 5.7 Hz, 1 H, C7-H), 6.30-6.23 (dd, J = 17.0, 
10.7, 1 H, C8-H), 6.04 (dd, J = 15.7, 1.4 Hz, 1 H, C6-H), 5.43 (dd, J = 17.0, 1.4 Hz, 1 H, 
C9-H), 5.28 (dd, J = 10.7, 1.4, 1 H, C9-H), 4.58-4.52 (m, 1 H, C3-H), 3.74 (s, 3 H, C11-
H), 3.53 (dd, J = 8.6, 6.4, 1 H, C1-H), 2.31 (dt, J = 12.1, 10.7 Hz, 1 H, C2-H), 2.19 (m, 1 
H, C2-H), 1.54 (s, 1 H, C5-H); 
13
C NMR for 1.264 (150 MHz, CDCl3) δ 166.3 (C10), 
145.4 (C7), 140.9 (C12), 138.1 (C15), 137.9 (C6), 129.9 (C13), 129.7 (C14), 122.0 (C8), 













vinyltetrahydrofuran-2-yl)hex-5-en-2-one (1.265) (nb-4-200).  Hoveyda-Grubbs 2
nd
 
generation catalyst (440 µg, 0.0007 mmol) in 1,2-dichloroethane (100 µL) was added to a 
solution of oxanorbornene 1.202 (20 mg, 0.07 mmol) and 5-hexene-2-one (68.6 mg, 81 
µL, 0.70 mmol) in 1,2-dichloroethane (300 µL) at reflux.  The reaction was stirred at 
reflux for 15 min, whereupon DMSO (40 µL) was added and the oil bath was removed; 
stirring continued for 12 h.  The solution was concentrated under reduced pressure and 
the residue was purified by flash chromatography with acetone/hexanes (10% to 20% 
gradient) to give 15.5 mg (59%) of 1.265 as a clear oil; 
1
H NMR for 1.265 (600 MHz, 
CDCl3) δ 7.87-7.74 (comp., 2 H), 7.60-7.49 (comp., 2 H), 5.86 (comp., 3 H), 5.26 (app. dt, J = 
17.1, 1.1 Hz, 1 H), 5.21-5.17 (app. dt, J =10.3, 0.9, 1 H),  4.41-4.28 (m, 1 H),  3.46 (dd, J = 12.1, 
6.4 Hz, 1 H), 2.60-2.56 (m, 2 H), 2.41-2.34 (m, 2 H), 2.30-2.23 (m, 1 H), 2.17 (s, 1 H), 2.16 (s, 3 
H), 2.11-2.03 (m, 1 H), 1.50 (s, 3 H); 
13
C NMR for 1.265 (150 MHz, CDCl3) δ 208.2, 140.7, 
138.5, 137.1, 131.3, 129.8, 129.7, 129.6, 117.9, 82.9, 77.8, 72.9, 42.8, 35.0, 29.9, 28.1, 
26.2; IR (neat) 1713, 1325, 1148 cm
-1
; HRMS (CI) m/z calculated for C19H24O4SCl 











(1.266) (nb-4-245).  A solution of oxabicycle 1.202 (20 mg, 0.07 mmol) in DCE (3 mL) 
was slowly sparged with ethylene gas while Hoveyda-Grubbs II catalyst (3 mg, 0.005 
mmol) in DCE (100 µL) was added.  The slow sparge was continued for 3 h after which 
time all the starting material was consumed by TLC.  DMSO (50 µL) was added and 
stirring continued for 3 h.  The solution was concentrated under reduced pressure and the 
residue was purified by flash chromatography with hexanes/EtOAc (15%) to give 21.8 
mg (99%) of 1.266 as white crystals: mp: 73-75 °C (clear needles by Et2O evaporation); 
1
H NMR for 1.266 (400 MHz, CDCl3) δ 7.89-7.76 (comp, 2 H), 7.65-7.45 (comp, 2 H), 6.29 
(dd, J = 17.0, 10.7 Hz, 1 H), 5.89 (ddd, J = 17.3, 10.2, 7.2 Hz, 1 H), 5.45 (dd, J = 17.0, 1.6 Hz, 1 
H), 5.29-5.28 (m, 1 H), 5.27-5.23 (m, 1 H), 1H), 5.21-5.17 (m, 1 H), 4.45-4.32 (m, 1 H), 3.50 (dd, 
J = 12.3, 6.3 Hz, 1 H), 2.29 (dt, J = 12.2, 10.7 Hz, 1 H), 2.15-2.01 (m, 1 H), 1.53 (s, 3 H);
 13
C 
NMR for 1.266 (125 MHz, CDCl3) δ 140.7, 138.4, 138.3, 137.1, 129.8, 129.6, 118.0, 
115.5, 83.3, 77.9, 72.7, 34.9, 27.9; IR (neat) 2982, 1326, 1149 cm
-1
; HRMS (CI) m/z 
calculated for C15H18O3SCl (M+1) 313.0665; found, 313.0667; mass spectrum, 295 








(1.255) (nb-3-256).  A solution of Hoveyda-Grubbs II catalyst (18.5 mg, 0.030 mmol) in 
DCE was sparged with ethylene gas for 5 minutes whereupon oxabicycle 1.203 (79.5mg, 
0.295 mmol) was added and the solution was let stir under an atmosphere of ethylene.  
After 30 min DMSO (50 µL) was added and stirring continued for 3 h.  The solution was 
concentrated under reduced pressure and purified by flash chromatography with 
hexanes/EtOAc (25%) to give 61.9 mg of 1.255 (71%) as a yellow oil;  
1
H NMR for 
1.255 (400 MHz, CDCl3) δ 7.84-7.72 (comp, 2 H), 7.60-7.43 (comp, 2 H), 6.29-6.14 (m, 
1 H), 5.86 (m, 1 H), 5.38-5.21 (comp, 4 H), 5.20-5.11 (m, 1 H), 4.56 (m, 1 H), 4.35-4.18 
(m, 1 H), 3.94-3.81 (m, 1 H), 2.28-2.08 (m, 1 H); 
13
C NMR for 1.255 (100 MHz, CDCl3) 
δ 140.6, 138.0, 136.6,  133.1, 129.9, 129.5, 119.1, 117.8, 79.9, 79.5, 66.8, 34.2; IR (neat) 
3088.9, 1149.2; Mass Spectrum (CI) m/z 299.0507 (base) [C14H16O3SCl (M+1) requires 
299.050] 297, 301. 
 
NMR ASSIGNMENTS FOR 1.255: 
 1
H NMR for 1.255 (400 MHz, CDCl3) δ 7.84-7.72 (comp, 2 H, C10-H), 7.60-7.43 
(comp, 2 H, C11-H), 6.29-6.14 (m, 1 H, C5-H), 5.86 (m, 1 H, C6-H), 5.38-5.16 (comp, 4 
H, C7-H and C8-H), 4.56 (m, 1 H, C1-H), 4.35-4.18 (m, 1 H, C4-H), 3.94-3.81 (m, 1 H, 
C-H), 2.28-2.08 (m, 1 H, C3-H); 
13




138.0 (C9), 136.6 (C6), 133.1 (C5), 129.9 (C10), 129.5 (C11), 119.1 (C7), 117.8 (C8), 






diyl)dimethanol (1.280) (nb-3-212).  A stream of O3/O2 was bubbled through a solution 
of oxabicycle 1.202 (30 mg, 0.10 mmol) and Sudan Red III (trace indicator) in 
acetone/H2O (95:5, 3 mL) at 0 °C for five sec until the red color of the solution had 
disappeared.  The reaction was flushed with N2 for 30 sec whereupon it was warmed to 
room temperature. After 1 h the solution was concentrated under reduced pressure and 
the residue was azeotroped with benzene (2 x 5 mL).  The residue was concentrated was 
dissolved in MeOH/CH2Cl2 (10:1, 3 mL) and cooled to 0 °C whereupon NaBH4 (25 mg, 
0.50 mmol) was added in a single portion. After 12 h saturated aqueous NH4Cl (5 mL) 
and stirring continued for 15 min. The layers were separated and the aqueous portion was 
extracted with CH2Cl2 (3 x 5 mL).  The combined organics were dried (MgSO4) and 
concentrated under reduced pressure.  The residue was purified by flash chromatography 






NMR for 1.280 (600 MHz, CDCl3) δ 7.90-7.86 (comp, 2 H), 7.62-7.57 (comp, 2 H), 
4.29-4.15 (comp, 2 H), 3.76-3.67 (m, 2 H), 3.56 (m, 2 H), 3.37 (dd, J = 11.5, 10.0 Hz, 1 
H), 3.05 (t, J = 12.7, 12.7 Hz, 1 H), 1.48 (dd, J = 12.1, 7.5 Hz, 1 H), 1.43 (s, 3 H), 1.10 
(s, 3 H); 
13
C NMR for 1.280 (151 MHz, CDCl3) δ 141.4, 137.4, 130.0, 129.7, 85.1, 83.2, 
71.9, 67.9, 67.6, 35.8, 29.7, 27.6, 25.5; IR (neat) 3400.2, 1148.1 cm
-1
; HRMS (CI) m/z 
calculated for C14H19O5SCl (M+Na+1) 357.05339; found, 313.05382; mass spectrum, 





dimethyltetrahydrofuran (1.284) (nb-3-241). A stream of O3/O2 was bubbled through a 
solution of oxabicycle 1.202 (30 mg, 0.10 mmol) and Sudan Red III (trace indicator) in 
acetone/H2O (95:5, 3 mL) at -78 °C for five sec. until the red color of the solution 
disappeared.  The reaction was flushed with N2 for 30 sec whereupon it was warmed to 
room temperature. After 1 h the solution was concentrated under reduced pressure and 
the residue was azeotroped with benzene (2 x 5 mL). residue was dissolved in MeOH (3 
mL) to which was added K2CO3 (55 mg, 0.4 mmol) and dimethyl-1-diazo-2-




layers were separated.  The aqueous portion was extracted with Et2O (2 x 10 mL) and the 
combined organics were dried (MgSO4) and concentrated under reduced pressure.  The 
residue was purified by flash chromatography with hexanes/EtOAc (15%) to give 16.7 
mg (53%) of 1.284 as a clear oil (4:1 mixture of isomers);  
1
H NMR for 1.284 (400 MHz, 
CDCl3) δ 7.93-7.85 (comp, 2 H), 7.61-7.52 (comp, 2 H), 3.42-3.35 (dd, J = 12.4, 7.3 Hz, 
1 H), 3.17 (t, J = 12.5 Hz, 1 H), 2.70 (s, 1 H), 2.54 (s, 1 H), 2.41-2.30 (dd, J = 12.6, 7.3 
Hz, 1 H), 1.64-1.56 (s, 3H), 1.50 (s, 3 H);
 13
C NMR for 1.284 (151 MHz, CDCl3) δ 141.2, 
137.3, 130.5, 129.6, 85.9, 80.4, 77.7, 76.7, 73.4, 72.5, 71.1, 41.3, 30.4, 28.1; IR (neat) 
3293.5, 1091.5 cm
-1
; HRMS (CI) m/z calculated for C16H16O3SCl (M+1) 323.0509; 
found, 323.0511; mass spectrum, 323 (base), 325. 
 
NMR ASSIGNMENTS FOR 1.284: 
 1
H NMR for 1.284 (400 MHz, CDCl3) δ 7.93-7.85 (comp, 2 H, C11-H), 7.61-7.52 
(comp, 2 H, C12-H), 3.42-3.35 (dd, J = 12.4, 7.3 Hz, 1 H, C2-H), 3.17 (t, J = 12.5 Hz, 1 
H, C3-H), 2.70 (s, 1 H, C13-H), 2.54 (s, 1 H, C14-H), 2.41-2.30 (dd, J = 12.6, 7.3 Hz, 1 
H, C3-H), 1.64-1.56 (s, 3H, C6-H), 1.50 (s, 3 H, C5-H);
 13
C NMR for 1.284 (151 MHz, 
CDCl3) δ 141.2 (C13), 137.3 (C10), 130.5 (C11), 129.6 (C12), 85.9 (C1), 80.4 (C4), 77.7 








yl)allyl)trimethylsilane (1.285) (nb-3-186). Na-Hg amalgam (10% Na) (506 mg, 2.2 
mmol) was added to a solution of sulfone 1.216 (89.5 mg, 0.22 mmol) in MeOH/H2O 
(8:1) at 0 °C.  After 6 h the reaction was filtered through celite with Et2O.  The combined 
organics were extracted with H2O (2 x 10 mL) and dried (MgSO4) and concentrated 
under reduced pressure (350 torr) at room temperature (product is volatile).  The residue 
was purified by flash chromatography with pentane/Et2O (10%) to give 41 mg (79%) of 
1.285 as a volatile clear oil;  
1
H NMR for 1.285 (400 MHz, CDCl3) δ 5.93 (dd, J = 17.3, 
10.7 Hz, 1 H), 5.65-5.52 (m, 1 H), 5.39 (td, J = 15.4, 1.2, 1.2 Hz, 1 H), 5.18 (dd, J = 
17.3, 1.6 Hz, 1 H), 4.95 (dd, J = 10.7, 1.6 Hz, 1 H), 1.96-1.86 (m, 2 H), 1.86-1.76 (m, 2 
H), 1.40 (dd, J = 8.1, 1.3 Hz, 2 H), 1.31 (s, 6 H), -0.03 (s, 9 H); 
13
C NMR for 1.285 (101 
MHz, CDCl3) δ 145.0, 135.2, 123.7, 111.3, 83.3, 83.1, 37.6, 37.2, 28.5, 27.7, 22.4, -2.0; 
IR (neat) 2964.3, 1247.8 cm
-1
; HRMS (CI) m/z calculated for C14H27OSi (M+1) 
239.1831; found, 239.1830; mass spectrum, 167, 221 (base), 239. 
 
NMR ASSIGNMENTS FOR 1.285:  
1
H NMR for 1.285 (400 MHz, CDCl3) δ 5.93 (dd, J = 17.3, 10.7 Hz, 1 H, C8-H), 
5.65-5.52 (m, 1 H, C9-H), 5.39 (td, J = 15.4, 1.2, 1.2 Hz, 1 H, C7-H), 5.18 (dd, J = 17.3, 




1.86-1.76 (m, 2 H, C3-H), 1.40 (dd, J = 8.1, 1.3 Hz, 2 H, C11-H), 1.31 (s, 6 H, C5-H and 
C6-H), -0.03 (s, 9 H, C12-H); 
13
C NMR for 1.285 (101 MHz, CDCl3) δ 145.0 (C8), 135.2 
(C7), 123.7 (C9), 111.3 (C10), 83.3 (C4), 83.1 (C1), 37.6 (C2), 37.2 (C3), 28.5 (C5), 27.7 





 (3S,6S)-3,6-Bis(hydroxymethyl)-1-methylpiperazine-2,5-dione (2.221). (nb-7-
32).  Diisopropylethylamine (5.74 mL, 32.93 mmol) was added to a stirred suspension of 
Cbz-N-methyl-serine
195
 2.217 (2.78 g, 10.98 mmol), serine methylester 2.194 (1.88 g, 
12.08 mmol), and Castro’s reagent (5.86 g, 10.98 mmol) in anhydrous CH2Cl2 (30 mL) at 
-20 ºC. After 10 min at -20 ºC, the reaction mixture was warmed to room temperature and 
stirred for another 14 h, whereupon the solvent was removed under reduced pressure.  
The crude oil was dissolved in EtOAc (50 mL), and the solution was extracted with 
saturated aqueous NaHCO3 (25 mL).  The aqueous layer was extracted was extracted 
with EtOAc (3 x 20 mL).  The combined organic layers were extracted with 1 M HCl (2 
x 25 mL), brine (1 x 40 mL).  The organic layer was dried (MgSO4) and concentrated 
under reduced pressure.  The residue was purified by flash chromatography eluting with 




oil.  This was then dissolved in MeOH (200 mL) and put under argon atmosphere.  
Palladium on carbon (245 mg) was added in a single portion with rapid stirring, and the 
atmosphere was exchanged to hydrogen.  The reaction was stirred for 2 h, after which 
time all the starting material was consumed by TLC.  The solution was filtered and 37% 
NH4OH was added (14 mL).  The reaction was stirred for 15 h and concentrated under 
reduced pressure to a colorless oil.  The residue was triturated with EtOAc (2 x 10 mL) 
and Et2O (1 x 10 mL) and dried under hi-vac to give 1.28 g (62% based on 2.217) of 
2.221 as a mixture (1.0:0.2) of isomers as a white foam;  
1
H NMR for 2.221 (major 
isomer) (400 MHz, DMSO) δ 8.15 (s, 1 H), 5.16 (d, J = 4.5 Hz, 1 H), 5.02 (d, J = 4.5 Hz, 
1 H), 3.91-3.45 (comp, 6 H), 2.84 (comp, 3 H); 
13
C NMR for 2.221 (major isomer) (125 
MHz, DMSO) δ 165.8, 164.6, 64.4, 63.6, 60.6, 57.5, 31.9; IR (neat) 3285, 1633, 1471, 
1334 cm
-1
; HRMS (CI) m/z calcd for C7H13N2O4+ (M+1), 189.0875; found 189.0876; 
mass spectrum, 190, 189 (base), 187.   
 
NMR Assignments for 2.221 (major isomer): 
1
H NMR for 2.221 (major isomer) (400 MHz, DMSO) δ 8.15 (s, 1 H, N-H), 5.16 
(d, J = 4.5 Hz, 1 H, C6-OH), 5.02 (d, J = 4.5 Hz, 1 H, C7-OH), 3.91-3.45 (comp, 6 H, 
C3-H, C5-H, C6-H, C7-H), 2.84 (m, 3 H, C8-H); 
13
C NMR for 2.221 (major isomer) (125 









methylenepiperazine-2,5-dione (2.202) (nb-7-87).  Freshly distilled mesyl chloride (310 
mg, 0.21 mL, 2.66 mmol) was added dropwise over 1 min to a solution of 
diketopiperazine 2.221 (200 mg, 1.06 mmol), dry triethylamine (537.2 mg, 0.74 mL, 5.31 
mmol) in dry DMF (10 mL) at 0 ºC.  The reaction was let stir for 1 h at 0 ºC, after which 
time the mixture was a dark orange cloudy suspension.  The reaction was allowed to 
warm to room temperature and was stirred for 1 h.  The suspension was filtered through a 
cotton plug under nitrogen into a flask charged with N-benzyl-isatin 2.201 (754 mg, 3.18 
mmol), anhydrous K2CO3 (1.17 g, 8.48 mmol), and MgSO4 (510 mg, 4.24 mmol).  The 
suspension was stirred in darkness for 36 h, after which time all starting material was 
consumed by TLC.  The reaction mixture was filtered through a Buchner funnel into a 
flask containing 50% saturated aqueous NH4Cl (20 mL) and stirred for 10 min before 
CH2Cl2 (20 mL) was added.  The mixture was transferred to a separatory funnel and the 
layers were separated.  The aqueous layer was extracted with CH2Cl2 (2 x 20 mL), and 
the combined organic layers were dried (Na2SO4) and concentrated under reduced 
pressure.  The residue was purified by flash chromatography eluting with EtOAc/hexanes 
(30% to 70% gradient) to give 293 mg (71% based on 2.221) of 2.202 as a gray foam: 1H 
NMR for 2.202 (400 MHz, DMSO) δ 10.20 (s, 1 H), 7.61 (s, 1 H, C13), 7.40 (dd, J = 7.3, 




Hz, 1 H), 5.64 (d, J = 1.3 Hz, 1 H), 5.55 (s, 1 H), 5.17 (s, 1 H), 4.92 (d, J = 15.7 Hz, 1 H), 
4.84 (d, J = 15.7 Hz, 1 H), 3.19 (s, 3 H);
 13
C NMR for 2.202 (125 MHz, DMSO) δ 175.0, 
155.2,  154.5, 141.5, 136.4, 135.8, 130.9, 130.5, 129.9, 128.6, 127.4, 127.2, 124.2, 123.2, 
112.4, 109.8, 103.2, 76.6, 54.8, 30.1; IR (neat) 3299, 1633, 1693, 1610, 1384 cm
-1
; 
HRMS (CI) m/z calcd for C22H19N3NaO4+ (M+Na), 412.12678; found 412.12688; mass 
spectrum, 390, 412 (base), 413, 536.   
 
NMR Assignments for 2.202: 
1
H NMR for 1.202 (400 MHz, DMSO) δ 10.20 (s, 1 H, N-H), 7.61 (s, 1 H, C13-
H), 7.40 (dd, J = 7.3, 1.0 Hz, 1 H, C6-H), 7.38-7.19 (comp, 6 H, C4-H, C10-H, C11-H, 
C12-H), 7.07 (dt, J = 7.6, 7.6, 0.8 Hz, 1 H, C5-H), 6.93 (d, J = 7.8 Hz, 1 H, C7-H), 5.64 
(d, J = 1.3 Hz, 1 H, C18-H), 5.55 (s, 1 H, C18-H), 5.17 (s, 1 H, C2-OH), 4.92 (d, J = 15.7 
Hz, 1 H, C8-H), 4.84 (d, J = 15.7 Hz, 1 H, C8-H), 3.19 (s, 3 H, C19-H);
 13
C NMR for 
2.202 (125 MHz, DMSO) δ 175.0 (C1), 155.2 (C15),  154.5 (C17), 141.5 (C20), 136.4 
(C16), 135.8 (C9), 130.9 (C4), 130.5 (C7), 129.9 (C3), 128.6 (C11), 127.4 (C14), 127.2 
(C10), 124.2 (C5), 123.2 (C6), 112.4 (C12), 109.8 (C13), 103.2 (C18), 76.6 (C2), 54.8 








methylenepiperazine-2,5-dione (2.209) (nb-7-142).  Freshly distilled TMSOTf (19 µL, 
0.105 mmol) was added to a suspension of tertiary alcohol 2.202 (20 mg, 0.051 mmol) 
and 2,6-di-tert-butylpyridine (20.4 mg, 24 µL, 0.108 mmol) in dry dichloroethane.  The 
suspension was stirred for 1 h, after which time it became a homogenous solution.  The 
reaction was cooled to 0 ºC and indole (30 mg, 0.255 mmol) followed by TMSOTf (11.1 
mg, 9 µL, 0.051 mmol) were added.  After 30 min, the reaction was warmed to room 
temperature and stirred for 1.5 h until all the starting material was consumed by TLC, 
whereupon saturated aqueous NaHCO3 (10 mL) was added and the layers were separated. 
The aqueous layer was extracted with CH2Cl2 (4 x 10 mL), and the combined organic 
layers were dried (Na2SO4) and concentrated under reduced pressure.  The residue was 
purified by flash chromatography eluting with EtOAc/hexanes (40% to 50%) to give 17.7 
mg (71%) of 2.209 as a white solid: mp 154-156 ºC; 
1
H NMR for 2.209 (400 MHz, 
DMSO) δ 11.18 (d, J = 2.1 Hz, 1 H), 10.30 (s, 1 H), 7.49 (d, J = 2.6 Hz, 1 H), 7.45-7.39 
(comp, 2 H), 7.39-7.26 (comp, 5 H), 7.25-7.16 (comp, 2 H), 7.10-6.93 (comp, 2 H), 6.67-
6.57 (m, 1 H), 6.50 (d, J = 8.0 Hz, 1 H), 6.09 (s, 1 H), 5.56 (d, J = 1.1 Hz, 1 H), 5.09 
(comp, 3 H), 3.21 (s, 3 H);
 13
C NMR for 2.209 (125 MHz, DMSO) δ 177.3, 155.7, 154.9, 




123.6, 121.4, 118.9, 118.2, 112.9, 111.9, 110.0, 109.8, 102.7, 52.4, 30.2; IR (neat) 3328, 
1685, 1609, 1386 cm
-1
; HRMS (ESI) m/z calcd for C30H25N4O3+ (M+1), 489.19212; 
found 489.19215; mass spectrum, 183, 489, 511 (base).   
 
NMR Assignments for 2.209: 
1
H NMR for 2.209 (400 MHz, DMSO) δ 11.18 (d, J = 2.1 Hz, 1 H, N-H), 10.30 
(s, 1 H, indole-NH), 7.49 (d, J = 2.6 Hz, 1 H, C26-H), 7.45-7.39 (comp, 2 H, C23-H, 
C21-H), 7.39-7.26 (comp, 5 H, C10-H, C11-H, C12-H), 7.25-7.16 (comp, 2 H, C5-H, C6-
H), 7.10-6.93 (comp, 2 H, C24-H, C25-H), 6.67-6.57 (m, 1 H, C4-H), 6.50 (d, J = 8.0 Hz, 
1 H, C7-H), 6.09 (s, 1 H, C13-H), 5.56 (d, J = 1.1 Hz, 1 H, C18-H), 5.09 (comp, 3 H, C8-
H, C18-H), 3.21 (s, 3 H, C19-H);
 13
C NMR for 2.209 (125 MHz, DMSO) δ 177.3 (C1), 
155.7 (C15), 154.9 (C17), 140.9 (C20), 137.1 (C16), 136.8 (C22), 135.7 (C9), 134.0 
(C3), 130.5 (C6), 128.7 (C10), 128.6 (C14), 127.9 (C11), 127.8 (C27), 125.6 (C5), 124.2 
(C4), 124.0 (C21), 123.6 (C24), 121.4 (C25), 118.9 (C26), 118.2 (C7), 112.9 (C13), 









(2.222) (nb-7-224).  AlH3NEtMe2 (0.5 M in toluene, 167.4 mg, 0.2 mL, 0.102 mmol) was added 
dropwise over 5 sec to a solution of oxindole 2.209 (25 mg, 0.051 mmol) in dry THF (5 mL) at 0 
ºC.  The dark yellow solution was immediately quenched with AcOH (2 M, 3 mL).  The solution 
was stirred for 20 sec, whereupon water (5 mL) was added along with EtOAc (4 mL) and the 
layers were separated.  The aqueous layer was extracted with EtOAc (3 x 4 mL) and the 
combined organics were dried (Na2SO4) and concentrated under reduced pressure.  The 
residue was purified by preparative TLC eluting with 15% EtOAc/CH2Cl2 to give 12.9 
mg (54%) of 2.222 as a yellow solid: mp 169-171 ºC; 
1
H NMR for 2.222 (400 MHz, 
CD3CN) δ 9.27 (s, 1 H), 7.44-7.35 (comp, 3 H), 7.30-7.20 (comp, 3 H), 7.15-7.02 (comp, 
3 H), 6.99-6.93 (m, 1 H), 6.73 (ddd, J = 8.0, 7.0, 1.0 Hz, 1 H), 6.70-6.58 (comp, 3 H), 
6.53 (s, 1 H), 6.30 (s, 1 H), 5.65 (d, J = 1.4 Hz, 1 H), 4.99 (dd, J = 8.7, 7.3 Hz, 2 H), 4.77 
(d, J = 16.0 Hz, 1 H), 3.25-3.20 (s, 3 H);
 13
C NMR for 2.222 (125 MHz, CD3CN) δ 156.7, 
155.7, 150.7, 139.6, 139.4, 138.2, 133.5, 131.5, 129.6, 129.4, 128.7, 128.2, 125.9, 125.4, 
124.1, 123.3, 122.9, 120.3, 120.0, 199.5, 116.9, 112.7, 108.8, 102.6, 89.3, 59.7, 51.7, 
30.1; IR (neat) 3344, 1684, 1603, 1420 cm
-1
; HRMS (ESI) m/z calcd for C30H25N4O2 





NMR Assignments for 2.222: 
1
H NMR for 2.222 (400 MHz, CD3CN) δ 9.27 (s, 1 H, N-H), 7.44-7.35 (comp, 3 
H, C12-H, C26-H, C23-H), 7.30-7.20 (comp, 3 H, C11-H, C21-H), 7.15-7.02 (comp, 3 H, 
C10-H, C2-H, C4-H), 6.99-6.93 (m, 1 H, C25-H), 6.73 (ddd, J = 8.0, 7.0, 1.0 Hz, 1 H, 
C5-H), 6.70-6.58 (comp, 3 H, C5-H, C6-H, C7-H), 6.53 (s, 1 H, C1-H), 6.30 (s, 1 H, 
C13-H), 5.65 (d, J = 1.4 Hz, 1 H, C18-H), 4.99 (dd, J = 8.7, 7.3 Hz, 2 H, C8-H, C18-H), 
4.77 (d, J = 16.0 Hz, 1 H, C8-H), 3.25-3.20 (s, 3 H, C19-H);
 13
C NMR for 2.222 (125 
MHz, CD3CN) δ 156.7 (C15), 155.7 (C17), 150.7 (C20), 139.6 (C9), 139.4 (C16), 138.2 
(C22), 133.5 (C3), 131.5 (C14), 129.6 (C4), 129.4 (C11), 128.7 (C10), 128.2 (C12), 
125.9 (C6), 125.4 (C27), 124.1 (C5), 123.3 (C24), 122.9 (C25), 120.3 (C26), 120.0 
(C23), 119.5 (C7), 116.9 (C28), 112.7 (C21), 108.8 (C1), 102.6 (C18), 89.3 (C13), 59.7 




2,5-dione (2.245) (nb-7-241).  Osmium tetroxide (2.5% in butanol) (18.6 mg, 23 µL, 0.0017 
mmol) was added to a solution of diene 2.222 (32.5 mg, 0.069 mmol) and N-methylmorpholine 




0 ºC for 3 h, whereupon saturated aqueous sodium thiosulfate (4 mL) and EtOAc (5 mL) were 
added and the mixture was stirred at room temperature for 15 min before the layers were 
separated.  The aqueous layer was extracted with EtOAc (3 x 5 mL) and the combined 
organic layers were washed with pH 7 phosphate buffer containing 0.1% EDTA (2 x 6 
mL).  The organic layer was concentrated under reduced pressure and the crude diol was 
dissolved in acetone/H2O (3.5 mL).  2,6-Lutidine (16 µL, 0.138 mmol) and PhI(OAc)2 
(44.5 mg, 0.138 mmol) were added and the reaction was stirred 30 min before saturated 
sodium thiosulfate (4 mL) and EtOAc (5 mL) were added and the mixture was stirred at room 
temperature for 10 min before the layers were separated.  The aqueous layer was extracted 
with EtOAc (4 x 5 mL) and the combined organics were dried (Na2SO4) and concentrated to a 
volume of approximately 1 mL, whereupon the product was precipitated from solution 
with pentane (6 mL).  The suspension was filtered via Bucher funnel and collected to 
give 26.8 mg (82%) of 2.245 as a yellow solid: mp 167-170 ºC;
 1
H NMR for 2.245 (400 
MHz, DMSO) δ 11.14 (s, 1 H), 7.39-7.28 (comp, 3 H), 7.27-7.15 (comp, 3 H), 7.09 (m, 2 
H), 7.05-6.93 (comp, 3 H), 6.72 (d, J = 8.0 Hz, 1 H), 6.66-6.60 (comp, 3 H), 6.19 (s, 1 H), 
4.96 (d, J = 15.8 Hz, 1 H), 4.71 (d, J = 15.8 Hz, 1 H), 3.13 (s, 3 H); 
13
C NMR for 2.245 
(125 MHz, DMSO) δ 157.5, 157.2, 150.1, 149.0, 137.7, 136.8, 131.4, 129.4, 128.7, 
128.3, 127.6, 127.1, 126.4, 124.6, 124.4, 123.4, 121.2, 118.8, 118.7, 118.2, 114.4, 111.6, 
107.7, 87.2, 58.7, 49.8, 26.6; IR (neat) 3270, 1680, 1486, 1422 cm
-1
; HRMS (ESI) m/z 
calcd for C29H23N4O3 (M+1), 475.17647; found 475.17572; mass spectrum, 475, 497 






NMR Assignments for 2.245: 
1
H NMR for 2.245 (400 MHz, DMSO) δ 11.14 (s, 1 H, N-H), 7.39-7.28 (comp, 3 
H, C25-H, C22-H, C12-H), 7.27-7.15 (comp, 3 H, C11-H, C8-H), 7.09 (m, 2 H, C10-H), 
7.05-6.93 (comp, 3 H, C4-H, C23-H, C24-H), 6.72 (d, J = 8.0 Hz, 1 H, C20-H), 6.66-6.60 
(comp, 3 H, C1-H, C5-H, C7-H), 6.19 (s, 1 H, C13-H), 4.96 (d, J = 15.8 Hz, 1 H, C8-H), 
4.71 (d, J = 15.8 Hz, 1 H, C8-H), 3.13 (s, 3 H, C18-H);
 13
C NMR for 2.245 (125 MHz, 
DMSO) δ 157.5 (C16), 157.2 (C15), 150.1 (C17), 149.0 (C19), 137.7 (C9), 136.8 (C21), 
131.4 (C3), 129.4 (C14), 128.7 (C4), 128.3 C11, 127.6 (C10), 127.1 (C26), 126.4 (C6), 
124.6 (C12), 124.4 (C20), 123.4 (C5), 121.2 (C23), 118.8 (C24), 118.7 (C25), 118.2 
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